The effects of gestational exposure to endocrine-disrupting chemicals on the adult social behavior in male and female rats by Reilly, Michael Patrick
 
 
 
 
 
 
 
 
 
Copyright 
by 
Michael Patrick Reilly 
2018 
 
 
  
The Dissertation Committee for Michael Patrick Reilly Certifies that this is the 
approved version of the following Dissertation 
 
THE EFFECTS OF GESTATIONAL EXPOSURE TO ENDOCRINE-
DISRUPTING CHEMICALS ON THE ADULT SOCIAL BEHAVIOR 
IN MALE AND FEMALE RATS 
 
 
 
Committee: 
 
 
 
 
Andrea Gore, Supervisor 
 
 
 
David Crews 
 
 
 
Karen Vasquez 
 
 
 
Juan Dominguez 
 
 
 
John Richburg 
 
 
 
THE EFFECTS OF GESTATIONAL EXPOSURE TO ENDOCRINE-
DISRUPTING CHEMICALS ON THE ADULT SOCIAL BEHAVIOR 
IN MALE AND FEMALE RATS 
 
 
by 
Michael Patrick Reilly 
 
 
 
Dissertation 
Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Doctor of Philosophy  
 
 
The University of Texas at Austin 
May 2018 
Dedication 
 
This dissertation is dedicated to my wife, Mindy, and my parents, Mike and Pattie. Their 
love and support serve as the foundation for all of my achievements, now and always. 
 
 
 v 
Acknowledgements 
 
None of this would have been possible without the wealth of encouragement and 
guidance offered to me by my mentor, Andrea Gore. The persevering yet patient nature 
of her mentorship has cultivated in me a refreshing sense of assurance toward any and all 
future endeavors.  
I would also like to thank David Crews for showing me how to balance creative 
thought with experimental feasibility. The time he set aside to serve as the sole audience 
member during practice presentations has allowed me to develop public speaking skills I 
would have never achieved otherwise.           
To all past and present members of the Gore and Crews lab, your companionship 
through the years has allowed me to persevere through countless hours of 
experimentation and analysis. Dr. Margaret Bell, Dr. Weiling Yin, Dr. Jan Mennigen, Dr. 
Alexandra Garcia, and Dr. Viktoria Topper were all incredible colleagues that showed me 
how to succeed. More recently, thanks to Mandee Bell, Dr. Krittika Krishnan, Morgan 
Hernandez, and Nicole Kunkel for the camaraderie that has helped maintain my sanity 
during this final year. Through his statistical and programming prowess, Ross Gillette 
allowed me to analyze and visualize my data in ways I never considered.  I especially 
want to thank Lindsay Thompson for always keeping the ship afloat and offering her 
logistical expertise when designing and maintaining my own colony of animals. Without 
her help, I along with many others would not be able to see our plans to completion. 
Among all of the amazing undergraduate assistants we’ve had, I want to thank Connor 
Weeks and Andrew Zentay for their time with me. Most of this dissertation could not 
have been possible without their help and dedication.  
 vi 
Finally, I want to thank the members of my dissertation committee (Dr. Karen 
Vasquez, Dr. Juan Dominguez, and Dr. John Richburg) who have provided me years of 
valuable insight that has allowed me to better plan, execute, and prepare the work present 
in this dissertation.   
 vii 
Abstract 
 
THE EFFECTS OF GESTATIONAL EXPOSURE TO ENDOCRINE-
DISRUPTING CHEMICALS ON THE ADULT SOCIAL BEHAVIOR 
IN MALE AND FEMALE RATS 
 
Michael Patrick Reilly, PhD 
The University of Texas at Austin, 2018 
 
Supervisor:  Andrea Gore 
 
Endocrine disrupting chemicals (EDC) exposures during critical periods of 
development influence neuronal development and the manifestation of sexually 
dimorphic behaviors that emerge in adulthood. Among these behaviors, social 
information processing is sexually dimorphic and regulated by sex steroids. Oxytocin and 
vasopressin serve as primary neurotransmitters mediating these behaviors; these 
neuroendocrine circuits are hormone sensitive and potential targets of prenatal EDC 
exposures. In dissertation, I assess the effects of gestational exposure to EDCs on the 
social behavior of male and females later in adulthood. A weakly estrogenic PCB 
mixture, Aroclor 1221, was administered to pregnant Sprague-Dawley rat dams during 
the time when the hypothalamus undergoes sexual differentiation. The brains of these 
animals were also used to quantify the presence of oxytocin or vasopressin in the two 
main regions of production: the paraventricular nucleus (PVN) and the supraoptic 
nucleus (SON). Another experiment extended this treatment paradigm to encompass a 
longer period of gestational development, added another EDC treatment group 
 viii 
(Vinclozolin), and looked at similar behavioral outcomes. Lastly, I provide a novel way 
of modeling complex social behaviors in a laboratory setting. Through all of this work, 
we show that the sexes are differentially susceptible to endocrine disruption by PCBs or 
vinclozolin. Additionally, we provide evidence that the traditional choice models of 
social behavior in the rodent may not be reflective of how an animal behaves in a more 
complex, naturalistic, environment.  
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
ORGANIZATION AND ACTIVATION OF THE DEVELOPING BRAIN 
Throughout all of life, but particularly during the period of gestation, sex steroid 
hormones organize and sustain the developing brain in a sexually dimorphic manner 
(Phoenix et al. 1959). The functional differences between the sexes is established through 
specific signaling cascades which, in the case of the fetal male, are mediated by the 
binding of estrogen receptors (ERs) in the brain by circulating levels of testosterone 
(from the fetal testes) that is aromatized to estradiol in the brain. The result of this ER-
mediated mechanism is a masculinization and defeminization of the developing male 
brain. Without developing testes, fetal females do not produce sufficient concentrations 
of estradiol to initiate this signaling cascade, thus the neurodevelopmental trajectory is 
demasculinizing and feminizing (Roselli et al. 1985). The differences in this period of 
sexual differentiation is known as the organizational phase of development. The 
differences in the development (organization) of male and female brain during the 
perinatal period underlie the sexually dimorphic response to gonadal hormones in 
adulthood (activation). The organizational-activational hypothesis presented by Phoenix 
et al. was perhaps one of the most crucial finding in the study of sexual differentiation.  
Although the activational effects of gonadal hormones were reversible, the organizational 
effects during a “critical period” of development were permanent. 
EXAMPLES OF SEX DIFFERENCES IN THE BRAIN AND BEHAVIOR OF MAMMALS 
As determined by this critical period, the male and female developmental 
trajectories are forever altered. The physiological and morphological differences 
observed in the sexes are reflective of these changes. Not surprisingly, the area of the 
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brain where the highest degree of sex differences are observed are in the hypothalamic 
regions implicated in sexual and reproductive behaviors.   One such region, the sexually 
dimorphic nucleus of the POA (SDN) is up to five-times larger in male rats compared to 
females (Gorski et al. 1980). Additional, there is a direct relationship between the size of 
the SDN in males and the degree of sexual behavior, with female-oriented male rams 
having an SDN twice the size of rams with a demaculinized preference for a male, rather 
than a female, partner (Roselli et al. 2004). Lesions of the SDN in rats have abolished 
normal partner preferences in rats (Paredes et al. 1998). The mechanism by which this 
sex differences arises occurs during gestation when aromatase expressed in this region in 
males converts circulating testosterone to estradiol, which in turn inhibits programmed 
cell death (Ito et al. 1986). Females, lacking sufficient concentrations of testosterone 
during fetal development, proceed with the apoptotic event that results in the feminized 
morphology and, thus behavior. Another example of a sexually dimorphic hypothalamic 
region directly related to prenatal gonadal steroids is the anteroventral periventricular 
nucleus (AVPV), which contains an impressive concentration of kisspeptin neurons that 
are involved in the regulation of gonadotropin releasing hormone (GnRH) neurons and 
the onset of the LH surge in females. In contrast to the SDN, testicular hormones in males 
lead to a reduction of AVPV volume in adulthood compared to females. Perinatal 
castration sex-reversed AVPV volume in males (Davis et al. 1996). Aside from 
reproductive behaviors, social behaviors are also crucial for an individual’s fitness in the 
wild. The sexes differ in the response to olfactory cues (Bergvall et al. 1991, Aron et al. 
1979). Integral to the processing of social cues, the medial amygdala (MeA) is an extra-
hypothalamic brain region that is sexually dimorphic from both a structural and 
neurochemical perspective (Nishizuka et al. 1983, Hines et al. 1992). Driven by 
circulating androgens, castration decreases the volume in males, while treatment with 
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exogenous androgen increases the volume in females (Cooke et al. 1999). These 
examples illustrate the exquisite sensitivity to circulating sex steroid hormones. 
SOCIAL BEHAVIOR AND THE NEUROENDOCRINE SYSTEM 
The degree to which animals socialize amongst each other runs the gamut. On one 
extreme, there exist solitary animals that display a high level of territorial defense against 
others of the same species (conspecifics). In this case, tolerance for company is reserved 
for two events in the animal’s life: when mating, or when rearing young. On the other end 
of the spectrum exist highly social animals that share a living space and form 
communities. In mammals, high levels of complexity in the type and duration of the 
social interaction between each other can characterize social groups. Members of these 
communities must possess the ability to recognize and identify others and their 
emotional-state. With such complexities, there must be precise, delicate, and powerful 
mechanisms by which social information is processed. Specific genes and gene products 
that facilitate social behaviors are often sexually dimorphic, likely reflecting the 
differences in behavior we see amongst sexes. Among all the neurobiological systems, 
neuroendocrine mechanisms play a prominent role with Oxytocin (OT) and arginine 
vasopressin (AVP) appearing to be especially important (Donaldson et al. 2008, Lee et al. 
2008, Takanagi et al. 2005). The brain distribution of OT and AVP receptors and their 
genes have been linked to the presence or absence of monogamy and pair bonding in 
voles and deer mice (Ross et al. 2009). Thus, OT and AVP appear to be key regulators of 
the evolution and expression of different types of social systems. OT and AVP are, in 
turn, under control of gonadal hormones of which the synthesis and mode of action are 
sexually dimorphic. Since sex steroids directly regulate gene expression, gonadal 
hormones mediate specific activation of different genes that can affect different social 
 4 
behaviors, even when these behaviors are ultimately regulated by different 
neurotransmitter systems in different brain regions. (Choleris, 2008). Most research 
regarding the underlying neurobiological mechanisms behind social interactions is done 
on mice and rats in a laboratory setting. Both are polygynous (a mating system which 
involves one male and multiple females) species that have undergone extensive research 
regarding the difference in sex of their social behaviors and the underlying 
neurobiological mechanisms. 
In order to assess the behavior of an animal in a laboratory setting, the use of 
standardized testing procedures is critical. By far, the most used model of social behavior 
in the rodent uses a three-chamber testing environment which is made up of two back-to-
back scenarios that engage two separate and critical aspects of sociality (Moy et al. 
2004). In each scenario, a binary choice of immobile stimulus options allows an 
investigatory to observe how a mobile subject animal spends it’s time within a social 
context.  Typically, the first test pairs a non-social stimulus with a social stimulus to gain 
insight into the subject’s affiliative nature. In the case of rats, the expected phenotype is 
to spend more time near/interacting with the social stimulus compared to the empty cage. 
During this test, the subject acquires a sense of familiarity (habituation) to the conspecific 
used as the social stimulus. The next stage of the test takes advantage of this by 
introducing a novel stimulus animal. The expected phenotype in rats during this phase of 
testing is for the subject to spend more time affiliating with the novel conspecific over the 
familiar. While the first stage of testing only provides insight into the general affiliative 
nature of a subject, the second test also engages the subject’s social memory as well as 
discriminatory abilities. The ubiquitous nature of this paradigm and comparisons across 
studies allow investigators to assess the social implications of a variety of experimental 
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manipulations. Such experimental manipulation has implicated the importance of the OT, 
AVP, and gonadal steroids on social recognition and discrimination. 
The Influence of Estrogens On Social Discrimination 
Gonadal hormones have been shown to be involved in social recognition, with 
modulation occurring through OT and AVP systems. Generally, in female mice, social 
recognition is increased during proestrus, when estrogen (E) and progesterone (P) levels 
are high. Intuitively, this makes sense as increased social recognition would be beneficial 
or necessary when reproductively active. Ovariectomy (OVX) leads to decreased social 
recognition in both rats and mice, but treatment with E can recover the deficit (Tang, 
2005). Additionally, ERαKO and OTKO females are completely impaired, while 
ERβKO mice maintain some amount of discrimination (Choleris, 2006). Thus, ERα and 
OT appear to be necessary for social recognition, while ERβ only facilitates it. Since 
levels of OT and OT mRNA levels depend on the presence of E, it has been proposed that 
E controls social recognition through the OT system. OT and OT mRNA levels fluctuate 
with the estrous cycle in a manner consistent with the fluctuating levels of E. Similarly, 
OVX animals have reduced levels of OT and OT mRNA, however this is not a complete 
reduction. Administration of estrogens directly regulated OT production by increasing the 
excitability of OT-producing neurons in the PVN. This is probably mediated by ERβ 
since its expression in the PVN is much higher than ERα. More evidence for this exists in 
the fact that ERβKO male and females do not show increased levels of OT in the PVN 
when estrogens are administered. Baseline levels of OT and OT mRNA for the OT gene 
in the PVN are otherwise normal. The baseline OT may be involved in the decreased 
disruption of social recognition in ERβKO animals. Treatment with estrogens also 
increased OTR density (as well as transcription of the gene encoding for OTR) in the 
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medial amygdala; this is where OT mediates social recognition. ERα is highly expressed 
in the medial amygdala and is required for the induction of the OTR. ERβ is also highly 
expressed in this brain region, but it is not required for transcription of the OTR gene. 
Also, binding of OT to the OTR is independent of ERβ. This could explain why ERβKO 
animals are still able to perform in the social discrimination paradigm. RNA interference 
of the OTR gene in the medial posteriodorsal amygdala blocks social recognition.  
The basis of estrogenic control of OT-mediated social recognition has been placed 
on four genes in two brain areas; known as the micronet model (Choleris, 2003). The four 
genes involved in the model encode for ERα, ERβ, OT, and OTR. The two brain regions 
involved are the PVN and medial amygdala. There must be delicate interplay between 
these genes and regions to result in normal social recognition. Estrogens control OT 
production in the PVN through ERβ while also controlling the expression of the OTR 
gene in the medial amygdala, where socially relevant olfactory information is processed. 
Pharmacological studies looking at rapid activation of ERα and ERβ by using their 
respective agonists prior to behavioral testing showed increased social recognition in only 
animals treated with PPT (ERα agonist) and not DPN (ERβ agonist) (Phan, 2011). This 
suggests that ERβ does not affect social recognition when acting through rapid, non-
genomic means. It also suggests that PPT activated (MAPK)-dependent signaling 
cascades, which are involved in synaptic plasticity and the formation of new memories 
(Thomas, 2004). The rapid effects of PPT are also seen in other forms of learning, so this 
is not specific to social recognition.  
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The Influence of Androgens on Social Discrimination 
Androgens are also suggested to play a role in social recognition. When exposed 
to a previously encountered juvenile animal, intact males only exhibit habituation when 
the second exposure is less than 60 minutes after the first. However, females and 
castrated males still exhibit habituation when the second exposure was three hours later. 
This suggests that intact males are less able to recognize familiar conspecifics. There 
exists a transient decreased in social recognition in castrated males post-castration that is 
fully recovered if the animals are tested 2-3 weeks post-surgery. Overall, androgens are 
indicated in being involved in social recognition, however the effects of castration 
depend on the timing of the testing as well as how many times the animals were tested 
post castration.  
Prenatal treatment with the androgen receptor (AR) antagonist flutamide did not 
affect social recognition in male rats. Thus, if testosterone (T) regulates social recognition 
in male rats, it does not do so via AR-mediated developmental effects. Studies in mice 
show an involvement of T on social recognition through estrogenic mechanisms 
(Pierman, 2008). Aromatase knockout (ArKO) male mice, with a mutated cyp19 gene 
resulting in an inability to aromatize T to E, have impaired social recognition. This 
suggests that the impairment of social recognition in the ArKO mice was due to 
activational and not organizational effects of the gene KO. ArKO males with impaired 
social recognition also had high levels of T, which could lead to two different 
interpretations. One possibility is, simply, E is important for social recognition in males. 
The other being that T’s activation of the AR impairs social recognition. More extensive 
studies regarding the role of T and AR in social recognition are required to further clarify 
this relationship.   
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With AVP expression being much higher in males, androgen effects on social 
recognition is likely mediated by AVP and regulated by circulating T.  Castration reduces 
AVP in several limbic brain areas in a manner that can be reversed by treatment with 
testosterone. Brain areas where AVP neurons are T-dependent are the BNST and the 
medial amygdala, which both project to the LS where AVP action is required for social 
recognition in males. Thus, AVP-enhancing effects of T may be mediated by its 
aromatization to estrogens. ArKO males had reduced AVP in the medial amygdala, LS, 
BNST, and the SON (Pierman, 2008).  
Studies with ERαKO and AR-mutated mice suggest that both ERα and AR 
contribute to AVP expression in the limbic system (Scordalakes, 2004).  In mice, 
estrogens induce a reduction of AVP in the PVN, which is opposite to the estrogen-
induced release of OT in the PVN. This effect was suppressed in ERβKO mice, 
suggesting a dual and opposite role of ERβ on OT and AVP synthesis in the PVN. 
Females and castrated males (who have a reduction in AVP projections from both the 
BNST and medial amygdala to the LS) still display social recognition that is not 
dependent on the AVP as evident by no change when subjected to an agonist or 
antagonist for the AVP receptors. AVP dependence of social recognition can be restored 
only in castrated males by treatment with T. Thus, it seems that, while treatment with T 
and E-dependent AVP mediates social recognition in male rats and mice, AVP is not 
essential for social recognition and alternate pathways can mediate the behavior when 
this pathway is disrupted. 
Complex involvement of OT, AVP their receptors, as well as sex steroid 
modulation serve as the bases for the complexities we can observe in social behavior in 
animals. With sex differences in AVP expression and sex hormone production, we can 
begin to infer mechanisms regarding the different emergent behaviors seen amongst 
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males and females. With a further understanding of the intricacies involved in the 
relationships between the brain, hormones, and behavior, it will be possible to develop 
more nuanced behavioral paradigms that aim toward a more naturalistic approach. As the 
mechanisms underlying social behavior become clearer, it will allow development of 
potential therapies aimed at improving deficits seen in various aspects of social behavior. 
In fact, Larry Young’s lab at Emory University has been interested in developing a model 
for the autism spectrum disorder (ASD) by employing a genetically modified prairie vole. 
While pharmacological treatments for ASD do not yet exist on the market, this system 
appears a likely prospect as an avenue by which therapies for disruptions in social 
behaviors may be addressed. 
ENDOCRINE-DISRUPTING CHEMICALS 
 For better or worse, Earth is subject to the innovations of it’s inhabitants. 
Through decades of agricultural, industrial, and technological advancements, humans 
have made a mark on this planet at the cost of environmental contamination. One such 
class of chemical contaminants are endocrine-disrupting chemicals (EDCs), which are 
defined as an “an exogenous chemical, or mixture of chemicals, that interferes with any 
aspect of hormone action” (Gore et al. 2014). Particular to the chemical properties of any 
one EDC, biological action is mediated through a variety of mechanisms which may 
produce adversities in developmental, reproductive, cardiovascular, metabolic, and 
immune function in humans (Schug et al. 2011). Implicated in the mechanism of action 
of many EDCs are the wide-spread thyroid, androgen, or estrogen -sensitive tissues, 
interference of which can lead to functional changes in receptor signaling and/or 
circulating concentrations of steroid hormones (Dickerson and Gore 2007; Bellingham et 
al. 2012). EDCs also have been shown to exert effects not directly mediated via steroid 
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receptor systems, but also through interference with neurotransmitter systems, steroid 
metabolism, or steroidogenic enzyme function (Diamanti-Kandarakis et al. 2010).   
Polychlorinated Biphenyls (PCBs) and Vinclozolin (VIN) 
 PCBs are a ubiquitous and mixture of EDCs that have contaminated the 
environment after decades of industrial use as a lubricating and insulating compound. 
Although PCB usage was banned in America in 1979, these organochlorides are known 
to persist in the environment and still pose equal or, due to bioamplification, greater risks 
to the environment and its inhabitants. Exposure via ingestion or inhalation has led to 
detectible levels of PCBs found in humans, particularly in those living in densely 
populated urban areas (Sun et al. 2007). Through human epidemiological studies, there 
have been linkages between exposure to mixtures of PCBs and various health adversities, 
including decreased performance on standardized testing in children born of mothers 
around the Great Lakes region, where there is an increased incidence of PCB-
contaminated fish consumption (Stewart et al 2008). The specific actions of PCBs depend 
highly on the degree of chlorination, which has an influence on the overall structure (and 
function) of the molecule (Giesy and Kannan 1998). One class, dioxin-like PCBs, exert 
their toxic effects primarily through the aryl hydrocarbon receptor (AhR) system (Zhang 
et al. 2012). Non-dioxin-like PCBs do are not processed by the AhR but rather induce 
their effects on the neuroendocrine systems, and it is these congener mixtures which have 
been implicated in interference the neuroendocrine system via estrogenic mechanisms 
(Arcaro et al. 1999, Shekhar et al. 1997). Aroclor 1221 (A1221) is the trade name of one 
such non-dioxin-like PCB mixture which is known to have estrogenic properties. This 
dissertation will focus on A1121 which has been shown to interfere with brain 
mechanisms that modulate anxiety, social, and reproductive behavior in adulthood 
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(Steinberg et al. 2007, Dickerson et al. 2011, Walker et al 2012, Topper at al. 2015, 
Reilly et al. 2015, Gillette et al 2017).  
Vinclozolin (VIN) is another compound classified as an EDC. This Fungicide is 
still widely used on food crops destined for human consumption (Cabras and Angoni 
2000). Through experimentation in the laboratory, VIN has been classified as an anti-
androgenic EDC. In rodent studies, exposure to VIN has been shown to result in 
alterations of mechanisms and behaviors mediated by the androgen receptor resulting in 
morphological abnormalities in both male and female rodents exposed during gestation 
(Ostby et al. 1999, Crews et al. 2000, Wolf et al. 2000, Buckley et al. 2006).  
 
EDCS AND SOCIAL BEHAVIOR 
There is a growing body of literature that correlate developmental perturbations 
via EDCs on the acquisition and manifestation of appropriate social behaviors. In 
particular, exposure to bisphenol A (BPA), phthalates, and PCBs have resulted in 
measurable differences in social behaviors in rodents. Pre or Perinatal exposures to BPA 
resulted in reduced territorial marking in male mice (Williams et al. 2013), altered 
novelty preference (Wolstenholme et al. 2013), reduced play and social grooming in 
females (Porrini et al. 2005), but increased play in males (Farabollini et al. 2002). Rats 
exposed to phthalates displayed abnormal social behaviors (BPP; Betz et al. 2013) and a 
reduction in copulatory behavior in both sexes (DBP, DINP, DEHA; Lee et al. 2006). 
Rats exposed to PCBs (congener 77) showed a decreased preference for maternal-
associated cues, but no impact on novel (odor) preference(Cromwell et al. 2007). Rats 
given a mixture of PCBs (congeners 47 and 77) prenatally showed impairments in social 
recognition (Jolous-Jamshidi et al.  2010). For the most part, many of the social 
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behavioral outcomes associated with BPA, Pthalate, or PCBs are sex-specific, suggesting 
that the sexes may be differentially susceptible. 
In general, the processes that govern the sex differences in the brain and behavior 
of mammals is sensitive to the actions of hormones during development. This critical 
period is particularly sensitive to the actions of EDCs and there is a growing body of 
literature that have shown how EDC interference may lead to life-long alterations in adult 
social behavior.  
 
SUMMARY OF DISSERTATION EXPERIMENTS AND OVERARCHING HYPOTHESIS 
This dissertation aimed to develop an in-depth behavioral characterization of 
animals exposed to EDCs during these critical periods of sexual differentiation during 
embryonic development. Observing both sexes allowed me to determine where the sexes 
differ in their behavior and test the overarching hypothesis that these sex differences 
present dissimilar susceptibilities to endocrine disruption. 
Chapter 2 tested the hypothesis that prenatal exposure to PCBs lead to 
observable changes in the adult social behavior in male and female rats.  
Here, I presented pregnant rats with one of two low-dose (biologically relevant) 
intraperitoneal injections of PCBs during the time when the hypothalamus was 
undergoing sexual differentiation. Following parturition, offspring were monitored for 
somatic and sexual development. After puberty, the animals were tested in the three-
chamber social test to see if PCB exposure led to any changes in affiliative or 
discriminatory behavior by using same-sex gonadectomized conspecific stimulus 
animals.  
 
 13 
Chapter 3 examined whether other EDCs and a longer duration of exposure 
affect social behaviors.  
In addition to the inclusion of another EDC (Vinclozolin) this chapter allowed to 
me see if a longer duration of EDC exposure led to outcomes that differed from the 
dosage paradigm presented in chapter 2. Although the social behavioral testing paradigm 
used here was the same as chapter 2, this chapter used same-sex intact stimulus animals.  
 
Chapter 4 presented a novel social environment in order to determine if the 
complex social setting provides further insight into the behavioral differences due to 
PCB exposure 
This chapter used the same dosage paradigm as chapter 2, but here I present a 
novel behavioral paradigm that doubles the number of stimulus choices available to the 
experimental animal. This allowed me to determine the influence of both sex and 
hormone on the affiliative properties of an animal exposed to PCBs during gestation.  
Chapter 5 tested whether changes in behavior due to prenatal PCBs resulted 
in changes in the brain. 
Using the brains of the animals that were behaviorally characterized in chapter 2, 
this chapter looks at the paraventricular and supraoptic nucleus (PVN and SON) of both 
sexes to see if any alterations in behavior can be related to the amount of oxytocin or 
vasopressin in the main sites of synthesis. 
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CHAPTER 2: THE EFFECTS OF PRENATAL PCBS ON ADULT 
SOCIAL BEHAVIOR IN RATS  
The text in this section is excerpted from Reilly MP, Weeks CD, Topper VY, 
Thompson LM, Crews D, Gore AC, Hormones and Behavior (2015), with permission 
from the journal. As first author, I was involved with all of the experimentation, analysis, 
and preparation of the manuscript. 
ABSTRACT  
Endocrine disrupting chemical (EDC) exposures during critical periods of 
development may influence neuronal development and the manifestation of sexually 
dimorphic sociability and social novelty behaviors in adulthood. In this study, we 
assessed the effects of gestational exposure to PCBs on the social behavior of males and 
females later in adulthood. A weakly estrogenic PCB mixture, Aroclor 1221 (A1221, 0.5 
or 1 mg/kg) was administered to pregnant Sprague-Dawley rat dams. Both a positive 
control (estradiol benzoate; EB, 50 μg/kg) and negative control (dimethylsulfoxide; 
DMSO in sesame oil vehicle) were similarly administered to separate sets of dams. The 
sexes responded differently in two tasks essential to sociality. Using a three-chamber 
apparatus that contained a caged, same-sex, gonadectomized stimulus animal and an 
empty stimulus cage, we found that both sexes showed a strong preference for affiliating 
with a stimulus animal (vs. an empty cage), an effect that was much more pronounced in 
the males. In the second task, a novel and a familiar stimulus animal were caged at 
opposite ends of the same apparatus. Females displayed a higher degree of novelty 
preference than the males. During both tests, females had significantly higher social 
approach behaviors while male engaged in significantly more interactive behaviors with 
the conspecific. Of particular interest, males born of dams that received prenatal A1221 
(0.5 mg/kg) exhibited an overall decrease in nose-to-nose investigations. These 
behavioral data suggest that the males are more sensitive to A1221 treatment than are 
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females. In addition to behavioral analysis, serum corticosterone was measured. Females 
born of dams treated with A1221 (0.5 mg/kg) had significantly higher concentrations of 
corticosterone than the DMSO female group; males were unaffected. Females also had 
significantly higher corticosterone concentrations than did males. Overall, our results 
suggest that the effects of gestational exposure to PCBs on adult social behavior are 
relatively limited within this particular paradigm. 
 
INTRODUCTION 
Prenatal exposure to endocrine disrupting chemicals (EDCs) can disrupt the 
neuroendocrine system, leading to alterations in adult social and sociosexual behaviors in 
a sexually-dimorphic manner. Most research has been conducted for bisphenol A (BPA), 
exposure to which causes a decrease in the territorial marking of male mice (Williams et 
al. 2013), as well as female-specific alteration of one-on-one social interactions in 
juvenile mice (Wolstenholme, 2011) and prairie voles (Sullivan et al. 2014). BPA also 
perturbs social recognition in mice (Wolstenholme, Goldsby, and Rissman 2013). 
Exposure to other EDCs such as atrazine (mice: Belloni et al., 2011), PCBs (rats: Jolous-
Jamshidi et al., 2010), and chlorpyrifos (mice: Venerosi et al., 2012) are associated with 
perturbations of normal social interactions. Polychlorinated biphenyls (PCBs) - including 
the Aroclor 1221 mixture (A1221) used in the current study – also disrupt sexual 
behavior in female rats (Chung and Clemens, 1999; Steinberg et al., 2007). However, 
beyond this work, studies of EDC effects on social affiliation (individual preference to 
associate with a conspecific) and social novelty (individual choice to affiliate with a 
strange versus a familiar conspecific) are limited. Research has shown sex differences in 
these behaviors, as male rats tend to spend more time interacting with an unfamiliar, 
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same-sex conspecific than do females (Carrier and Kabbaj 2012; Slamberová et al. 2011; 
Stack et al. 2010). However, to our knowledge there are no studies investigating the 
effects of gestational exposure to PCBs on this paradigm.      
 
The purpose of this study was to provide a thorough characterization of the social 
behavioral phenotype caused by gestational EDC exposure. We assessed how treatment 
of a pregnant rat dam with A1221 during the third trimester of gestation affected the 
social behavior of male and female offspring later in adulthood. Two dosages of A1221 
(0.5 and 1 mg/kg) were administered during the last trimester of gestation, during a 
critical period of sexual differentiation of the hypothalamus (Davis, Popper, and Gorski 
1996; Jacobson et al. 1980). Both positive control (estradiol benzoate; EB) and negative 
control (DMSO vehicle) groups were used for comparison. Using this model, we were 
able to address hypotheses about sex differences in performance in two types of socially 
relevant tests, and to test the hypothesis that prenatal exposure to EDCs in these 
responses would have sex-specific effects. Because it is known that male and female rats 
differ in their basal concentrations of corticosterone (Kitay, 1961; Gillette et al., 2014) 
and, further, that circulating levels of corticosterone influences social behaviors in rats 
(Veenit et al. 2013), we also measured concentrations of this hormone in our 
experimental rats. 
 
MATERIALS AND METHODS 
Experimental Design.  
Sprague-Dawley rats were purchased from Harlan Sprague-Dawley (Houston, 
TX), and all animal procedures were conducted in compliance with protocols approved 
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by IACUC at the University of Texas at Austin. They were housed in a colony room with 
controlled temperature (22 C) and light cycle (12:12 dark:light, lights on at 2400). Virgin 
females were mated with sexually experienced males. The day following successful 
mating, as indicated by a sperm-positive vaginal smear, was termed embryonic day 1 
(E1). Male and female stimulus rats were purchased as young adults from Harlan, and 
gonadectomized under isoflurane anesthesia. Stimulus animals were not treated with 
EDCs or vehicle. 
 
Pregnant rats were exposed to one of four treatments, administered via 
intraperitoneal injections, on E16 and E18, the beginning of the period of brain sexual 
differentiation(Davis, Popper, and Gorski 1996; Jacobson et al. 1980). The dosages used 
were based on prior work conducted in the Gore lab that showed physiological, 
behavioral, and neuroendocrine effects (Steinberg et al., 2007, 2008; Dickerson et al., 
2011a; Walker et al., 2013, 2014): (1) Vehicle (3% DMSO/sesame oil mix), (2) Estradiol 
benzoate (EB; 50 μg/kg), (3) Aroclor 1221 (A1221, 0.5 mg/kg), or (4) A1221 (1 mg/kg). 
The number of litters per treatment was 11, 11, 10, and 10, respectively. Although we did 
not measure body burden or tissue content in the exposed offspring, the literature 
suggests that maternal-fetal transfer results in an exposure to approximately 1-2 μg/kg 
A1221, and 100 ng/kg EB, in the fetuses (Takagi et al., 1986). 
 
The day of parturition was called postnatal day 0 (P0). At P1, the newborn pups 
were weighed and their anogenital distance measured; litters were culled to 4 males and 4 
females. The pups were monitored daily for eye opening, while body weights and 
anogenital distance were taken weekly following birth. The pups were weaned at P21 and 
rehoused in same-sex groups where they were monitored daily for signs of pubertal 
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development: vaginal opening in females and preputial separation in males (Steinberg, 
Juenger, and Gore 2007; Walker et al. 2012). Following vaginal opening, daily vaginal 
smears were taken and cell cytology was examined as a measure of estrous cyclicity in 
the females. Beginning at P60 animals were subjected to a battery of the following tests 
in random order: sociability and social novelty, mate preference, open field and elevated 
plus maze; fear conditioning always was the last test. The total number of behaviorally 
characterized animals was 82 females and 80 males. Order of testing had no effect on 
behavioral outcomes. Experimental rats were weighed and euthanized 30 days after 
testing was completed, and bloods centrifuged and frozen for hormone assay, and 
adrenals and gonads removed and weighed.    
 
Hormone Radioimmunoassay 
Around P90, animals were euthanized by rapid decapitation and trunk blood was 
collected; females were euthanized in proestrus. In addition, animals from the same litters 
that were not behaviorally tested were used to increase sample size; this resulted in a total 
number of 158 females and 153 males. 10 μl of sample from each individual was used to 
measure serum corticosterone concentration in a single non-human radioimmunoassay 
(MP Biomedicals; Corticosterone 3H RIA - 07120002). Assay sensitivity was 7.7 ng/ml, 
and intra-assay variability was 4.1%.  
 
Behavioral Paradigm  
A three-chamber social apparatus (100 cm x 100 cm; Stoelting, Figure 2.1) was 
used as the testing arena (Crews et al. 2012; Moy et al. 2004). Testing was conducted 
under dim red light during the dark period of their light-dark cycle, approximately two 
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hours following lights out. The experimental animal was placed in the middle chamber of 
the apparatus, with doors to the two side chambers closed. For females, estrous cycle 
status on the day of testing was recorded to identify any potential differences relating to 
the behaviors examined. Same-sex gonadectomized stimulus animals were placed in a 7 
cm x 15 cm cylindrical stimulus cage located in a corner of the lateral chambers; bars 
allowed for nose-to-nose investigation but did not permit further contact.  
Sociability and Social Novelty.  
A five minute habituation period was used to allow the experimental rats access to 
the center chamber only. The doors were then opened and the experimental animal 
allowed to freely move around the entire apparatus for the two ten minute periods. All 
behaviors were video recorded throughout the testing. The entire apparatus was 
dismantled and all surfaces wiped clean with a 70% ethanol solution between each test.   
During the first Sociability test, one of the stimulus cages, randomly selected, held a 
novel same-sex (untreated by EDCs, and gonadectomized in adulthood) rat while the 
other stimulus cage remained empty (Figure 2.1A). At the test’s conclusion, the 
experimental animal was removed from the apparatus and temporarily placed in a holding 
cage. The original stimulus rat, and a novel same-sex, gonadectomized stimulus animal, 
were each placed into stimulus cages and were randomly placed into opposite sides of the 
testing arena. The experimental animal was then reintroduced to the center chamber, 
marking the beginning of Social Novelty. The experimental animal was then allowed to 
interact with the now-familiar and novel stimulus animals for ten minutes (Figure 2.1B).  
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Figure 2.1: The Three-
Chamber Apparatus 
A diagram of the 3-chamber 
apparatus, with a 
representative tracking 
profile from Any-Maze for 
an individual rat, is shown 
for the Sociability (A) and 
Social Novelty (B) tests. In 
Sociability (A), the stimulus 
rat (Stim 1) was a same-sex, 
gonadectomized rat, and the 
other cage was empty. In 
Social Novelty (B), the same 
animal (Stim 1) was used 
again as the familiar rat, 
together with an unfamiliar 
same-sex, gonadectomized 
rat in the other cage (Stim 2). 
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AnyMaze (Stoelting Co.) was used to track behaviors. Automated computer-
scored measures were: total distance travelled, and average speed throughout the entire 
apparatus. The time in proximity (defined as one body length) to the stimulus cage was 
also determined by the program. The video recordings of the tests were manually scored 
for the following behaviors: nose touching (the time each experimental animal spent in 
direct nose-to-nose contact with the stimulus animals), stimulus rat investigation (the 
time spent investigating the stimulus animal, but not necessarily nose-touching), 
grooming (time spent self-grooming), and rearing (time spent on hind legs without 
support from any walls).  
 
Statistical Analyses 
Because of non-homogeneity of behavioral datasets, the Kruskal-Wallis test was 
used to compare effects of treatment within sexes. A generalized extreme studentized 
deviate (ESD) test was used to detect outliers, limited to a maximum of two per group. 
Any animals that were outstanding outliers across multiple endpoints were removed from 
the analyses. Posthoc analyses included t-test for sex effects, Tukey HSD for treatment 
effects within sexes, or Steel-Dwass for treatment effects within sexes when the data did 
not satisfy the assumptions for parametric analyses. Cohen’s d analysis was used to 
determine the effect size, within each group, for the Social Novelty data. An effect size of 
0.8 or higher is equivalent to Cohen’s standard LARGE, and indicates that the mean of 
the control group (Familiar) is at the 79th percentile and sharing 69% overlap with the 
comparison group (Novel). The hormone data were homogeneous and a two-way 
ANOVA identified main effects of treatment and sex; subsequent one-way ANOVA was 
performed to determine the effects of treatment within sexes. Initial statistical analyses 
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were used to identify any potential cohort or litter effects within groups; none were 
identified, and therefore, analysis was conducted using individuals within a litter as 
separate datapoints (no more than 2 per sex per litter). This resulted in 10-11 litters per 
treatment, with 20-22 males and 20-22 females per endpoint for behaviors. 
 
RESULTS 
There were no significant effects of female estrous cycle status, corticosterone 
concentration, litter, or cohort on any of the behavioral measures examined for 
Sociability or Social Novelty.  
 
Corticosterone 
A two-way ANOVA indicated a sex difference (F1, 312 = 114.01, p < 0.0001), with 
females having a significantly higher serum concentration than males (Figure 2.2). 
Subsequent analyses of effects of treatment within each sex showed significant 
differences in females (F3,154 = 4.13, p < 0.009); a Tukey HSD post hoc test found the 
A1221 (0.5 mg/kg) group to have significantly higher corticosterone concentrations than 
the DMSO group. There were no significant differences among the male treatment 
groups. 
 
 
 
 
 23 
0
500
1000
Co
nc
en
tra
tio
n 
(n
g/
m
l)
Females Males
DMSO EB A1221
(0.5mg/kg)
A1221
(1mg/kg)
DMSO EB A1221
(0.5mg/kg)
A1221
(1mg/kg)
Serum Corticosterone
N = 43 N = 42 N = 37 N = 36 N = 38 N = 47 N = 36 N = 38
*
 
 
 
 
 
 
 
 
 
Figure 2.2: Serum Corticosterone Concentration For Both Sexes 
Circulating concentrations of corticosterone are shown for adult males and females 
receiving prenatal exposure to the vehicle (DMSO), estradiol benzoate (EB) or Aroclor 
1221 (A1221, 0.5 or 1 mg/kg). Females had significantly higher corticosterone 
concentrations than males (p < 0.0001). Within females, A1221 (0.5 mg/kg) rats had 
significantly higher concentrations of serum corticosterone than the DMSO females. Data 
shown are mean + standard error, with individual values shown as circles. *, p < 0.05. 
N’s are indicated below each bar. 
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Body weight 
A Student’s t-test indicated that males (  = 415 g) weighed significantly more 
than females (  = 264 g), regardless of treatment (p < 0.0001). A one-way ANOVA 
within each sex revealed that rats that were prenatally treated with either dosage of 
A1221 had significantly greater body weight (p < 0.001) at the age at euthanasia (~P90; 
Table 2.1).  
 
Adrenal gland weight 
 A two-way ANOVA (Sex x Treatment) indicated a main effect of sex, with 
females (   = 0.06 g) having heavier adrenals than males (  = 0.05 g), regardless of 
treatment (p < 0.0001; Table 2.1). However, there were no significant effects of treatment 
on adrenal weight in either sex.  
 
Gonad weight 
One-way ANOVA within each sex indicated no effect of treatment on ovarian 
weight in females, or testicular weight in males (Table 2.1). 
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Table 2.1: Somatic Measures in Prenatally Exposed Rats 
Body weight, adrenal weight, and gonad weight were sexually dimorphic. Prenatal 
treatment with vehicle (DMSO), estradiol benzoate (EB), and Aroclor 1221 at 0.5 or 1 
mg/kg did not affect these endpoints. Data shown are mean + SEM. 
 
Measure Sex Treatment Mean Sex Diff. 
DMSO 257 ± 4
EB 263 ± 3
A1221 (0.5) 270 ± 2
A1221 (1) 265 ± 3
DMSO 400 ± 9
EB 413 ± 6
A1221 (0.5) 427 ± 7
A1221 (1) 419 ± 4
DMSO 0.057 ± 1.7 x 10-3
EB 0.059 ± 1.8 x 10-3
A1221 (0.5) 0.065 ± 2.5 x 10-3
A1221 (1) 0.062 ± 1.5 x 10-3
DMSO 0.048 ± 1.4 x 10-3
EB 0.05 ± 1.1 x 10-3
A1221 (0.5) 0.049 ± 1.2 x 10-3
A1221 (1) 0.052 ± 2.1 x 10-3
DMSO 0.13 ± 4.7 x 10-3
EB 0.13 ± 4.0 x 10-3
A1221 (0.5) 0.13 ± 3.7 x 10-3
A1221 (1) 0.13 ± 5.0 x 10-3
DMSO 4.0 ± 5.0 x 10-2
EB 4.2 ± 6.5 x 10-2
A1221 (0.5) 4.0 ± 5.7 x 10-2
A1221 (1) 4.1 ± 5.0 x 10-2
Males
Adrenal gland 
weight (g)
N/A
N/A
F < M             
p < 0.0001
F > M             
p < 0.0001
Females
Males
SEM
Gonad weight (g)
Females
Males
Body weight (g)
Females
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Sociability Test 
Sociability tests were completed on 82 females and 80 males. Three animals (all 
male) that never entered the chamber containing the stimulus animal during the first stage 
(Sociability) had to be excluded, as they had never interacted with the animal and could 
therefore not distinguish a novel from a familiar conspecific. The computer-generated 
data for the diagnostic behaviors of the Sociability tests are shown in Table 2.2A, and 
investigator-scored data related to behaviors that took place in proximity to a stimulus 
animal are shown in Table 2.3A. Main effects of sex were determined by grouping the 
treatment groups within each sex and running a Student’s t-test, with results shown in 
Tables 2.2A and 2.3A. Females traveled a greater distance, were faster, and engaged in 
more grooming and rearing than males. Males had longer latencies to investigate the 
stimulus animal and to engage in the first nose touch, than did females. Males also spent 
more time investigating the stimulus animal and nose touching than females. The sexes 
were equivalent in time spent in proximity to the stimulus rat. Although rats spent more 
time in the chamber containing a stimulus animal than the empty chamber, regardless of 
sex or treatment (H = 197.40; p < 0.0001), within each sex there were no treatment 
effects. Two representative behaviors are shown in Figure 2.3 for latency to investigate 
the stimulus animal, and time spent nose touching, illustrating the sex difference but no 
significant treatment effects.  
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Measure Sex Treatment Mean Sex Diff. Measure Sex Treatment Mean Sex Diff.
DMSO 53.0 ± 2.6 DMSO 46.6 ± 2.3
EB 53.0 ± 2.2 EB 48.4 ± 3.1
A 0.5 52.0 ± 2.6 A 0.5 45.5 ± 2.4
A 1.0 57.4 ± 4.7 A 1.0 48.6 ± 2.6
DMSO 37.7 ± 2.8 DMSO 33.9 ± 2.1
EB 48.4 ± 4.9 EB 33.7 ± 2.2
A 0.5 46.0 ± 2.4 A 0.5 41.0 ± 3.0
A 1.0 39.0 ± 2.4 A 1.0 36.6 ± 2.2
DMSO 8.8 ± 0.4 DMSO 7.9 ± 0.4
EB 8.9 ± 0.3 EB 8.1 ± 0.5
A 0.5 8.7 ± 0.4 A 0.5 7.6 ± 0.4
A 1.0 9.6 ± 0.8 A 1.0 8.1 ± 0.4
DMSO 6.3 ± 0.4 DMSO 5.6 ± 0.3
EB 8.1 ± 0.8 EB 5.6 ± 0.4
A 0.5 7.7 ± 0.4 A 0.5 6.9 ± 0.4
A 1.0 6.3 ± 0.4 A 1.0 6.1 ± 0.4
DMSO 6.6 ± 1.2 DMSO 13.8 ± 2.1
EB 8.1 ± 1.9 EB 15.4 ± 2.7
A 0.5 6.3 ± 1.3 A 0.5 16.5 ± 2.8
A 1.0 4.1 ± 0.7 A 1.0 11.3 ± 2.2
DMSO 3.6 ± 1.1 DMSO 11.3 ± 2.9
EB 4.7 ± 1.0 EB 11.3 ± 1.5
A 0.5 3.3 ± 0.9 A 0.5 10.8 ± 1.7
A 1.0 5.7 ± 1.5 A 1.0 8.6 ± 1.9
DMSO 6.2 ± 1.3 DMSO 20.5 ± 5.2
EB 4.2 ± 1.2 EB 9.4 ± 2.3
A 0.5 5.5 ± 1.5 A 0.5 11.4 ± 3.2
A 1.0 4.2 ± 1.0 A 1.0 10.5 ± 2.7
DMSO 2.8 ± 0.9 DMSO 2.4 ± 0.8
EB 3.3 ± 0.9 EB 3.9 ± 1.1
A 0.5 1.9 ± 0.4 A 0.5 4.1 ± 1.3
A 1.0 2.3 ± 1.6 A 1.0 4.2 ± 1.6
A. Sociability B. Social Novelty
F > M         
p < 0.0001
F > M         
p < 0.0001
F > M         
p < 0.05
F > M         
p < 0.0001
F > M         
p < 0.0001
F > M         
p < 0.003
Speed (cm/s)
Females
Males
Distance (m)
Females
Males
Rearing (s)
Females
Males
Grooming (s)
Females
Males
Distance (m)
Speed (cm/s)
Females
Males
Grooming (s)
Females
Males
Females
Males
F > M         
p < 0.03
SEM SEM
F > M         
p < 0.0001Rearing (s)
Females
Males
 
 
 
 
 
 
 
Table 2.2: Sociability And Social Novelty Diagnostic Behaviors 
Behaviors are shown that were computer-scored and used as diagnostic measures in the 
two social behavioral tests. Sex differences and direction of change are indicated for each 
behavior. P-values are provided when sexes were significantly different from one 
another. Data shown are mean + SEM. 
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(Table 2.3 continued on next page) 
Mean Mean
Vehicle 221 ± 17.7 82 ± 7.6
EB 199 ± 9.4 83 ± 9.6
A1221 (0.5) 201 ± 18.5 68 ± 6.8
A1221 (1) 220 ± 17.7 68 ± 9.0
Vehicle 218 ± 19.7 45 ± 7.0
EB 216 ± 16.4 52 ± 5.5
A1221 (0.5) 226 ± 13.7 59 ± 6.8
A1221 (1) 262 ± 25.6 34 ± 4.7
Vehicle 133 ± 12.2 44 ± 4.8
EB 127 ± 9.2 46 ± 6.5
A1221 (0.5) 113 ± 10.2 35 ± 4.6
A1221 (1) 131 ± 12.8 37 ± 5.7
Vehicle 144 ± 16.1 23 ± 3.8
EB 148 ± 12.5 28 ± 3.5
A1221 (0.5) 159 ± 12.1 33 ± 4.4
A1221 (1) 167 ± 21.5 16 ± 3.0
Vehicle 55 ± 11.2 N/A
EB 51 ± 10.7 N/A
A1221 (0.5) 48 ± 48.5 N/A
A1221 (1) 40 ± 7.0 N/A
Vehicle 128 ± 34.1 N/A
EB 78 ± 26.2 N/A
A1221 (0.5) 81 ± 17.5 N/A
A1221 (1) 76 ± 26.5 N/A
Vehicle 7.6 ± 1.0 N/A
EB 9.9 ± 1.3 N/A
A1221 (0.5) 7.6 ± 1.2 N/A
A1221 (1) 8.8 ± 1.4 N/A
Vehicle 13.4 ± 2.3 N/A
EB 11.1 ± 1.4 N/A
A1221 (0.5) 13.9 ± 1.5 N/A
A1221 (1) 12.9 ± 2.0 N/A
Vehicle 58 ± 11.5 N/A
EB 48 ± 8.9 N/A
A1221 (0.5) 65 ± 13.8 N/A
A1221 (1) 72 ± 23.0 N/A
Vehicle 133 ± 34.0 N/A
EB 79 ± 25.6 N/A
A1221 (0.5) 91 ± 17.5 N/A
A1221 (1) 90 ± 30.2 N/A
Latency to first 
nose touch (s)
Females
Males
F < M            
p < 0.001
Time spent nose 
touching (s)
Females
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Males
F < M            
p < 0.0001
F = M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Males
Time in proximity 
to stimulus animal 
(s)
Females
Social NonSocial Sex Diff.Treatment
Chamber
SEM SEM
Time spent 
investigating 
stimulus animal (s)
Females
Measure Sex
A. Sociability
Latency to 
investigate 
stimulus animal (s)
Females
F < M            
p < 0.005
Males
Males
F < M           
p < 0.004
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
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Mean Mean
Vehicle 96 ± 8.7 147 ± 11.9
EB 97 ± 12.6 146 ± 14.1
A1221 (0.5) 92 ± 12.7 154 ± 21.5
A1221 (1) 110 ± 12.3 129 ± 12.6
Vehicle 121 ± 17.0 169 ± 15.8
EB 98 ± 12.1 194 ± 19.3
A1221 (0.5) 107 ± 12.1 138 ± 13.0
A1221 (1) 122 ± 14.4 175 ± 11.4
Vehicle 54 ± 6.5 74 ± 9.2
EB 50 ± 5.5 76 ± 8.2
A1221 (0.5) 54 ± 9.1 70 ± 7.6
A1221 (1) 57 ± 7.2 68 ± 8.7
Vehicle 78 ± 11.7 95 ± 10.4
EB 63 ± 9.0 118 ± 11.3
A1221 (0.5) 66 ± 8.4 87 ± 9.2
A1221 (1) 78 ± 11.8 101 ± 11.2
Vehicle 2.8 ± 0.5 5.2 ± 0.9
EB 3.3 ± 0.6 5.2 ± 0.7
A1221 (0.5) 2.9 ± 0.5 4.4 ± 0.8
A1221 (1) 3.4 ± 0.8 3.8 ± 0.5
Vehicle 4.4 ± 1.0 10.1 ± 1.7
EB 5.7 ± 1.3 10.4 ± 1.1
A1221 (0.5) 3.6 ± 0.8 6.1 ± 1.1
A1221 (1) 3.7 ± 0.8 7.8 ± 1.1
Vehicle 100 ± 21.0 45 ± 12.1
EB 138 ± 25.9 41 ± 18.3
A1221 (0.5) 136 ± 31.6 44 ± 14.4
A1221 (1) 109 ± 25.0 38 ± 19.4
Vehicle 68 ± 29.2 52 ± 8.5
EB 121 ± 26.7 49 ± 11.9
A1221 (0.5) 170 ± 33.1 52 ± 14.0
A1221 (1) 138 ± 22.9 39 ± 15.7
Latency to first nose 
touch (s)
Females
Males
Males
Males
Time spent nose 
touching (s)
Females
Chamber
Familiar Novel
Time in proximity to 
stimulus animal (s)
Females
SEM SEM
Measure Sex Treatment
B. Social Novelty
Sex Diff.
F < M           
p < 0.004
F < M            
p < 0.001
F < M            
p < 0.001
Time spent 
investigating 
stimulus animals (s)
Females
Males
F = M
 
 
Table 2.3: Sociability and Social Novelty Measures in Proximity to the Stimulus Cage 
Behaviors are shown that were investigator-scored that took place in relationship to the 
stimulus animal, within at least one body length. Sex differences and direction of change 
are indicated for each behavior. P values are provided when sexes were significantly 
different from one another. Data shown are mean + SEM. 
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Figure 2.3: Sociability Test 
Sociability test results are shown for the latency to investigate the stimulus animal (A), 
and the time spent nose touching (B). These measures were both sexually dimorphic, and 
higher in males than females (p < 0.005, 0.0001, respectively). However, no significant 
treatment effects within each sex were found. Data shown are mean + standard error, with 
individual values shown as circles. N’s are indicated below each bar. 
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Social Novelty 
The computer-generated data for the diagnostic behaviors of the Social Novelty 
tests are summarized in Table 2.2B and investigator-scored data related to behaviors that 
took place in proximity to a stimulus animal are shown in Table 2.3B. Similar to the 
Sociability test, in the Social Novelty test there were many significant sex differences: 
females traveled a greater distance, were faster, and engaged in more grooming and 
rearing than males (Table 2.2B). Males spent more time investigating the stimulus animal 
and nose touching than females, as well as time in proximity to the stimulus rat. The 
sexes were equivalent in the latency to the first nose touch (Table 2.3B). 
For the behaviors that took place in proximity to the stimulus animals, the dataset 
violated the assumptions for parametric analyses, despite any attempts at transformation. 
Student’s t-test identified significant effects of sex for these behaviors (Table 2.3B), and 
overall the expected preference to engage in behaviors with a novel over a familiar 
animal was observed. Further analysis by Cohen’s d effect size test revealed that this was 
altered in a sex- and dose-specific manner (Table 2.4). For the time spent in proximity to 
the stimulus animal (Figure 2.4A; Table 2.4A), three groups’ effect sizes [females 
(A1221, 1 mg/kg) and males (DMSO; A1221, 0.5 mg/kg)] did not meet Cohen’s d 
LARGE effect cut-off. For total time investigating the stimulus animal (Figure 2.4B; 
Table 2.4B), a LARGE effect size was only observed in EB males. Lastly, for time spent 
in direct nose-to-nose contact (Figure 2.4C; Table 2.4C), all non-vehicle female groups 
had a disrupted novelty preference; a LARGE effect size in the DMSO group was lost in 
the EB, and both A1221 groups. Among males, only the A1221 (0.5 mg/kg) group had an 
altered preference from DMSO.  There was also an effect of treatment in the males, for 
which the A1221 (0.5 mg/kg) group spent significantly less time in direct nose-to-nose 
contact than both male control groups (p < 0.05; Figure 2.4C). 
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Figure 2.4: Social Novelty Test 
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Three measures involving social interactions during Social Novelty are shown for 
time spent in proximity to the stimulus animal (A), time exploring the stimulus animal 
(B), and time spent nose touching (C). In (A), for females the Cohen’s d LARGE effect 
size was found for DMSO, EB, and A1221 (0.5 mg/kg), but not for A1221 (1 mg/kg). In 
males, the Cohen’s d LARGE effect size was found for EB and A1221 (1 mg/kg) but not 
DMSO or A1221 (0.5 mg/kg). In (B) Cohen’s d LARGE effect size was found only in the 
male EB group. In (C), in females, the Cohen’s d LARGE effect size was found only in 
the DMSO group, whereas in males, the LARGE effect size was found in DMSO, EB, 
and A1221 (1 mg/kg) animals but not A1221 (0.5 mg/kg). In addition, total time spent 
nose touching was significantly different in the male A1221 (0.5 mg/kg) compared to 
male DMSO or EB groups (p < 0.05 for both). Data shown are mean + standard error, 
with individual values shown as circles. *, p < 0.05. Groups with an identified Cohen’s d 
LARGE effect size are indicated by a, and those without this effect by b. N’s are 
indicated below the bars for each group and are the same for A, B, and C. 
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Table 2.4: Cohen’s d Effect Size for Behaviors 
Cohen’s d effect size was calculated for time spent in proximity to, investigating, and 
nose touching with, the familiar vs. the novel stimulus animal, in the Social Novelty test. 
An effect size of 0.8 or higher (in bold) is equivalent to Cohen’s standard LARGE, which 
indicates that the mean of the control group (Familiar) is at the 79th percentile and 
sharing 69% overlap with the comparison group (Novel) 
Females
Cohen's d effect 
size
Percentile 
standing Overlap (%)
DMSO 1.0 84 62
EB 1.6 95 42
A1221 (0.5) 0.8 79 69
A1221 (1) 0.3 62 88
Males
DMSO 0.7 76 73
EB 1.3 90 52
A1221 (0.5) 0.5 69 80
A1221 (1) 0.9 82 65
Females
Cohen's d effect 
size
Percentile 
standing Overlap (%)
DMSO 0.7 76 73
EB 0.7 76 73
A1221 (0.5) 0.5 69 80
A1221 (1) 0.2 58 92
Males
DMSO 0.2 58 92
EB 1.2 88 55
A1221 (0.5) 0.6 73 76
A1221 (1) 0.5 69 80
Females
Cohen's d effect 
size
Percentile 
standing Overlap (%)
DMSO 1.4 92 48
EB 0.5 69 80
A1221 (0.5) 0.4 66 84
A1221 (1) 0.5 69 80
Males
DMSO 0.9 82 65
EB 0.8 79 69
A1221 (0.5) 0.5 69 80
A1221 (1) 1.0 84 62
A. Time in Proximity to Stimulus Animal
B. Time Investigating Stimulus Animal
C. Time Spent Nose Touching
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DISCUSSION 
This study tested effects of prenatal PCB exposures on suites of behaviors 
exhibited in tests of sociability and social novelty. Significant sex differences in these 
behaviors were observed. In the Sociability test, both sexes showed a strong preference 
for affiliating with a stimulus animal (vs. an empty cage), though in general, experimental 
males exhibited more interactions with the stimulus males than did experimental females 
with the stimulus females. In the Social Novelty test, there were several sexually 
dimorphic responses, but treatment resulted in few differences within each sex.  
 
During the Sociability test, though the preference to spend time associating with 
the stimulus animal (vs the empty stimulus cage) was present in both sexes, the degree to 
which the animals interacted differed. Females were quicker to initiate contact with the 
stimulus animals than males; however, males spent more time investigating and 
interacting with the stimulus animal. While the increased interactions in male rats has 
been previously observed (Meaney and Stewart 1979), to our knowledge the reported 
differences in latency-to-investigation are novel. Consistent with the literature on social 
behavior in this particular paradigm (Choleris et al. 2006; Engelmann, Wotjak, and 
Landgraf 1995), there was a strong social preference, with the experimental animals 
spending more time in the chamber containing the stimulus animal than the chamber 
containing an empty stimulus cage.  
 
During the Social Novelty test, sexual dimorphisms were again observed; males 
had longer latencies to initiate interactions, but ultimately interacted with both stimulus 
animals more so than did the females. Both sexes tended to associate and interact more 
with the novel conspecific compared to the familiar, in accordance with the literature 
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(Cox and Rissman 2011; Nadler et al. 2004; Wolstenholme et al. 2011). Our data suggest 
that (1) treatment does not alter the ability to acquire familiarity during the Sociability 
Stage, and (2) all animals are able to recognize and distinguish between the familiar and 
novel animal during the Social Novelty test. 
 
Although most groups exhibited a strong novelty preference, there were 
exceptions, namely, the A1221 (1 mg/kg) female and the A1221 (0.5 mg/kg) male 
groups. This suggests that males and females have different sensitivities to A1221. Our 
laboratory has previously reported other sexually dimorphic changes due to gestational 
PCB exposure: only females have an increased postnatal body weight; only males exhibit 
an increased anogenital distance (Dickerson et al., 2011b; Walker et al., 2013). 
Developmental EDC exposure can also lead to sex-specific changes in behavior 
(Jacobsen et al., 2012; Kundakovic et al., 2013; Sobolewski et al., 2014; Williams et al., 
2013).The male A1221 (0.5 mg/kg) group in our study also showed significantly less 
nose-to-nose interactions than vehicle males during Social Novelty, which was not seen 
in any of the female treatment groups. The degree of nose-touching that the A1221 (0.5 
mg/kg) males displayed could be due to feminization of the brain areas involved in this 
behavior, as the behaviors were more similar to those observed in females. This also 
suggests that the males have an increased sensitivity of A1221-induced changes to adult 
social behaviors when compared to females. The EB groups were the only animals to 
lack the strong concordance of effect sizes when comparing the time spent in proximity 
and nose touching. EB animals in both sexes had the largest novelty preference in the 
time spent in proximity to the two stimulus animals but not in the nose-to-nose 
interactions, for which the female EB group lost the LARGE effect size comparison. This 
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suggests that EB treatment, regardless of sex, amplifies the tendency toward social 
approach, rather than interactive behavior.  
 
Overall, the females showed significantly higher locomotor behaviors (average 
speed, distance, grooming, and rearing) than the males. The behaviors scored in 
proximity to the stimulus animals (time near the stimulus animal and cage, time 
investigating the stimulus animal and cage, time actively nose touching the stimulus 
animal), indicative of an interaction with the conspecific, were significantly higher in the 
males. When these same animals were presented with opposite sex stimulus animals 
during mate preference in a separate study, it was the males that displayed more approach 
than the females, the latter which were the more interactive sex (Topper, et al., 2014). 
This discrepancy illuminates how these interactions depend upon the context.  
 
There was a sex- and dose-specific increase in the concentration of serum 
corticosterone in our experimental animals. Adrenal weights were heavier in females than 
in males, consistent with observations of Richter (1956) and our previous work using a 
transgenerational EDC (vinclozolin) exposure and evaluation of F3 descendants (Gillette 
et al., 2014). Circulating corticosterone concentrations were also higher in females 
relative to males. Within the females, the A1221 (0.5 mg/kg) group had a significantly 
higher concentration of this hormone, the latter unlikely to be due to a larger adrenal size 
as there were no treatment effects on this latter endpoint within each sex. This sex-
specificity is parallel to a similar observation made for vinclozolin, another EDC that led 
to a female-only increase in corticosterone concentration in the F3 descendants (Gillette 
et al. 2014). Though A1221 is known to be weakly estrogenic, differences with the EB 
group in the present study suggests an alternate (non-estrogenic) mechanism. It is known 
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that the female rat is most sensitive to stress during proestrus (Viau and Meaney 1991); 
thus, the increase observed only in the A1221 (0.5 mg/kg) females may be due to an 
altered hormonal phenotype at the time of euthanasia, during which all females were in 
proestrus.  
 
Previous studies indicate that prenatal exposure to Bisphenol A, diethylstilbestrol, 
and organophosphate insecticides result in changes in the social, anxiety, exploratory, and 
sex behavior (reviewed in Frye, 2014). However, many of the studies that found 
alterations in behavior lacked a positive control group. Using large sample sizes and a 
thorough characterization of the social behavioral phenotype in our experimental rats, we 
revealed relatively few differences between negative control (DMSO), positive control 
(EB), and two dosages of A1221. The sexually dimorphic nature of the changes observed, 
though few, demonstrate that the neurobiological mechanisms underlying the sex 
differences may present a means of varying vulnerabilities to the organizational processes 
leading to the acquisition of normal social behavior. This dichotomy must be accounted 
for when assessing the effects of any environmental toxicant.  
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CHAPTER 3: IDENTIFYING THE EFFECTS OF AN EXTENDED 
GESTATIONAL EXPOSURE TO EDCS ON THE ADULT SOCIAL 
BEHAVIOR IN MALE AND FEMALE RATS 
ABSTRACT 
Endocrine disrupting chemicals (EDCs) can lead to both temporary and 
permanent changes in physiology through diverse mechanisms by which exposure can 
perturb the hormonal system of an organism. EDC action 
during critical developmental periods could lead to long-lasting behavioral effects by 
disturbing the hormone-driven organization of the brain during gestation, which alters 
the activational response to endogenous hormones later in life. Polychlorinated biphenyls 
(PCBs) and Vinclozlin (VIN) are well-studied classes of EDCs that have been shown to 
act through estrogenic and anti-androgenic processes, respectively. Exposure to these 
compounds during gestation has been shown to have lasting effects on mating behaviors. 
Recently, gestational exposure to PCBs during late gestation have been found to elicit 
sex- and dose-specific changes in social interactions. The purpose of this experiment was 
to determine how exposure to these two EDCs during a n extended period of embryonic 
development may lead to alterations in the social behavior of male and female rats. Using 
the three-chamber apparatus, two tasks essential to the social behavior of rodents was 
assessed. While there was no effect of treatment on the preference of affiliate with a 
same-sex conspecific over an empty cage, males treated with VIN did not display the 
expected novelty preference when presented with a familiar and novel stimulus animal.  
We also observed several instances of exacerbated sex differences due to both PCB or 
VIN treatment. Overall, these data suggest that males are more susceptible to the effects 
of gestational exposure to VIN in the manifestation of adult social behavior.  
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INTRODUCTION 
Appropriate social behavior is an essential component of reproductive fitness. The 
processes governing the manifestation of normal adult behaviors are sexually dimorphic 
and established during gestation by hormone-sensitive organizational processes that 
govern brain development (Phoenix et al. 1959). Through activational processes induced 
by endogenous hormones during puberty, the manifestation of female- or male-typical 
adult social behaviors reflect the differences established during organization of the fetal 
brain (Arnold and Breedlove, 1985). This critical period of brain sexual differentiation is 
particularly sensitive to disruption via exposure to endocrine-disrupting chemicals 
(EDCs), as this life stage is characterized by differential exposures of the male and 
female brains to gonadal androgens and estrogens, perturbations of which change brain 
organization (Arnold and Breedlove, 1985).  
 
Defined as an exogenous chemical or mixture of chemicals capable of interfering 
with any aspect of hormone function (Gore et al., 2015), EDCs are increasingly present in 
the environment. Though contamination of the food chain, inhalational, or occupational 
exposure, humans are exposed to potential EDCs on a regular basis (Reviewed by Frye et 
al. 2012).  Of particular concern in the context of developmental neuroendocrinology are 
those EDCs capable of interfering with the systems governing the sexual differentiation 
of the brain during fetal development (Crews et al, 2006). Polychlorinated biphenyls 
(PCBs) and Vinclozolin (VIN) are two classes of EDCs shown to elicit changes in gene 
and protein expression, as well as alterations to sexual, anxiety, and social behaviors 
(Steinberg et al. 2008, Walker et al. 2014, Reilly et al. 2015, Gillette et al. 2017). 
Although not confined to any one particular hormonal pathway, the actions of PCBs and 
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VIN are at least partially mediated via estrogenic or anti-androgenic mechanisms, 
respectively (Jansen et al. 1993, Gray et al. 1994).  
 
The present study aims to build upon literature of gestational exposure to these 
compounds can lead to functional alterations in the adult behavioral phenotype within a 
social setting. By observing both male and female rats exposed prenatally to EDCs, we 
tested the hypotheses that the sexes are differentially susceptible to disruption by 
different classes of EDCs. This study will also allow the ability to assess the influence of 
the duration of exposure, which encompasses a larger period of gestational development 
 
MATERIALS AND METHODS 
Animals and husbandry  
This study was conducted under a protocol approved by the Institutional Animal 
Care and Use Committee (IACUC) at the university of Texas at Austin. Female and Male 
Sprague-Dawley rats were ordered in young adulthood (approximately 120 days old) 
from Harlan (Indianapolis, IN). Animals were housed in groups of 2-3 within standard 
clear polycarbonate rat cages and provided with a low phytoestrogen rat chow ad-libitum 
(Harlan-Tekland Extruded 2019 Global Rat Diet). For the duration of the experiment, the 
animals were maintained on a reverse 12:12 light cycle (lights on at 2300 h) and, 
following a one week habituation to the colony, handled weekly to familiarize the 
animals with tactile manipulation. Females were smeared daily for identification and 
recording of estrous cycle status. When a smear indicated proestrous, the females were 
paired with a sex-experienced male two hours after lights out and observed under red 
light for copulatory behaviors. If the female displayed receptive behaviors, the pair would 
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be left together overnight with food and water. A vaginal smear including sperm 
confirmed that mating took place and this event was deemed embryonic day 0 (E0). After 
a successful mating occurred, the male and female were separated and the pregnant 
female was single-housed in a cage for the duration of gestation. Nesting material was 
provided to the female several days prior to parturition on E21.  
 
Gestational Exposure to Endocrine Disrupting Chemicals 
 Beginning on E8, pregnant dams were injected intraperitoneally at approximately 
9:30am every morning for 11 days with the last injection taking place on E18. The three 
experimental treatment groups were as follows: Vehicle (6% dimethysulfoxide in sesame 
oil); Aroclor 1221 (A1221; a PCB mixture at a concentration of 1mg/kg; AccuStandard, 
New Haven, CT); and Vinclozolin (VIN; a fungicide at a concentration of 1mg/kg; Chem 
Service #N-13745, West Chester, PA). For the rest of the manuscript, the three treatment 
groups will be referred to as Vehicle, A1221, and VIN, respectively.  E21 was the day of 
parturition, now deemed postnatal day 0 (P0). All F1 offspring were identified for sex, 
weighed, and anogenital distance measured to assist in culling the litter down to 5 pups 
from each sex in order to maintain a consistent sex ratio. The remaining 10 pups were 
returned to the dam’s cage and monitored daily for somatic and sexual development. On 
P21 the pups were weaned into same-sex cages of 2-3 and provided with water and chow 
ad libitum. The weaned animals were weighed weekly and, beginning around P28 
monitored for pubertal development (vaginal opening (VO) in females, preputial 
separation (PPS) in males). Following VO, females were smeared daily and cycle status 
recorder for the duration of their use in the experiment. Beginning ~ P90 the animals 
were placed through a battery of tests engaging their behavior within social, sexual, and 
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anxiogenic contexts. This report will focus on sociability and social novelty behavior, 
described below.  
 
Stimulus Animals and the Social Behavioral Testing Paradigm 
Stimulus Sprague-Dawley rats were bred within our colony. These animals were 
untreated with any chemicals. To avoid behavioral changes due to repeated testing, 
stimulus rats were not used for more than 3 trials in a day. Female stimulus animals were 
only used on diestrus, as indicated by vaginal smear.  
 
A three-chamber apparatus (100 cm x 100 cm; Stoelting Co, Wood Dale, IL) was 
used as the testing arena for the two behavioral tasks (Moy 2004, Crews et al 2012, Reilly 
2015). The testing area resembles an open field, separated into thirds. Doors in the central 
region of each wall allow an animal to pass from the central chamber to either lateral 
chamber, each containing a stimulus cage in the far corners. Behavioral testing occurred 
under dim red light during the dark phase of the animal’s light cycle, approximately two 
hours following lights out. The experimental animal was placed in the central chamber to 
habituate to the apparatus for 5 minutes while the doors to the two lateral chambers were 
closed.  Experimental females (F1 generation from the 3 treatment groups) were only run 
on days of diestrus, to avoid any confound of estrous cyclicity on behavioral outcomes. 
The same-sex stimulus animals used during testing were placed in a cylindrical cage (7 
cm x 15 cm) located at the lower corner of the lateral chambers within the apparatus. 
Although the cage limited the movement of the stimulus animals throughout the test 
environment, direct interactions could take place across the bars of the cage. This enabled 
sniffing and nose-to-nose contact between the stimulus and experimental animals.  
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Sociability 
 Following the habituation period, the doors to the side chambers were lifted, 
allowing access to the two lateral chambers of the apparatus. For Sociability testing, only 
one of the stimulus cages contained a same-sex stimulus animal; the other chamber was 
empty. Placement of the stimulus rat on the left or right side was randomized. The 
experimental animal was allowed to roam freely in this configuration for 10 minutes 
while computer software (AnyMaze, Stoelting Co) tracked the experimental animal’s 
position and video recorded the test. After 10 minutes, both the experimental and 
stimulus animals were removed from the apparatus and temporarily placed in their 
respective holding cages so that the apparatus could be dismantled and wiped clean with 
70% ethanol prior to the next texting phase, which occurred immediately following 
Sociability.   
Social Novelty 
 In the second test, the experimental rat was offered two stimuli: the same rat from 
Sociability (now familiar), and a novel, same-sex stimulus animal. Again, female 
stimulus rats were in diestrus. The two stimulus cages, each now containing a stimulus 
animal were randomly placed into the far corners of the testing arena. The experimental 
animal was returned to the center chamber and allowed to freely roam the entire 
apparatus for a 10-minute period, during which the same behaviors were recorded as in 
Sociability.  
 
The AnyMaze computer software was used to track the animal’s behavior during 
testing. Automatic measures were: total distance travelled (m) and average speed (m/s) 
throughout the apparatus. Being able to define discrete boundaries from within the 
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software, the program was also able to provide the time spent on each lateral side of the 
apparatus in addition to the time spent in proximity (defined as one body length away) 
from each stimulus cage. Video recordings of the tests were manually scored by an 
investigator blind to the sex or treatment of the animals. Investigator-scored behaviors 
were: (1) the active investigation of the stimulus cage (Time Spent Exploring Stimulus) 
or (2) instances when animals were in direct nose-to-nose contact (Time Spent Nose 
Touching). The latency (amount of time prior to the initial performance of each behavior) 
for the two investigator-scored behaviors was also included in analysis.  
Behavioral Analyses  
The measures used to analyze behaviors (defined in Table 3.1) were both 
computer- and investigator-scored. The former were considered for their diagnostic 
(Total Distance, Average speed) and descriptive (Time in each whole side: 
Social/Empty/Novel/Familiar/Center) qualities.  Of these, one computer-scored measure 
(Time in Proximity to Stimulus Cage) and two investigator-scored measures (Time Spent 
Exploring Stimulus Cage and Time Spent Nose Touching) were evaluated in the context 
of the binary choice and a preference for one stimulus over another was defined at the 
group level through statistical analyses.   
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Total Distance The total distance (m) travelled by the experimental animal for the entire duration of  the 10 minute test
Average Speed The average speed of the experimental animal (m/s) for the duration of the experiment
Time in Social Side
The total amount of time (s) an experimental animal spent on the side 
of the apparatus containing a stimulus cage holding a same-sex 
stimulus animal
Time in Empty Side The total amount of time (s) an experimental animal spent on the side of the apparatus contaning an empty stimulus cage
Time in Center The total amount of time (s) an experimental animal spent in the center of the apparatus, which held no stimulus cage
Time in Proximity to Stimulus Cage* The total amount of time (s) an experimental animal spent within one body-length of either stimulus cage
Total Distance The total distance (m) travelled by the experimental animal for the entire duration of  the 10 minute test
Aerage Speed The average speed of the experimental animal (m/s) for the duration of the experiment
Time in Novel  Side
The total amount of time (s) an experimental animal spent on the side 
of the apparatus containing a stimulus cage holding an unfamiliar 
same-sex stimulus animal
Time in Familiar Side
The total amount of time (s) an experimental animal spent on the side 
of the apparatus contaning a stimulus cage holding the same stimulus 
animal from the previous test
Time in Center The total amount of time (s) an experimental animal spent in the center of the apparatus, which held no stimulus cage
Time in Proximity to Stimulus Cage* The total amount of time (s) an experimental animal spent within one body-length of either stimulus cage
Latency to First Stimulus Explore Event* The amount of time (s) prior  to the first Stimulus Explore event
Time Spent Exploring Stimulus Cage* The amount of time (s) the experimental animal spent actively exploring the stimulus cage
Latency to First Nose Touch Event* The amount of time (s) prior to the first Nose Touch event
Time Spent Nose Touching* The amount of time (s) the experimental animal spent in direct nose-to-nose contact with the stimulus animal
Computer-Scored Behaviors
Investigator-Scored Behaviors
Sociability
Social Novelty
Sociability & Social 
Novelty
 
Table 3.1 Behaviors Quantified for Sociability and Social Novelty 
A definition of the terminology used to describe the behavioral analysis of animals in 
Sociability and Social Novelty tests. Behaviors marked with an asterisk (*) indicate the 
measures of most salience for this paradigm., which were analyzed with respect to each 
stimulus option.  
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Statistical analyses 
 For each measure, a one-way ANOVA was used to determine the effects of 
treatments within sex. To test sex differences within treatment, a t-test was used. To 
determine Social or Novel preferences, a paired t-test was used within each group. Data 
that did not meet the assumptions of normality or homogeneity of variance were analyzed 
with the appropriate non-parametric methods. All statistics are accompanied by effect 
size values (partial-ηp2, or ε2 for ANOVA and Kruskal-Wallis tests, respectively; Cohen’s 
d values for t-tests). Interpretation of the effect size values for partial-ηp2 and ε2 were as 
follows: 0.01 = Small; 0.09 = Medium; 0.25 = Large). For Cohen’s d: 0.2 = small; 0.5 = 
Medium; 0.8 = Large). Significance was set at p < 0.05.  
 
RESULTS 
Sociability test 
In both sexes, there were no effects of treatment for any of the following 
measures (Table 3.2): Total distance, average speed, or total time in any of the three 
portions of the apparatus (social, empty, or center). In males, there was a trend toward 
significance (p = 0.06) regarding the amount of time each treatment group spent in the 
center chamber of the apparatus; this was associated with a Medium effect size. 
Regardless of treatment, there was a significant sex difference (F>M) in total distance 
and average speed, with a Cohen’s d value indicative of a Large effect size (Table 3.2C). 
A significant sex difference was also found in the time A1221 or VIN, but not vehicle, 
animals spent in the portion of the chamber containing an empty stimulus cage (F>M). 
Lastly, the VIN animals were the only group to show a significant sex difference in the 
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time spent in the central chamber (M>F). All of these significant differences were 
associated with a Cohen’s d value indicative of a Medium effect size (Table 3.2C).  
 
Time Spent in Proximity to Stimulus Cage 
Comparing the time spent within one body length of either stimulus cage, all 
groups spent significantly more time near the cage containing a stimulus rat compared to 
an empty cage (Figure 3.1A; p < 0.05 in vehicle males and females; p < 0.0001 in A1221 
and VIN animals).  
 
Time Spent Exploring Stimulus and Latency to First Stimulus Explore Event 
No significant effects of treatment were observed in the latency to first 
exploration of a stimulus cage (Table 3.2), but significant sex differences in this behavior 
were observed in all treatment groups (M>F; Table 3.2C). Vehicle and A1221 sex 
differences were accompanied by a Large effect size, while the difference in VIN animals 
was met with a Medium Cohen’s d value. There were no significant effects of treatment 
on the total time spent exploring the stimulus cages in either sex. Additionally, no sex 
differences in this behavior were observed. All treatment groups, regardless of sex, spent 
significantly (p < 0.0001) more time exploring the cage containing a stimulus animal 
compared to the empty stimulus cage (Figure 3.1B).  
 
Nose Touching And Latency to First Nose Touch Event 
In females, a significant effect of treatment was seen in the latency to the first 
Nose Touch event with a Medium effect size (Table 3.2A). Post hoc analyses indicated 
that this was driven by a significant difference between the VIN and A1221 females 
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(VIN<A1221; p < 0.05). No significant effects of treatment were seen in males. A 
significant sex difference in this measure was seen only in the VIN-treated animals 
(Medium effect size). No effects of treatment or sex were observed in the total time spent 
nose touching during the Sociability Test (Figure 3.1C).  
 
 
 
 
 
 
(Table 3.2 continued on next page) 
 
Treatment N Mean ± SEM Test
F (df) for 
ANOVA; X2 
(df) for KW
P-value
ηp2 for 
ANOVA; 
ε2 for KW
Vehicle 27 54.72 ± 1.62
A1221 29 51.75 ± 2.03
VIN 30 54.07 ± 2.35
Vehicle 27 0.09 ± 0.004
A1221 29 0.09 ± 0.003
VIN 30 0.09 ± 0.003
Vehicle 27 287.19 ± 11.96
A1221 30 292.07 ± 8.21
VIN 30 300.19 ± 12.36
Vehicle 27 212.80 ± 10.66
A1221 30 207.48 ± 7.52
VIN 30 196.63 ± 10.01
Vehicle 27 99.67 ± 5.76
A1221 30 100.04 ± 4.96
VIN 30 103.15 ± 5.34
Vehicle 27 15.19 ± 1.78
A1221 30 17.37 ± 3.01
VIN 30 15.82 ± 2.59
Vehicle 27 148.56 ± 7.91
A1221 30 177.06 ± 11.86
VIN 30 148.93 ± 12.29
Vehicle 27 72.83 ± 10.33
A1221 30 86.42 ± 13.30
VIN 30 46.74 ± 9.53
Vehicle 27 15.42 ± 2.14
A1221 30 17.98 ± 3.01
VIN 30 14.50 ± 2.36
A. Female Treatment Effects
Measure
Average Speed (m/s) ANOVA F(3,83) = 0.61 0.55 0.01
Total Distance (m) ANOVA F(3,83) = 0.57 0.57 0.01
0.47 0.02
Time in Social Side (s) ANOVA F(3,84) = 0.35 0.70 0.01
 Time in Center (s) ANOVA F(3,84) = 0.13 0.88 0.003
Time in Empty Side (s) ANOVA F(3,84) = 0.76
Time Spent Exploring Stimulus Cage KW X2(3) = 4.90 0.08 0.06
Latency to First Stimulus Explore Event KW X2(3) = 0.20 0.91 0.003
Latency to First Nose Touch Event KW X2(3) = 6.73 0.03 0.08
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Time Spent Nose Touching KW X2(3) =0.62 0.73 0.01
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(Table 3.2 continued on next page) 
Treatment N Mean ± SEM Test
F (df) for 
ANOVA; X2 
(df) for KW
P-value
ηp2 for 
ANOVA; 
ε2 for KW
Vehicle 26 41.24 ± 3.89
A1221 29 40.52 ± 2.46
VIN 28 38.61 ± 2.82
Vehicle 26 0.07 ± 0.006
A1221 29 0.07 ± 0.004
VIN 28 0.06 ± 0.005
Vehicle 29 286.00 ± 21.43
A1221 29 313.15 ± 15.52
VIN 28 298.97 ± 17.07
Vehicle 29 198.30 ± 20.20
A1221 29 175.36 ± 13.55
VIN 28 158.92 ± 11.62
Vehicle 28 98.67 ± 6.19
A1221 29 111.35 ± 7.25
VIN 27 124.65 ± 9.32
Vehicle 28 32.97 ± 5.37
A1221 30 31.81 ± 3.81
VIN 28 27.48 ± 3.86
Vehicle 28 166.45 ± 14.21
A1221 30 183.26 ± 6.74
VIN 28 150.06 ± 12.16
Vehicle 28 103.82 ± 21.62
A1221 30 109.90 ± 19.76
VIN 28 105.61 ± 19.42
Vehicle 28 15.17 ± 1.93
A1221 30 18.91 ± 2.18
VIN 28 14.06 ± 2.18
B. Male Treatment Effects
Measure
Average Speed (m/s) ANOVA F(3,80) = 0.20 0.82 0.03
Total Distance (m) KW X2(3) = 0.92 0.92 0.002
0.21 0.04
Time in Social Side (s) ANOVA F(3,82) = 0.56 0.57 0.01
 Time in Center (s) ANOVA F(3,81) = 2.83 0.06 0.07
Time in Empty Side (s) ANOVA F(3,82) = 1.60
Time Spent Exploring Stimulus Cage KW X2(3) = 4.61 0.10 0.05
Latency to First Stimulus Explore Event KW X2(3) = 1.00 0.60 0.003
Latency to First Nose Touch Event KW X2(3) = 0.07 0.96 0.001
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Time Spent Nose Touching KW X2(3) = 2.42 0.29 0.03
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Table 3.2 Computer- and Investigator-Scored Measurements During the Sociability Test 
A comprehensive report of the computer- and investigator scored measures during 
Sociability  for females (A) and males (B). Sex differences are also shown (C). Data here 
and in Table 3 are shown as mean + SEM. Statistical tests used, values and degrees of 
freedom, and effect sizes are indicated. (SMALL = 0.01; MEDIUM = 0.09; LARGE = 
0.25). The statistics for within-treatment sex differences and Cohen's d effect sizes are 
shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with directionality of the effect. 
There was one significant effect of treatment in females in the Latency to First Nose 
Touch Event. There were numerous sex differences, all are indicated. F=female, 
M=male. 
Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.003 0.88 Large F>M
A1221 0.001 1.36 Large F>M
VIN 0.000 1.41 Large F>M
Vehicle 0.003 1.44 Large F>M
A1221 0.001 1.43 Large F>M
VIN 0.0001 1.57 Large F>M
Vehicle 0.96 0.01 Small
A1221 0.24 -0.32 Small
VIN 0.10 0.04 Small
Vehicle 0.52 0.17 Small
A1221 0.04 0.55 Medium F>M
VIN 0.02 0.66 Medium F>M
Vehicle 0.91 0.03 Small
A1221 0.20 -0.33 Small
VIN 0.05 -0.53 Medium M>F
Vehicle 0.004 -0.95 Large M>F
A1221 0.005 -0.80 Large M>F
VIN 0.02 -0.72 Medium M>F
Vehicle 0.27 -0.15 Small
A1221 0.65 -0.12 Small
VIN 0.94 -0.02 Small
Vehicle 0.20 -0.39 Small
A1221 0.32 -0.26 Small
VIN 0.01 -0.79 Medium M>F
Vehicle 0.93 0.02 Small
A1221 0.80 -0.07 Small
VIN 0.89 0.04 Small
Latency to First Stimulus Explore Event
Time Spent Exploring Stimulus Cage
Latency to First Nose Touch Event
Time Spent Nose Touching
C. Sex Effects within Treatment
Total Distance (m)
Average Speed (m/s)
Time in Social Side (s)
Time in Empty Side (s)
 Time in Center (s)
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Figure 3.1: Sociability Test 
Computer (A) and investigator-scored (B and C) measures of social exploration and 
interaction during the Sociability test. All groups spent significantly more time near (one 
body length away) the stimulus rat compared to the empty cage (A). All groups spent 
significantly more time exploring the stimulus cage containing the animal compared to 
the empty cage (B). There were no effects of treatment in the total time spent Nose 
Touching during this test (C). Mean and SEM are shown. * = p < 0.05; ** = p < 0.01; 
*** = p < 0.001; **** = p < 0.0001  
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Social Novelty test 
No significant effects of treatment were observed in the total distance travelled, 
average speed, or total time spent within any of the three chambers of the apparatus (table 
3.3) . However, several treatment-specific sex differences were seen. In both total 
distance travelled and average speed, the Vehicle and A1221 treatment groups displayed 
a significant sex difference (F>M) that was not observed in the VIN groups (Table 3.3C). 
These differences in the Vehicle and A1221 groups were associated with Large and 
Medium effect sizes, respectively. The time spent in the chamber containing the Novel 
stimulus animal was sexually dimorphic only in the VIN group (F>M; Large effect size). 
Also unique to the VIN treatment group was a significant sex difference was seen in the 
time spent in the chamber containing the familiar stimulus animal (M>F; Medium effect 
size).  
 
Time Spent in Proximity to Stimulus Cage 
Comparing the time spent within one body length of either stimulus cage, the 
Vehicle and A1221 group, regardless of sex, spent significantly (p < 0.01) more time near 
the cage containing a Novel stimulus animal compared to the cage containing the 
Familiar animal (Figure 3.2A). In the VIN animals, only the females spent significantly 
more time near the novel animal.  
 
Time Spent Exploring Stimulus and Latency to First Stimulus Explore Event  
In both sexes, no effects of treatment were seen in the latency to the first stimulus 
explore event. Significant sex differences were seen in the A1221 and VIN group, but not 
the Vehicle. These differences were associated with Medium effect sizes. In the total time 
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spent exploring the stimulus cages, there were no effects of treatment or sex. Comparing 
the time spent exploring the Novel vs. Familiar stimulus animal, the VIN-treated males 
were the only group that did not spend significantly more time exploring the novel 
stimulus animal (Figure 3.2B).  
 
Nose Touching and Latency to First Nose Touch Event.  
No effect of treatment was seen in either sex in the latency to the first Nose Touch 
event or in the total time spent Nose Touching. Only the Vehicle-treated animals 
displayed a significant sex difference in these measures, both associated with a Large 
effect size. Comparing the sexes, only the Vehicle group had significant sex differences 
for Time Spent Nose Touching (F>M; Large effect size) and Latency to First Nose Touch 
Event (M>F; Large effect size). Comparing the time spend Nose Touching the Novel vs. 
Familiar stimulus animals, all groups except for the VIN males spent significantly more 
time Nose Touching the Novel stimulus animal compared to the Familiar (Figure 3.2C). 
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(Table 3.3 continued on next page) 
Treatment N Mean ± SEM Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value
ηp2 for 
ANOVA; ε2 
for KW
Vehicle 27 52.43 ± 3.25
A1221 28 48.49 ± 1.99
VIN 30 46.67 ± 1.85
Vehicle 27 0.09 ± 0.01
A1221 28 0.08 ± 0.00
VIN 30 0.08 ± 0.00
Vehicle 26 293.13 ± 10.33
A1221 30 287.92 ± 13.05
VIN 30 307.13 ± 10.17
Vehicle 27 196.46 ± 12.52
A1221 30 192.49 ± 12.15
VIN 30 168.80 ± 8.14
Vehicle 27 117.02 ± 5.86
A1221 29 113.49 ± 6.75
VIN 29 118.59 ± 7.08
Vehicle 27 8.83 ± 2.22
A1221 30 4.95 ± 0.78
VIN 30 5.40 ± 1.01
Vehicle 27 151.03 ± 9.33
A1221 30 172.23 ± 8.73
VIN 30 168.09 ± 10.41
Vehicle 27 17.59 ± 3.37
A1221 30 21.03 ± 3.70
VIN 30 19.26 ± 2.61
Vehicle 27 19.78 ± 2.32
A1221 30 19.52 ± 2.58
VIN 30 18.98 ± 2.66
A. Female Treatment Effects
Measure
Average Speed (m/s) KW X2(3) = 1.17 0.56 0.01
Total Distance (m) KW X2(3) = 1.15 0.56 0.01
0.16 0.04
Time in Novel Side (s) KW X2(3) = 1.75 0.42 0.02
 Time in Center (s) ANOVA F(3,82) = 0.16 0.85 0.004
Time in Familiar Side (s) ANOVA F(3,84) = 1.85
Time Spent Exploring Stimulus Cage ANOVA F(3,8e) = 1.35 0.26 0.04
Latency to First Stimulus Explore Event KW X2(3) =1.01 0.60 0.01
Latency to First Nose Touch Event KW X2(3) =0.56 0.76 0.01
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Time Spent Nose Touching KW X2(3) =0.26 0.87 0.00
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(Table 3.3 continued on next page) 
Treatment N Mean ± SEM Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value
ηp2 for 
ANOVA; ε2 
for KW
Vehicle 29 38.31 ± 3.46
A1221 28 37.84 ± 3.33
VIN 28 37.40 ± 5.12
Vehicle 29 0.06 ± 0.01
A1221 28 0.06 ± 0.01
VIN 28 0.06 ± 0.01
Vehicle 28 283.45 ± 13.36
A1221 30 283.07 ± 12.43
VIN 28 247.28 ± 16.42
Vehicle 29 199.36 ± 10.70
A1221 30 210.43 ± 13.74
VIN 27 211.91 ± 13.11
Vehicle 28 116.53 ± 8.29
A1221 30 106.19 ± 8.85
VIN 28 126.80 ± 12.01
Vehicle 28 9.96 ± 2.68
A1221 30 13.35 ± 4.24
VIN 28 12.21 ± 2.90
Vehicle 28 147.38 ± 9.38
A1221 30 166.61 ± 8.41
VIN 28 165.51 ± 9.87
Vehicle 28 34.36 ± 5.17
A1221 30 37.32 ± 7.44
VIN 28 27.63 ± 4.01
Vehicle 28 11.42 ± 1.47
A1221 30 15.39 ± 1.80
VIN 28 15.79 ± 2.15
B. Male Treatment Effects
Measure
Average Speed (m/s) KW X2(3) = 1.41 0.50 0.02
Total Distance (m) KW X2(3) = 1.46 0.48 0.02
0.88 0.00
Time in Novel Side (s) KW X2(3) = 3.05 0.22 0.04
 Time in Center (s) KW X2(3) = 3.10 0.21 0.04
Time in Familiar Side (s) KW X2(3) = 0.24
Time Spent Exploring Stimulus Cage KW X2(3) =3.63 0.16 0.04
Latency to First Stimulus Explore Event KW X2(3) =0.21 0.90 0.002
Latency to First Nose Touch Event KW X2(3) =0.78 0.68 0.01
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Time Spent Nose Touching KW X2(3) =2.11 0.35 0.02
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Table 3.3: Computer- and Investigator-Scored Measurements During the Social Novelty 
Test 
A comprehensive report of the computer- and investigator scored measures during Social 
Novelty  for females (A) and males (B). Sex differences are also shown (C). Data here 
and in Table 2 are shown as mean + SEM. Statistical tests used, values and degrees of 
freedom, and effect sizes are indicated. (SMALL = 0.01; MEDIUM = 0.09; LARGE = 
0.25). The statistics for within-treatment sex differences and Cohen's d effect sizes are 
shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with directionality of the effect. 
There were no effects of treatment. There were numerous sex differences, all are 
indicated. F=female, M=male. 
Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.004 0.82 Large F>M
A1221 0.01 0.72 Medium F>M
VIN 0.09 0.44 Small
Vehicle 0.004 0.99 Large F>M
A1221 0.01 0.76 Medium F>M
VIN 0.10 0.44 Small
Vehicle 0.56 0.16 Small
A1221 0.78 0.06 Small
VIN 0.003 0.83 Large F>M
Vehicle 0.86 -0.05 Small
A1221 0.33 -0.25 Small
VIN 0.01 -0.75 Medium M>F
Vehicle 0.96 0.03 Small
A1221 0.51 0.16 Small
VIN 0.55 -0.15 Small
Vehicle 0.75 -0.10 Small
A1221 0.03 -0.54 Medium M>F
VIN 0.03 -0.65 Medium M>F
Vehicle 0.78 0.02 Small
A1221 0.64 0.16 Small
VIN 0.86 0.05 Small
Vehicle 0.01 -0.87 Large M>F
A1221 0.06 -0.55 Medium
VIN 0.08 -0.52 Medium
Vehicle 0.004 0.91 Large F>M
A1221 0.19 0.35 Small
VIN 0.35 0.27 Small
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Figure 3.2: Social Novelty Test 
Computer (A) and investigator-scored (B and C) measures of social exploration and 
interaction during the Sociability test. All groups except for the VIN males spent 
significantly more time in proximity to (A) exploring (B) and nose touching (C) the 
stimulus cage containing a novel stimulus animal compared to the familiar. Mean and 
SEM are shown. * = P < 0.05; ** = P < 0.01; *** = P < 0.001; **** = P < 0.0001. 
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DISCUSSION 
 
The aim of this experiment was to determine the behavioral implications of 
gestational exposure to the polychlorinated biphenyl mixture (A1221) or the fungicide 
Vinclozolin (VIN), two compounds classified as endocrine-disrupting chemicals. With an 
exposure paradigm that encompasses the beginning of the hormone-sensitive period of 
sexual differentiation (Breedlove et al. 1992, Rees at al. 1990, Wagner et al. 1998), we 
determined how interfering with the developmental processes in the fetus leads to life-
long changes in the sexually-dimorphic adult social phenotype. Overall, we found in a 
test that gauges the animal’s affiliative behavior by providing a choice between a 
stimulus rat and an empty cage, all groups, regardless of treatment, displayed a clear-cut 
preference for the stimulus animal - a phenotype expected in this species (Engelmann et 
al. 1995, Moy et al. 2004, Choleris et al. 2006, Crews et al. 2012, Reilly et al. 2015). 
When presented with a familiar vs. an unknown stimulus animal, a subject rat will 
typically spend more time associating with the novel conspecific (Nadler et al. 2004, Cox 
and Rissman 2011, Wolstenholme et al. 2011). This task tests the subject’s ability to 
discriminate between, to remember, and/or to demonstrate a preference for, a novel or 
familiar rat. Here, all groups except for the males prenatally treated with VIN displayed 
the expected preference for the Novel conspecific. Therefore, while there do not appear 
to be effects of A1221 or VIN on the affinity to engage in social behaviors, gestational 
exposure to VIN has a sex-specific influence. There are several non-mutually exclusive 
explanations for this outcome: VIN may have changed an animal’s capacity to 
discriminate one stimulus from another, abolished the preference for a novel animal, or 
affected social memory.  
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Effects of EDCs on Social Behaviors 
 
Our results showed that for both the Sociability and the Social Novelty tests, there 
were no effects of treatment on the total distance travelled or average speed, indicating 
that these treatments had no effects on the locomotive capabilities of these animals. This 
finding is consistent with previous studies looking at this outcome in rats (Reilly et al. 
2015, Gillette et al. 2017). Aside from a trend (p = 0.06) toward significance in the time 
that males spent in the central portion of the chamber during Sociability, there were no 
effects of treatment in the overall time spent in the Social or Empty chambers during 
Sociability. During Social Novelty, there were no effects of treatment on the overall time 
spent in the Novel, Familiar, or Center chambers. By comparison, those measures that 
required close-in interactions (Stimulus Explore and Nose Touching) revealed some 
treatment effects. For Social Novelty, there was a significant effect of treatment in 
females on the latency to initiate the first Nose Touch event where VIN females 
performed this behavior faster than females treated with A1221.  
 
In the test of Sociability, in accordance with previous studies on the effects of 
PCBs in the social behaviors of the animals (Reilly et al. 2015, Bell et al. 2015), there 
were no alterations of preference, with all groups to spend more time investigating and 
interacting with the stimulus cage holding an animal compared to the empty cage. Studies 
with PCBs that have shown differences in an animal’s preference for a social vs. non-
social stimuli did not use A1221, but a mixture of congeners A1247 and A1277 (Jolous-
Jamshidi et al. 2010). During Social Novelty, most groups, with the exception of the VIN 
males,  spent more time associating and interacting with the novel stimulus animal, the 
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expected choice. Similarly, for other measures of interaction (Time Near, Stimulus 
Exploration, and Nose Touching) the VIN males did not display the expected preference. 
This adds to a growing body of literature which implicates EDC exposure to an alteration 
of social behaviors. (PCBs: Jolous-Jamshidi et al. 2010, Reilly et al. 2015; BPA: Adriani 
et al. 2003, Wolstenholme et al. 2013, Pthalates: Wang et al. 2016).   
 
Sex Differences in EDC Effects 
The behaviors selected for this study are sexually dimorphic; EDCs abolished 
some sex differences and introduced others. Vinclozolin treatment led to the most 
disruptions in this regard. Four sex differences found in Vehicle animals were abolished 
in VIN-treated animals. VIN treatment also induced 7 instances of sex differences not 
seen in Vehicle animals.  . For A1221, 4 sex differences were altered compared to 
Vehicle (2 abolished, 2 induced). This corroborates the hypothesis that the gestational 
processes that differentially organize the sexes are subject to changes by exposure to 
EDCs. A previous study in rats treated with A1221 using the same 3-chambered 
apparatus (Reilly et al. 2015), albeit using a shorter exposure time (dams were treated on 
E16 and E18 only, compared to the present study when treatment was from E8-E18) 
showed several sex differences that were not present here. Most surprising was the 
absent, or in some cases reversed, sex difference (M>F) in the amount of time spent Nose 
Touching the stimulus animals. That prior study also used gonadectomized stimulus 
animals that were untreated with hormone whereas the current study utilized intact rats 
(with female stimulus rats used on diestrus); the differences in stimuli could certainly 
affect their salience and the motivation for the experimental rats to interact.  
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Conclusions and Further Research Needs 
The results of this experiment indicated that the behavioral phenotype of the sexes 
is differentially susceptible to the actions of gestational EDC exposure. Through the use 
of the three-chamber test, we provide evidence that gestational exposure to the PCB 
mixture A1221 or the fungicide Vinclozolin did not alter an adult rat’s social motivation, 
as tested during Sociability. The results of Social Novelty suggest that gestational 
Vinclozolin, but not A1221, led to sex-specific alterations of the brain, particularly in 
males, that that was demonstrated by functional differences in social novelty preference. 
The lack of preference shown in these animals may due to an inability to discriminate; 
alternatively, the animals may be capable of distinguishing a novel vs. a familiar rat, with 
treatment altering the preference toward the familiar animal. Finally, there may be 
deficits in social memory. Further experimentation into the motivations underlying an 
animal’s penchant for proximity is needed.   
 
In addition to the behavioral effects of VIN, we failed to observe any changes in 
the Novelty Preference of A1221 in either sex. It was previously reported at A1221 led to 
a sex- and dose-specific disruption of the Novelty Preference phenotype (0.5 mg/kg and 
1.0 mg/kg dosages in females, and 0.5 mg/kg dose in males). Here, the A1221 animals 
(all 1.0 mg/kg) were similar to vehicle.  
 
Further experimentation on the mechanisms and brain regions underlying social 
behavior in these animals will provide insight into the way that fetal PCBs or VIN may 
lead to the phenotypes observed. Specific neural circuits have been implicated in the 
processes governing normal social functioning; in particular, the nonapeptides oxytocin 
and vasopressin are crucial in the regulation of anxiety, social, and sex behavior, and are 
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steroid-sensitive (Bale et al. 2001, Bielsky et al. 2004, Egashira et al. 2007, Young et al. 
2006, Veenema et al. 2013).  Future work will focus on how EDCs sculpt the 
development of these neuropeptide systems. 
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CHAPTER 4: APPLICATION OF A NOVEL SOCIAL CHOICE 
PARADIGM TO ASSESS EFFECTS OF PRENATAL ENDOCRINE-
DISRUPTING CHEMICAL EXPOSURE IN RATS 
The text in this section is excerpted from Reilly MP, Weeks CD,  Crews D, and 
Gore AC. Journal of Comparative Psychology (2018), with permission from the journal. 
As first author, I was involved with all of the experimentation, analysis, and preparation 
of the manuscript. 
ABSTRACT 
Endocrine disrupting chemicals (EDCs) exposures during critical periods of 
gestation cause long-lasting behavioral effects, presumably by disturbing the hormone-
driven organization of the brain. Among such EDCs are polychlorinated biphenyls 
(PCBs), a class of industrial chemicals. PCB exposure in utero lead to alterations in 
mating behaviors and other sexually-dimorphic social interactions in rats. Many of the 
previous studies on social behavior give the experimental animal a single or binary 
choice. This study applies a more complex behavioral apparatus. Using a X-shaped 
Plexiglas apparatus (FourPlex) the experimental animal is able to distinguish and choose 
among stimulus animals of the same or opposite sex, and of different hormonal status. 
Behavioral choices were affected by the sex of the experimental rat, but there was little 
evidence that prenatal exposure to PCB affected the decision-making processes. This may 
be due to the relatively low levels and short duration of the EDC used. Importantly, the 
results differ from our prior results of a simple binary choice model, showing that how an 
animal behaves in a more complex social paradigm does not predict the outcome in a 
simple choice model, and vice versa. 
INTRODUCTION 
Sociality is a complex trait; it arises from the qualities within an individual and 
the social interactions between individuals. The spectrum of social systems is enormous, 
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from animals that live in total isolation except to mate, and others that live in groups from 
dyads to thousands. To reduce this complexity in the laboratory setting, behavioral 
neuroscientists have most commonly taken the reductionist approach. For laboratory 
rodents, most tests comprise a two-choice paradigm, in which an animal is given a choice 
between an empty compartment and a stimulus animal, or between two animals that 
differ in some way (e.g., male vs. female; hormone-primed vs. unprimed; females in 
different stages of receptivity; etc.). Exceptions have been the socioecological work 
pioneered by RD Lisk and M McClintock in their laboratory studies of hamsters and rats 
in large enclosures (Huck, Lisk, & Gore, 1985; McClintock, 1987). More recently, D 
Kimchi and J Curley independently developed methods of quantifying social interactions 
within groups of mice (So, Franks, Lim, & Curley, 2015; Weissbrod et al., 2013). Other 
labs have adopted a multiple-choice system in social models of mate choice (Ferreira-
Nuño, Morales-Otal, Paredes, & Velázquez-Moctezuma, 2005). Results of these studies 
challenge the premise that results from a two-choice paradigm can be extrapolated to 
more complex interactions; yet the two-choice paradigm continues to be the norm.  
Using behavior as a biomarker, our overall goal was to characterize the effects of 
prenatal exposure to ecologically-relevant levels of a class of endocrine-disrupting 
chemicals (EDCs), polychlorinated biphenyls (PCBs). Humans and wildlife continue to 
have detectable levels of PCBs in body tissues, despite the ban of these chemicals in 
developed countries in the 1970s (Gladen, Doucet, & Hansen, 2003). PCBs are persistent, 
are in the food chain, and can be transported around the world by air and water currents, 
as well as by migratory species that feed in contaminated areas for part of the year 
(Crews & Gore, 2011). Previous experimental work from our lab and others on rodents 
has shown that the brain is sensitive to environmental contamination, especially when 
exposure occurs during critical periods of development. One such life stage is that of 
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brain organization, when gonadal steroid hormones exert influences on the developing 
nervous system in a sex-typical manner, setting the stage for subsequent pubertal 
hormones to activate these neural pathways. This enables the manifestation of sexually 
dimorphic behaviors involved in reproduction (McCarthy & Arnold, 2011).  
Exposures to PCBs during periods of organization and/or activation perturb adult 
reproductive physiology and behavior (Dickerson, Cunningham, & Gore, 2011; 
Steinberg, Walker, Juenger, Woller, & Gore, 2008; Walker, Goetz, & Gore, 2013). While 
other sexually-dimorphic social behaviors have also been investigated for effects of 
developmental EDC exposures, this research has exclusively relied upon two-choice 
systems (Belloni et al., 2011; Crews et al., 2012; Gillette et al., 2014; Reilly et al., 2015; 
Venerosi, Ricceri, Tait, & Calamandrei, 2012; Wolstenholme et al., 2011). However, 
mate and social choice in naturalistic settings are complex processes that involve, among 
other things, the complementarity of the chooser and the chosen, with the mutual 
evaluation of qualities related to a mate’s fitness (Crews, 2010; Carson, 2003). In the 
mate choice literature, the terms appetitive and consummatory are used to describe 
exploratory/proceptive behaviors prior to mating, and the act of coitus itself, respectively. 
These concepts that can be extrapolated to more complex social settings where 
conspecifics are first evaluated (i.e., prosocial behaviors) and subsequently decide to 
engage in or avoid interactions. Here, we sought to develop and validate a unique four-
choice paradigm, referred to as the FourPlex, that retains the basic choice aspect but 
allows for a greater variety of social stimuli to better model the types of interactions 
encountered in nature. The stimulus rats were opposite- and same-sex conspecifics of 
differing hormonal status, and results showed that when this complexity was added, these 
clear choices of individuals were quite different from those observed in the dyadic 
situation. 
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MATERIALS AND METHODS 
Animals and Husbandry 
Sprague-Dawley rats were purchased from Harlan (Indianapolis, IN), and all 
animal procedures were conducted in compliance with a protocol (AUP-2013-00054) 
approved by the Institutional Animal Care and Use Committee at the University of Texas 
at Austin, following the guidelines from the NIH. All animals were housed in a colony 
room with controlled temperature (22 C) and light cycle (12:12 dark:light, lights on at 
2400). Rats were fed a low-phytoestrogen diet (Harlan, Indianapolis, IN Cat. # 2019) 
available ad libitum. Virgin females were mated with sexually experienced males. The 
day following successful mating, as indicated by a sperm-positive vaginal smear, was 
termed embryonic day 1 (E1).  
Gestational Exposure Paradigm 
Following confirmed pregnancy, dams were exposed to one of four treatments, 
administered via intraperitoneal injections, on E16 and E18, the beginning of the period 
of brain sexual differentiation (Davis, Popper, & Gorski, 1996; Jacobson, Shryne, 
Shapiro, & Gorski, 1980). The experimental treatment groups were as follows: (1) 
Vehicle [Negative control - 3% dimethylsulfoxide (DMSO) in sesame oil]; (2) Estradiol 
benzoate [(EB) 50 μg/kg – positive control for the estrogenic effects of PCBs)]; (3) the 
PCB mixture, Aroclor 1221 (A1221, 0.5 mg/kg), or (4) A1221 (1 mg/kg). We 
henceforward refer to these groups as vehicle, EB, A1221 (0.5) and A1221 (1.0), 
respectively, as summarized in Table 4.1. Selected treatments and dosages were based on 
prior work conducted in the Gore lab that showed physiological, behavioral, and 
neuroendocrine effects that were manifested in a sex- and developmental age-specific 
manner; however, these dosages caused no overt toxicity or pregnancy complications 
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(Dickerson et al., 2011; Steinberg, Juenger, & Gore, 2007; Steinberg et al., 2008; Topper, 
Walker, & Gore, 2015; Walker et al., 2013, Gillette et al., 2014; Reilly et al. 2015). The 
number of litters per treatment was 9, 10, 10, and 10, respectively. Although we did not 
measure body burden or tissue content in the exposed offspring, the literature suggests 
that maternal-fetal transfer results in a body burden of approximately 1-2 μg/kg A1221, 
and 100 ng/kg EB in the fetuses (Takagi, Aburada, Hashimoto, & Kitaura, 1986). This 
falls in the approximate range of human exposures (DeKoning & Karmaus, 2000; Lin, 
Pessah, & Puschner, 2013). 
The day of parturition was postnatal day 0 (P0). The day after birth, P1, the pups 
were weighed and their anogenital distance measured; litters were culled to 4 males and 4 
females. The pups were monitored daily for age at eye opening, and body weight and 
anogenital distance was measured and recorded weekly from birth to weaning, which 
occurred at P21. Once rehoused in same-sex groups, rats were monitored daily for signs 
of pubertal development: vaginal opening in females and preputial separation in males 
(Steinberg et al., 2007; Walker, Kirson, Perez, & Gore, 2012). In females, beginning on 
the day of vaginal opening, daily vaginal smears were taken and cell cytology was 
examined as a measure of estrous cyclicity in the females. Weekly body weights 
continued to be recorded for all animals throughout their lifetimes. There were no effects 
of prenatal treatment on litter size or sex ratio, age at puberty, or estrous cyclicity (data 
not shown), as previously published (Gillette et al., 2017; Reilly et al., 2015). 
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Table 4.1. Treatment Group Terminology 
Pregnant rats were injected subcutaneously in late gestations (embryonic days 16 and 18) 
with the above treatments. Prenatally exposed rats were the experimental subjects, tested 
in the FourPlex. Experimental groups are referred to by the group names. 
 
Stimulus Rats 
Ten male and 10 female stimulus rats (Sprague-Dawley) were purchased as young 
adults from Harlan and gonadectomized under isoflurane anesthesia. After ovariectomy 
(OVX), females were implanted subcutaneously, in the nape of the neck, with a Silastic 
capsule (1.98mm I.D. × 3.18mm O.D. × 5-mm length; Dow Corning Corporation, 
Midland, MI). Five females received capsules packed with 5% crystalline 17β-estradiol 
(Cat. #: E8875; Sigma-Aldrich, St. Louis, MO) with 95% cholesterol; and 5 females 
received a 100% cholesterol capsule (Wu et al., 2010). Five males received capsules 
containing 100% testosterone (Cat. #: T1500; Sigma-Aldrich, St. Louis, MO) and 5 
received cholesterol capsules (Wu et al., 2010). This resulted in 4 categories of stimulus 
rats (n = 5 per category) as described below. Stimulus animals were untreated with EDCs 
or their controls.  
 
Compound Group name Function
Dimethylsulfoxide (DMSO) 3% in sesame oil Vehicle Negative control
Estradiol benzoate (EB) 50 μg/kg, dissolved in vehicleEB Positive estrogenic control
Aroclor 1221 (A1221) 0.5 mg/kg, dissolved in vehicle A1221 (0.5) Experimental PCB, lower dosage
Aroclor 1221 (A1221) 1.0 mg/kg, dissolved in vehicle A1221 (1.0) Experimental PCB, higher dosage
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Behavioral Testing Paradigm 
Behavioral Testing 
Beginning when experimental (EDC or vehicle-treated) rats were aged P56, one 
male and one female from each litter was used for testing. The total number of 
behaviorally characterized animals was 39 females and 39 males. Females were only 
used on diestrus to remove the possible confound of estrous cycle status on behavioral 
outcomes. Testing was conducted under dim red light during the dark period of their 
light-dark cycle, beginning approximately two hours following lights out. Between 
animals, the behavioral apparatus was thoroughly cleaned with a 70% ethanol solution. 
Apparatus  
The FourPlex apparatus was designed to reveal the ability of the experimental 
animal to discriminate between, and preferentially associate with, four possible stimulus 
partners (Figure 4.1). Four opaque Plexiglas inserts were constructed and placed inside of 
a 100 cm x 100 cm apparatus (Stoelting), resulting in an X-shaped testing arena. Each of 
the four arms held a stimulus cage in the far corner of the apparatus. For the purposes of 
analyses, each arm was further divided into two distinct regions: a zone one body length 
from the stimulus cage and the residual length of the arm, more remote from the cage.  
Each test utilized one stimulus rat from each of four categories: a castrated, 
testosterone-treated male; a castrated male without hormone treatment; an 
ovariectomized, estradiol-treated female; and an ovariectomized female without hormone 
treatment. We refer to the stimulus rats relative to the experimental animal as opposite-
sex (OS) or same-sex (SS); with (+) or without (-) hormone. Thus, the four stimulus 
options were: OS+, OS-, SS+, SS-. On the day of testing, stimulus rats were placed, in 
random order, into one of the four holding cages in the corners. Then, the experimental 
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animal was placed in the middle of the apparatus, marking the beginning of the 10-
minute trial. Between tests, in addition to rearranging the stimulus animals’ placement, 
we periodically replaced stimulus rats to minimize possible consequences of stimulus rat 
fatigue due to prolonged housing in the holding cages.  
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Figure 1: The Four Plex Apparatus 
A
B
1
2
#
 
Figure 4.1. The FourPlex Apparatus 
The FourPlex apparatus is shown viewed from one corner (A) and in a bird’s eye view 
(B). Four opaque Plexiglas inserts were fabricated to fit inside of a square apparatus (100 
cm x 100 cm), resulting in an X-shaped testing arena. As seen in B, each of the four arms 
emanated from a common central area (outer circle labeled “3”) that projected via four 
arms to a holding cage in each corner. For the purposes of behavioral analyses, each arm 
was further divided into two distinct regions: a zone one body length from the walls of 
the stimulus cage (1; the “near” region), and the remaining length of the arm (2; the 
“remote” region). At the onset of the test, the experimental rat (indicated by #) was 
placed into the innermost center circle, labeled “4.” 
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Behavioral Analysis 
Animal tracking and behavior scoring. ANY-maze (Stoelting Co.) was used to 
simultaneously video record and track behaviors during the test. All scoring was done 
blind to the stimulus or experimental rats’ status, and codes were broken only after 
scoring was complete. We used the software to analyze measures of duration or 
frequency relative to the animal’s position within the apparatus, namely: the time spent in 
each whole arm (“Time in Whole Arm”); time spent in proximity to the stimulus rats’ 
cage (“Time Near Stimulus Cage” = within one body length); and “Time in Remote 
Arm,” calculated by subtracting the Time Near Stimulus Cage from the Time in Whole 
Arm. The number of times each animal entered (80% of body volume) an arm was 
automatically determined by the software. Then, the video recordings of the tests were 
manually scored for the following additional behaviors: “Number of Stimulus Explore 
Events” was the number of times an animal spent investigating the stimulus chamber by 
sniffing and exploring. The number of times the animals engaged in nose-to-nose contact, 
or “Number of Nose Touch Events,” was also scored. These investigator-scored 
behaviors, chosen as the most salient aspect of social investigation, have been used 
before in a previous study on sociality (Reilly et al., 2015). The relative contribution each 
stimulus had on the cumulative expression of each behavior can be assessed qualitatively 
by graphing the means of each measure as a percentage of the whole (Figure 4.2).  
During initial analysis, we established that the vast majority of the experimental 
animals had visited every stimulus option by the end of the first two minutes. When this 
happened, rats were able to make an ‘Informed Choice’ about all of their stimulus 
options. An example of a rat visiting each of the four stimulus animals is shown in the 
Supplemental video. Therefore, our assessment and presentation of social behavior in this 
study comprises the behavior of the animals during the latter eight-minute period of time 
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during which the experimental animals’ behavior reflects this informed choice. Any 
animals that did not visit all four stimulus options during the two-minute habituation 
period were removed from all subsequent analyses. This resulted in two rats being 
excluded: one vehicle female, and one vehicle male. 
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Figure 2. Stimulus Choice Contribution
Figure 4.2. Qualitative Expression of 
Choice   
The contribution each stimulus choice 
had on the behavioral output is shown 
for the six variables measured. Data are 
shown separately for each of the four 
treatment groups in females and males. 
Bars are always set at 100%, and the 
percentage of time each behavior is 
displayed toward each of the stimulus 
categories is shown. This enables 
visualization that most behaviors are 
predominantly exhibited towards the 
opposite-sex hormone-treated rat, 
which is the most socially salient, and 
validates that the FourPlex enables 
animals to make this distinction. 
Terminology here and throughout the 
manuscript is OS-: opposite-sex 
castrated rat (no hormone); OS+: 
opposite-sex castrated rat given 
hormone (estradiol in females, 
testosterone in males); SS-: same-sex 
castrated rat, no hormone; and SS+: 
same-sex castrated rat, given hormone. 
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Statistical Analysis 
Outliers  
A generalized extreme studentized deviate (ESD) test was used to detect outliers, 
limited to a maximum of two per group per endpoint. Any individuals repeatedly detected 
as outliers across multiple endpoints were removed from analyses; this was the case for 
two vehicle animals (one per sex) and one EB female. Initial statistical analyses were 
used to identify any potential cohort or litter effects within groups; none were found.  
Statistical tests 
Because of the sexual dimorphism in social and sociosexual behavior, analyses 
were done separately for each sex. First, each dataset was inspected for homogeneity of 
variance and normality to determine if it met criteria for parametric analysis by ANOVA. 
Those endpoints that met criteria were analyzed this way using R (version 3.3.2), and 
effect sizes were calculated using the lsr package, and reported as partial eta-squared 
(ηp2) values in the tables. When data did not satisfy the assumptions for parametric 
statistics, the non-parametric Kruskal-Walis (KW) test was run using JMP (version 12), 
with effect sizes reported as epsilon-squared (ε2) values. The Tukey HSD and Steel-
Dwass all-pairs tests were used as post-hoc tests for the ANOVA and KW, respectively. 
In order to determine whether there were sex differences within treatment groups, a 
Student’s t-test was used, and effect sizes were determined using Cohen’s d values with 
the online effect size calculator (http://www.uccs.edu/~lbecker/). In the tables, those 
effects that were significant at p < 0.05 and/or had LARGE effect sizes are indicated with 
bold text. 
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Multivariate analyses 
Principle Components Analysis (PCA) was employed to analyze the entire 
behavioral ethogram within each sex (Scarpino, Gillette, & Crews, 2014; Gillette et al., 
2014). The full list of behaviors in the ethogram is shown in Supplemental Figure 4.1. 
Rotation was applied such that the axis would capture the maximal amount of variance. 
Three principle components were identified as contributing to the majority of the 
variance (53%) in both sexes (Supplemental Figure 4.1). Then, linear discriminate 
analysis (LDA) was used to conduct systematic pairwise comparisons of each component 
for all animals, as well as within each sex, to establish how the principle components 
clustered (Supplemental Table 4.1). Finally, functional landscape analysis was conducted 
for sex differences on two behavioral outcomes, one representing an appetitive behavior, 
the other a consummatory behavior. This allows visual graphic representation and 
quantitative analysis of phenotypic traits first as absolute measures towards the four 
stimuli, as well as sex differences for each treatment group (Scarpino, Gillette, & Crews, 
2014). 
Results 
Overview of Behaviors in the FourPlex Test 
For each sex, data were initially analyzed for effects of treatment on total time 
and numbers of events during the 8-minute “informed choice” part of the test, 
irrespective of which stimulus rat to which they were directed (Table 4.2). There were no 
significant effects of treatment in females or males. We also determined sex differences. 
The number of nose touch events in the EB and A1221 (0.5) groups was significantly 
sexually dimorphic (male > female) and had LARGE Cohen’s d effect sizes. The time 
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near the stimulus cage had a LARGE effect size for the sex difference in vehicle rats 
(female > male) although it was not statistically significantly different. 
 
 
 
 
 
(Table 4.2 continued on next page) 
Measure Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 286 ± 23
EB 297 ± 14
A1221 (0.5) 330 ± 10
A1221 (1.0) 301 ± 19
Vehicle 160 ± 21
EB 198 ± 13
A1221 (0.5) 225 ± 13
A1221 (1.0) 188 ± 14
Vehicle 126 ± 18
EB 99 ± 16
A1221 (0.5) 105 ± 14
A1221 (1.0) 114 ± 11
Vehicle 96 ± 6
EB 95 ± 6
A1221 (0.5) 102 ± 4
A1221 (1.0) 104 ± 7
Vehicle 137 ± 26
EB 137 ± 21
A1221 (0.5) 145 ± 10
A1221 (1.0) 156 ± 15
Vehicle 24 ± 5
EB 21 ± 5
A1221 (0.5) 23 ± 4
A1221 (1.0) 33 ± 3
Kruskal-
Wallis 0.39
0.12
0.63
0.58
0.86F(3,34) = 0.25
X2(3) = 3.01
X2(3) = 5.92
F(3,34) = 0.59
F(3,34) = 0.66
Kruskal-
Wallis
ANOVA
ANOVA
ANOVA
ANOVA
SEM
Time in Remote 
Arm (sec) 0.16
Time in Whole Arm 
(sec) 0.08
Number of Arm 
Entries 0.06
A. Female Treatment Effects
Time Near 
Stimulus Cage 
(sec)
0.05
Number of Nose 
Touch Events 0.16
Number of 
Stimulus Explore 
Events
0.02
0.13F(3,34) = 2.05
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(Table 4.2 continued on next page) 
Measure Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 289 ± 26
EB 299 ± 14
A1221 (0.5) 349 ± 16
A1221 (1.0) 300 ± 23
Vehicle 200 ± 19
EB 202 ± 23
A1221 (0.5) 241 ± 23
A1221 (1.0) 192 ± 20
Vehicle 89 ± 12
EB 97 ± 13
A1221 (0.5) 108 ± 14
A1221 (1.0) 108 ± 6
Vehicle 85 ± 9
EB 83 ± 4
A1221 (0.5) 92 ± 8
A1221 (1.0) 102 ± 5
Vehicle 129 ± 18
EB 151 ± 9
A1221 (0.5) 179 ± 19
A1221 (1.0) 162 ± 9
Vehicle 26 ± 3
EB 32 ± 3
A1221 (0.5) 38 ± 5
A1221 (1.0) 35 ± 6
X2(3) = 7.50
X2(3) = 0.68
F(3,34) = 0.62
X2(3) = 7.37
X2(3) = 3.58Kruskal-Wallis
Kruskal-Wallis
Kruskal-Wallis
ANOVA
Kruskal-Wallis
SEM
Time in Remote 
Arm (sec) 0.87
Time in Whole Arm 
(sec) 0.06
Number of Arm 
Entries 0.06
B. Male Treatment Effects
Time Near 
Stimulus Cage 
(sec)
0.61
Number of Nose 
Touch Events 0.23
Number of 
Stimulus Explore 
Events
0.31
F(3,34) = 1.51ANOVA
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Table 4.2. Summary of Behaviors 
A summary of all behaviors is shown for Female (A) and Male (B) rats. Data are shown 
as mean + SEM, statistical tests, values and degrees of freedom, and effect sizes are 
indicated (SMALL = 0.01; MEDIUM = 0.09; LARGE = 0.25). No significant treatment 
effects were found for either sex. (C) The statistics for within-treatment sex differences 
and Cohen’s d effect sizes for the sex differences are shown (SMALL = 0.2; MEDIUM = 
0.5; LARGE = 0.8), with directionality indicated (M=male, F=female). Where there are 
significant differences or LARGE effect sizes, data are shown in bold text. 
Measure Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.94 -0.04 SMALL
EB 0.89 -0.06 SMALL
A1221 (0.5) 0.34 -0.44 SMALL
A1221 (1.0) 0.95 0.03 SMALL
Vehicle 0.30 -0.52 MEDIUM
EB 0.91 0.05 SMALL
A1221 (0.5) 0.48 0.32 SMALL
A1221 (1.0) 0.62 -0.23 SMALL
Vehicle 0.10 0.85 LARGE F > M
EB 0.94 0.04 SMALL
A1221 (0.5) 0.89 -0.06 SMALL
A1221 (1.0) 0.66 0.20 SMALL
Vehicle 0.35 0.48 SMALL
EB 0.12 0.74 MEDIUM
A1221 (0.5) 0.26 0.52 MEDIUM
A1221 (1.0) 0.75 0.15 SMALL
Vehicle 0.79 0.13 SMALL
EB 0.54 -0.28 SMALL
A1221 (0.5) 0.12 -0.72 MEDIUM
A1221 (1.0) 0.73 -0.16 SMALL
Vehicle 0.72 -0.17 SMALL
EB 0.05 -0.96 LARGE M > F
A1221 (0.5) 0.02 -1.17 LARGE M > F
A1221 (1.0) 0.80 -0.12 SMALL
C. Sex Effects within Treatment
Time in Whole Arm 
(sec)
Time in Remote Arm 
(sec)
Time Near Stimulus 
Cage (sec)
Number of Arm 
Entries
Number of Stimulus 
Explore Events
Number of Nose 
Touch Events
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Social Investigation of Stimulus Animals 
Each of the behaviors was subsequently analyzed for effects of treatment and sex, 
with the 4 stimulus rats as variables. The following analyses were conducted on the 8-
minute “informed choice” period. 
Time in Whole Arm (Table 4.3; Figure 4.2A) 
Regardless of sex or treatment, experimental rats spent the most time in the arm 
leading up to the OS+ stimulus animal. However, there were no main effects of 
treatment. There was one significant sex difference found for the EB groups towards the 
OS+ stimulus rat (male > female), with a LARGE Cohen’s d effect size. 
 
 
 
(Table 4.3 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 77 ± 7
EB 63 ± 4
A1221 (0.5) 72 ± 4
A1221 (1.0) 63 ± 7
Vehicle 102 ± 12
EB 92 ± 5
A1221 (0.5) 111 ± 11
A1221 (1.0) 96 ± 10
Vehicle 47 ± 6
EB 65 ± 7
A1221 (0.5) 64 ± 5
A1221 (1.0) 65 ± 4
Vehicle 86 ± 10
EB 75 ± 7
A1221 (0.5) 83 ± 6
A1221 (1.0) 85 ± 4
F(3,33) = 1.52
X2(3) = 2.37
F(3,33) = 2.27
F(3,32) = 0.67 0.58
0.23
0.50
0.10
0.12
0.07
0.18
0.06
OS+
SS-
SS+
ANOVA
Kruskal-
Wallis
ANOVA
ANOVA
OS-
SEM
A. Female Treatment Effects
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(Table 4.3 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 62 ± 8
EB 58 ± 6
A1221 (0.5) 82 ± 6
A1221 (1.0) 61 ± 7
Vehicle 96 ± 9
EB 132 ± 9
A1221 (0.5) 115 ± 13
A1221 (1.0) 109 ± 8
Vehicle 64 ± 9
EB 52 ± 7
A1221 (0.5) 68 ± 8
A1221 (1.0) 68 ± 7
Vehicle 75 ± 8
EB 70 ± 8
A1221 (0.5) 83 ± 8
A1221 (1.0) 81 ± 5
F(3,35) = 2.76
F(3,35) = 2.14
F(3,36) = 0.99
F(3,33) = 0.61 0.61
0.06
0.11
0.41
0.20
0.16
0.08
0.05
OS+
SS-
SS+
ANOVA
ANOVA
ANOVA
ANOVA
OS-
SEM
B. Male Treatment Effects
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Table 4.3. Time in Whole Arm (seconds) 
Time spent in the whole arm (seconds) is shown for Females (A) and Males (B). Data 
here, and in subsequent Tables 4-7, are shown as mean + SEM. Statistical tests used, 
values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM 
= 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences and 
Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. There were no differences due to treatment. The one 
significant sex difference is indicated. M=male, F=female.   
 
 
 
 
Stimulus Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.66 0.76 MEDIUM
EB 0.52 0.40 SMALL
A1221 (0.5) 0.13 -0.72 MEDIUM
A1221 (1.0) 0.80 0.12 SMALL
Vehicle 0.67 0.21 SMALL
EB 0.002 -1.58 LARGE M > F
A1221 (0.5) 0.80 -0.12 SMALL
A1221 (1.0) 0.37 -0.43 SMALL
Vehicle 0.81 -0.78 MEDIUM
EB 0.14 0.61 MEDIUM
A1221 (0.5) 0.69 -0.18 SMALL
A1221 (1.0) 0.69 -0.18 SMALL
Vehicle 0.39 0.44 SMALL
EB 0.77 0.21 SMALL
A1221 (0.5) 0.97 0.01 SMALL
A1221 (1.0) 0.51 0.31 SMALL
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
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Time in Remote Arm (Table 4.4; Figure 4.2B) 
Rats spent the most time in the OS+ stimulus animals’ arm. In females, there was 
a main effect of treatment within the SS- arm, with post-hoc analysis indicating that the 
EB, A1221 (0.5) and A1221 (1.0) females spent significantly more time there than did 
the vehicle females. Regarding sex differences, a significant difference was observed in 
the EB group toward the OS+ stimulus animal (male > female), with a LARGE effect 
size. The other significant sex difference was seen in the vehicle group toward the SS- 
stimulus animal (male > female), again with a LARGE effect size. 
 
 
 
 
(Table 4.4 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 33 ± 9
EB 42 ± 4
A1221 (0.5) 46 ± 5
A1221 (1.0) 46 ± 7
Vehicle 63 ± 15
EB 57 ± 7
A1221 (0.5) 89 ± 12
A1221 (1.0) 61 ± 9
Vehicle 21 ± 7
EB 52 ± 7
A1221 (0.5) 43 ± 5
A1221 (1.0) 42 ± 3
Vehicle 43 ± 10
EB 46 ± 5
A1221 (0.5) 47 ± 5
A1221 (1) 38 ± 10
SS+ 0.00
SS- 0.32Kruskal-Wallis
Kruskal-
Wallis
X2(3) = 11.67 0.01
X2(3) = 0.0597 1.00
OS+ 0.16
OS- 0.06Kruskal-Wallis
Kruskal-
Wallis
X2(3) = 2.06 0.56
X2(3) = 5.67 0.13
SEM
A. Female Treatment Effects
 85 
 
 
 
 
 
 
 
 
 
 
 
(Table 4.4 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 45 ± 7
EB 35 ± 10
A1221 (0.5) 54 ± 7
A1221 (1.0) 43 ± 5
Vehicle 62 ± 7
EB 93 ± 12
A1221 (0.5) 95 ± 18
A1221 (1.0) 52 ± 15
Vehicle 45 ± 6
EB 36 ± 4
A1221 (0.5) 37 ± 5
A1221 (1.0) 45 ± 4
Vehicle 48 ± 9
EB 37 ± 10
A1221 (0.5) 55 ± 7
A1221 (1) 51 ± 11
SS+ 0.06
SS- 0.07ANOVA
Kruskal-
Wallis
F(3,36) = 0.89 0.46
X2(3) = 2.26 0.48
OS+ 0.11
OS- 0.05Kruskal-Wallis
Kruskal-
Wallis
X2(3) = 1.83 0.61
X2(3) = 4.08 0.25
SEM
B. Male Treatment Effects
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Table 4.4. Time in Remote Arm (seconds) 
Time spent in the remote arm (seconds) is shown with significant (p < 0.05) and/or 
LARGE effect sizes indicated. See Table 4.2 for explanations of statistics and data 
presentation. 
 
Time Near Stimulus Cage (Table 4.5; Figure 4.2C) 
There were no significant treatment effects for this measure, although there was a 
trend toward significance in both the males (p = 0.06) and the females (p = 0.10) for the 
OS- arm. Regarding sex differences, for the OS- arm, there was a LARGE effect size 
Stimulus Treatment P-Value Cohen's d Effect Size Directionality
EB 0.76 -0.19 SMALL
A1221 (0.5) 0.80 -0.12 SMALL
A1221 (1.0) 0.82 -0.11 SMALL
Vehicle 0.21 -0.38 SMALL
EB 0.05 -1.11 LARGE M > F
A1221 (0.5) 0.64 0.25 SMALL
A1221 (1.0) 0.56 -0.28 SMALL
Vehicle 0.02 -1.23 LARGE M > F
EB 0.09 0.60 MEDIUM
A1221 (0.5) 0.39 0.40 SMALL
A1221 (1.0) 0.51 -0.30 SMALL
Vehicle 0.63 0.17 SMALL
EB 0.97 -0.12 SMALL
A1221 (0.5) 0.72 -0.17 SMALL
A1221 (1) 0.13 -0.78 MEDIUM
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
 87 
(female > male) although this did not attain significance. Two significant sex differences 
were seen for the SS+ arm for vehicle and A1221 (1.0) groups, associated with a 
MEDIUM and LARGE Cohen’s d effect size, respectively (female > male for both).  
 
 
 
 
 
 
 
 
 
 
 
(Table 4.5 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 35 ± 7
EB 21 ± 4
A1221 (0.5) 26 ± 4
A1221 (1.0) 18 ± 4
Vehicle 44 ± 8
EB 35 ± 7
A1221 (0.5) 27 ± 4
A1221 (1.0) 35 ± 6
Vehicle 20 ± 4
EB 20 ± 3
A1221 (0.5) 21 ± 5
A1221 (1.0) 23 ± 4
Vehicle 36 ± 9
EB 27 ± 7
A1221 (0.5) 37 ± 6
A1221 (1.0) 39 ± 5
SS+ 0.06
SS- 0.01ANOVA
ANOVA
F(3,32) = 0.13 0.94
F(3,33) = 0.70 0.56
OS+ 0.10
OS- 0.17ANOVA
ANOVA
F(3,33) = 2.25 0.10
F(3,32) = 1.05 0.38
SEM
A. Female Treatment Effects
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(Table 4.5 continued on next page) 
Stimulus Treatment Mean (s) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 20 ± 4
EB 18 ± 4
A1221 (0.5) 32 ± 5
A1221 (1.0) 18 ± 3
Vehicle 33 ± 5
EB 48 ± 4
A1221 (0.5) 29 ± 5
A1221 (1.0) 45 ± 7
Vehicle 19 ± 5
EB 16 ± 3
A1221 (0.5) 31 ± 8
A1221 (1.0) 23 ± 4
Vehicle 24 ± 5
EB 26 ± 6
A1221 (0.5) 31 ± 7
A1221 (1.0) 24 ± 3
SS+ 0.04
SS- 0.09Kruskal-Wallis
ANOVA
X2(3) = 3.28 0.35
F(3,32) = 0.41 0.74
OS+ 0.19
OS- 0.20ANOVA
ANOVA
F(3,34) = 2.69 0.06
F(3,31) = 2.41 0.09
SEM
B. Male Treatment Effects
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Table 4.5. Time Near Stimulus Cage (seconds) 
Time spent near (one body length) each stimulus rat's holding cage is shown with 
significant (p < 0.05) and/or LARGE effect sizes indicated. See Table 4.2 for 
explanations of statistics and data presentation. 
 
Number of Arm Entries (Table 4.6; Figure 4.2D) 
All treatment groups entered the arm containing the OS+ stimulus animal most 
often. A main effect of treatment was seen in females for the SS- arm, driven by a 
significantly higher number of entries for the A1221 (1.0) females entered the arm 
compared to females in the vehicle group. There were no main effects of treatment in 
males. There was one instance of a significant sex difference for EB rats with respect to 
the SS- stimulus (female > male); this difference was associated a LARGE effect size.  
Stimulus Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.10 0.90 LARGE F > M
EB 0.53 0.43 MEDIUM
A1221 (0.5) 0.38 -0.41 SMALL
A1221 (1.0) 0.95 0.03 SMALL
Vehicle 0.35 0.60 MEDIUM
EB 0.16 -0.48 SMALL
A1221 (0.5) 0.78 -0.15 SMALL
A1221 (1.0) 0.29 -0.49 SMALL
Vehicle 0.71 0.07 SMALL
EB 0.42 0.47 SMALL
A1221 (0.5) 0.27 -0.51 MEDIUM
A1221 (1.0) 0.97 -0.02 SMALL
Vehicle 0.04 0.66 MEDIUM F > M
EB 0.87 0.22 SMALL
A1221 (0.5) 0.53 0.29 SMALL
A1221 (1.0) 0.02 1.24 LARGE F > M
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
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(Table 4.6 continued on next page) 
 
 
Stimulus Treatment Mean (#) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 24 ± 2
EB 20 ± 1
A1221 (0.5) 22 ± 1
A1221 (1.0) 22 ± 2
Vehicle 29 ± 4
EB 27 ± 1
A1221 (0.5) 31 ± 3
A1221 (1.0) 30 ± 4
Vehicle 17 ± 2
EB 22 ± 2
A1221 (0.5) 22 ± 1
A1221 (1.0) 27 ± 2
Vehicle 26 ± 3
EB 25 ± 2
A1221 (0.5) 27 ± 2
A1221 (1.0) 26 ± 1
SS+ 0.02
SS- 0.32ANOVA
ANOVA
F(3,34) = 5.12 0.01
F(3,34) = 0.23 0.87
OS+ 0.03
OS- 0.06ANOVA
Kruskal-
Wallis
F(3,34) = 0.75 0.53
X2(3) = 1.04 0.79
SEM
A. Female Treatment Effects
Stimulus Treatment Mean (#) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 21 ± 1
EB 17 ± 1
A1221 (0.5) 23 ± 2
A1221 (1.0) 24 ± 3
Vehicle 29 ± 3
EB 29 ± 3
A1221 (0.5) 26 ± 3
A1221 (1.0) 28 ± 3
Vehicle 19 ± 3
EB 17 ± 2
A1221 (0.5) 19 ± 3
A1221 (1.0) 23 ± 2
Vehicle 21 ± 1
EB 23 ± 2
A1221 (0.5) 24 ± 3
A1221 (1.0) 26 ± 2
SS+ 0.08
SS- 0.11ANOVA
Kruskal-
Wallis
X2(3) = 1.37 0.27
X2(3) = 3.09 0.38
OS+ 0.02
OS- 0.20Kruskal-Wallis
Kruskal-
Wallis
X2(3) = 7.30 0.06
X2(3) = 0.79 0.85
SEM
B. Male Treatment Effects
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Table 4.6. Number of Arm Entries 
The mean  number of entries into each of the arms is shown with significant (p < 0.05) 
and/or LARGE effect sizes indicated. See Table 4.2 for explanations of statistics and data 
presentation. 
 
Number of Stimulus Explore Events (Table 4.7; Figure 4.2E)  
For all treatments and both sexes, the number of times the experimental animal 
explored the stimulus cage was highest toward the OS+ animal. No effects of treatment 
were seen in females. A main effect of treatment was observed in the males towards the 
Stimulus Treatment P-Value Cohen's d Effect size Directionality
Vehicle 0.78 0.56 MEDIUM
EB 0.16 0.76 MEDIUM
A1221 (0.5) 0.62 -0.23 SMALL
A1221 (1.0) 0.54 -0.28 SMALL
Vehicle 0.54 0.02 SMALL
EB 0.69 -0.18 SMALL
A1221 (0.5) 0.27 0.51 MEDIUM
A1221 (1.0) 0.74 0.15 SMALL
Vehicle 0.61 -0.25 SMALL
EB 0.05 0.81 LARGE F > M
A1221 (0.5) 0.21 0.58 MEDIUM
A1221 (1.0) 0.16 0.65 MEDIUM
Vehicle 0.17 0.71 MEDIUM
EB 0.65 0.28 SMALL
A1221 (0.5) 0.45 0.35 SMALL
A1221 (1.0) 0.93 -0.04 SMALL
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
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OS- stimulus rats, with post-hoc analysis showing A1221 (0.5) > vehicle and EB. Several 
main effects of sex were observed. Compared to EB females, EB males explored the OS+ 
stimulus significantly more; this difference was associated with a LARGE effect size. 
With respect to the SS- stimulus, a main effect of sex was found for the EB (female > 
male) and A1221 (0.5) (male > female). The Cohen’s d effect sizes associated with these 
differences were both LARGE.  
 
 
 
 
 
 
 
 
 
(Table 4.7 continued on next page) 
Stimulus Treatment Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 36 ± 9
EB 34 ± 6
A1221 (0.5) 35 ± 4
A1221 (1.0) 33 ± 6
Vehicle 44 ± 8
EB 46 ± 2
A1221 (0.5) 47 ± 5
A1221 (1.0) 52 ± 6
Vehicle 26 ± 6
EB 37 ± 3
A1221 (0.5) 25 ± 2
A1221 (1.0) 33 ± 5
Vehicle 36 ± 8
EB 42 ± 8
A1221 (0.5) 45 ± 7
A1221 (1.0) 43 ± 5
SS+ 0.04
SS- 0.15
ANOVA
Kruskal-
Wallis X
2
(3) = 5.15 0.16
F(3,32) = 0.39 0.76
OS+ 0.04
OS- 0.02ANOVA
Kruskal-
Wallis
F(3,34) = 0.18 0.91
X2(3) = 1.37 0.71
SEM
A. Female Treatment Effects
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(Table 4.7 continued on next page) 
Stimulus Treatment Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 24 ± 5
EB 26 ± 4
A1221 (0.5) 47 ± 6
A1221 (1.0) 31 ± 5
Vehicle 45 ± 7
EB 65 ± 5
A1221 (0.5) 60 ± 11
A1221 (1.0) 69 ± 10
Vehicle 32 ± 3
EB 25 ± 3
A1221 (0.5) 35 ± 4
A1221 (1.0) 33 ± 2
Vehicle 39 ± 5
EB 37 ± 4
A1221 (0.5) 44 ± 5
A1221 (1.0) 40 ± 4
SS+ 0.04
SS- 0.14
ANOVA
ANOVA F(3,34) = 1.83 0.16
F(3,34) = 0.43 0.73
OS+ 0.11
OS- 0.28ANOVA
ANOVA
F(3,33) = 4.13 0.01
F(3,35) = 1.41 0.26
SEM
B. Male Treatment Effects
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Table 4.7. Number of Stimulus Explore Events 
The mean number of stimulus explore events is shown with significant (p < 0.05) and/or 
LARGE effect sizes indicated. See Table 4.2 for explanations of statistics and data 
presentation. 
 
 
Number of Nose Touch Events (Table 4.8; Figure 4.2F) 
The OS+ stimulus animals again elicited the greatest number of nose touches, and 
there were no main effects of treatment in either sex. There were several sex differences, 
all male > female, as indicated by p-values and/or LARGE effect sizes. Specifically, sex 
differences were found for the OS- stimulus [A1221 (0.5)]; for the OS+ stimulus (EB); 
and for both the SS- and the SS+ stimuli [A1221 (0.5)]. 
 
Stimulus Treatment P-Value Cohen's d Effect size Directionality
Vehicle 0.80 0.58 MEDIUM
EB 0.55 0.50 MEDIUM
A1221 (0.5) 0.15 -0.68 MEDIUM
A1221 (1.0) 0.83 0.10 SMALL
Vehicle 0.83 -0.06 SMALL
EB 0.01 -1.61 LARGE M > F
A1221 (0.5) 0.29 -0.52 MEDIUM
A1221 (1.0) 0.17 -0.63 MEDIUM
Vehicle 0.69 -0.42 MEDIUM
EB 0.03 1.31 LARGE F > M
A1221 (0.5) 0.03 -1.12 LARGE M > F
A1221 (1.0) 0.97 0.02 SMALL
Vehicle 0.84 -0.13 SMALL
EB 0.95 0.23 SMALL
A1221 (0.5) 0.87 0.07 SMALL
A1221 (1.0) 0.67 0.20 SMALL
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
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(Table 4.8 continued on next page) 
Stimulus Treatment Mean (#) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 6.8 ± 2.1
EB 4.4 ± 1.2
A1221 (0.5) 6.3 ± 1.2
A1221 (1.0) 6.8 ± 1.9
Vehicle 9.8 ± 2.4
EB 7.8 ± 2.5
A1221 (0.5) 10.3 ± 2.4
A1221 (1.0) 14.4 ± 2.4
Vehicle 3.4 ± 1.6
EB 1.9 ± 0.8
A1221 (0.5) 2.4 ± 0.6
A1221 (1.0) 5.0 ± 1.3
Vehicle 4.3 ± 1.6
EB 7.9 ± 2.3
A1221 (0.5) 5.0 ± 1.4
A1221 (1.0) 7.6 ± 1.2
0.45SS+ X2(3) = 2.67
SS- X2(3) = 3.67Kruskal-Wallis
Kruskal-
Wallis
0.11
0.08
0.30
OS+ X2(3) = 4.08
OS- X2(3) = 1.42Kruskal-Wallis
Kruskal-
Wallis
0.04
0.12
0.70
0.25
SEM
A. Female Treatment Effects
Stimulus Treatment Mean (#) Test
F (df) for ANOVA; 
X2 (df) for KW P-value
ηp2 for ANOVA; 
ε2 for KW
Vehicle 5.8 ± 2.2
EB 7.3 ± 1.9
A1221 (0.5) 10.0 ± 1.6
A1221 (1.0) 4.9 ± 1.3
Vehicle 11.6 ± 3.2
EB 14.3 ± 1.8
A1221 (0.5) 14.3 ± 2.5
A1221 (1.0) 17.1 ± 3.9
Vehicle 4.1 ± 1.0
EB 3.0 ± 0.6
A1221 (0.5) 5.7 ± 1.0
A1221 (1.0) 4.4 ± 1.2
Vehicle 5.3 ± 1.1
EB 8.2 ± 1.7
A1221 (0.5) 10.1 ± 2.1
A1221 (1.0) 9.1 ± 1.7
0.29SS+ X2(3) = 3.73
SS- F(3,33) = 1.30ANOVA
Kruskal-
Wallis
0.11
0.10
0.29
OS+ X2(3) = 1.90
OS- X2(3) = 4.43Kruskal-Wallis
Kruskal-
Wallis
0.12
0.05
0.22
0.59
SEM
B. Male Treatment Effects
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Table 4.8. Number of Nose Touch Events 
The mean number of nose touch events is shown with significant (p < 0.05) and/or 
LARGE effect sizes indicated. See Table 2 for explanations of statistics and data 
presentation. 
 
Multivariate Analyses of Behavior 
Principle components analysis and linear discriminate analysis.  
In females, PCA determined that 53% of the variance could be accounted for 
within the first 3 principle components (Figure 4.3A). Linear discriminate analysis (Table 
4.9) revealed that the EB and vehicle datasets differed from each other significantly 
within females. In males, again, PCA determined that 53% of the variance could be 
accounted for within the first 3 principle components (Figure 4.3B). There were no 
Stimulus Treatment P-Value Cohen's d Effect size Directionality
Vehicle 0.41 0.15 SMALL
EB 0.23 -0.55 MEDIUM
A1221 (0.5) 0.09 -0.81 LARGE M > F
A1221 (1.0) 0.43 0.38 SMALL
Vehicle 0.06 -0.21 SMALL
EB 0.01 -0.64 MEDIUM M > F
A1221 (0.5) 0.26 -0.55 MEDIUM
A1221 (1.0) 0.56 -0.26 SMALL
Vehicle 0.18 -0.19 SMALL
EB 0.22 -0.29 SMALL
A1221 (0.5) 0.01 -1.34 LARGE M > F
A1221 (1.0) 0.77 0.14 SMALL
Vehicle 0.09 -0.26 SMALL
EB 0.92 0.03 SMALL
A1221 (0.5) 0.06 -0.90 LARGE M > F
A1221 (1.0) 0.48 -0.33 SMALL
C. Sex Effects within Treatment
OS-
OS+
SS-
SS+
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effects of treatment found on the datasets within the males. When the sexes were 
considered together, female EB and male EB rats also differed (Table 4.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Figure 4.3 continued on next page) 
Figure S1. Principle Component Plots 1-3 
0.2
0.1
0.0
0.1
Distance traveled - Center
# Entries - Center
Time in Center
# Arm entries - OS-
# Arm entries - OS+
# Arm entries - SS-
# Arm entries - SS+
Time near stimulus cage - OS-
Time near stimulus cage - OS+
Time near stimulus cage - SS-
Time near stimulus cage - SS+
# Nose touch events - OS-
# Nose touch events - OS+
# Nose touch events - SS-
# Nose touch events - SS+
Time nose touching - OS-
Time nose touching - OS+
Time nose touching - SS-
Time nose touching - SS+
Distance traveled - Innermost center
# Entries - Innermost center
Time in innermost center
# Stimulus explore events - OS-
# Stimulus explore events - OS+
# Stimulus explore events - SS-
# Stimulus explore events - SS+
Time spent in stimulus explore - OS-
Time spent in stimulus explore - OS+
Time spent in stimulus explore - SS-
Time spent in stimulus explore - SS+
Time in whole arm - OS-
Time in whole arm - OS+
Time in whole arm - SS-
Time in whole arm - SS+
PC1
0.3
0.2
0.1
0.0
0.1
0.2
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC2
0.2
0.0
0.2
0.4
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC3
0.2
0.0
0.2
PC1
0.3
0.2
0.1
0.0
0.1
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC2
0.4
0.2
0.0
0.2
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC3
Females
Males
Distance traveled - Center
# Entries - Center
Time in Center
# Arm entries - OS-
# Arm entries - OS+
# Arm entries - SS-
# Arm entries - SS+
Time near stimulus cage - OS-
Time near stimulus cage - OS+
Time near stimulus cage - SS-
Time near stimulus cage - SS+
# Nose touch events - OS-
# Nose touch events - OS+
# Nose touch events - SS-
# Nose touch events - SS+
Time nose touching - OS-
Time nose touching - OS+
Time nose touching - SS-
Time nose touching - SS+
Distance traveled - Innermost center
# Entries - Innermost center
Time in innermost center
# Stimulus explore events - OS-
# Stimulus explore events - OS+
# Stimulus explore events - SS-
# Stimulus explore events - SS+
Time spent in stimulus explore - OS-
Time spent in stimulus explore - OS+
Time spent in stimulus explore - SS-
Time spent in stimulus explore - SS+
Time in whole arm - OS-
Time in whole arm - OS+
Time in whole arm - SS-
Time in whole arm - SS+
PC1 PC2 PC3
PC1 PC2 PC3
 98 
 
Figure 4.3. Principle Component Plots 1-3 
 
Correlation plots derived from analysis of the first three principle components are shown 
for females (A) and males (B). These principle components, accounting for 53% of 
variance in both sexes, were derived from the analysis of the entire ethogram, with 
behaviors indicated on the y-axis. Along with those behaviors discussed elsewhere in the 
manuscript, behaviors relative to the center of the chamber are indicated with reference to 
the full center area (labeled “3” in Figure 4.1) or an innermost center (labeled “4” in 
Figure 4.1). For each measure listed on the vertical axis, the bar displays the magnitude 
and direction of correlation (loading) on each of the principle components 1-3, expressed 
as a correlation coefficient on the horizontal axes. Bars in the same direction indicate 
measures that correlate together. The dashed line indicates a threshold beyond which any 
measure can be stated to significantly influence each principle component, defined as one 
half the absolute value of the largest loading. 
 
Figure 3: Principle Component Plots 1-3 
0.2
0.1
0.0
0.1
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC1
PC1
0.3
0.2
0.1
0.0
0.1
0.2
PC2
PC2
0.2
0.0
0.2
0.4
PC3
0.2
0.0
0.2
Center_dist
Center_entries
Center_time
Entries_Osm
Entries_Osp
Entries_SSm
Entries_SSp
NearTime_Osm
NearTime_Osp
NearTime_SSm
NearTime_SSp
NoseTouch_count_Osm
NoseTouch_count_Osp
NoseTouch_count_SSm
NoseTouch_count_SSp
NoseTouch_time_Osm
NoseTouch_time_Osp
NoseTouch_time_SSm
NoseTouch_time_SSp
SmallCenter_Dist
SmallCenter_entries
SmallCenter_Time
StimExplore_Count_Osm
StimExplore_Count_Osp
StimExplore_Count_SSm
StimExplore_Count_SSp
StimExplore_time_Osm
StimExplore_time_Osp
StimExplore_time_SSm
StimExplore_time_SSp
WholeTime_OSm
WholeTime_OSp
WholeTime_SSm
WholeTime_SSp
M
easure
PC1
PC1
0.3
0.2
0.1
0.0
0.1
PC2
PC2
0.4
0.2
0.0
0.2
t
s
e
m
p
m
p
m
p
m
p
m
p
m
p
m
p
m
p
t
s
e
m
p
m
p
m
p
m
p
m
p
m
p
PC3
Females
Males
 99 
   
Probability Distance
Female A1221 (0.5) Male A1221 (0.5) 0.51 41.77
Female A1221 (0.5) Female A1221 (1.0) 0.81 27.79
Female A1221 (0.5) Male A1221 (1.0) 0.42 41.66
Female A1221 (0.5) Female Vehicle 0.65 40.26
Female A1221 (0.5) Male Vehicle 0.72 34.30
Female A1221 (0.5) Female EB 0.26 46.96
Female A1221 (0.5) Male EB 0.20 48.00
Male A1221 (0.5) Female A1221 (1.0) 0.16 57.74
Male A1221 (0.5) Male A1221 (1.0) 0.57 39.77
Male A1221 (0.5) Female Vehicle 0.30 57.05
Male A1221 (0.5) Male Vehicle 0.15 60.99
Male A1221 (0.5) Female EB 0.08 68.77
Male A1221 (0.5) Male EB 0.19 53.09
Female A1221 (1.0) Male A1221 (1.0) 0.15 49.40
Female A1221 (1.0) Female Vehicle 0.16 54.76
Female A1221 (1.0) Male Vehicle 0.93 24.85
Female A1221 (1.0) Female EB 0.75 28.77
Female A1221 (1.0) Male EB 0.03 60.18
Male A1221 (1.0) Female Vehicle 0.11 61.94
Male A1221 (1.0) Male Vehicle 0.22 49.21
Male A1221 (1.0) Female EB 0.07 57.44
Male A1221 (1.0) Male EB 0.66 32.61
Female Vehicle Male Vehicle 0.30 50.41
Female Vehicle Female EB 0.04 69.55
Female Vehicle Male EB 0.03 67.16
Male Vehicle Female EB 0.88 28.77
Male Vehicle Male EB 0.08 55.16
Female EB Male EB 0.01 65.14
A. All Animals
Comparison
(Table 4.9 Continued on next page) 
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Table 4.9. Linear Discriminate Analysis 
Systematic pairwise comparisons were made via linear discriminate analysis (LDA) of 
the entire dataset. Both probability and Mahalanobis distance values are shown for all 
animals (A), or for each sex separately (Females, B; Males, C). Instances of significant 
separation between compared behavioral datasets are shown in bold. 
Probability Distance
A1221 (0.5) A1221 (1.0) 0.80 27.66
A1221 (0.5) Vehicle 0.65 40.60
A1221 (0.5) EB 0.32 46.35
A1221 (1.0) Vehicle 0.12 56.94
A1221 (1.0) EB 0.77 28.84
Vehicle EB 0.04 70.32
B. Females Only
Comparison
Probability Distance
A1221 (0.5) A1221 (1.0) 0.59 39.91
A1221 (0.5) Vehicle 0.20 60.40
A1221 (0.5) EB 0.26 53.42
A1221 (1.0) Vehicle 0.26 49.10
A1221 (1.0) EB 0.68 31.99
Vehicle EB 0.06 56.56
C. Males Only
Comparison
 101 
 
Functional Landscape Analysis of Behaviors for Sex Differences 
Two variables, Time in Whole Arm and Number of Nose Touch Events were 
further analyzed by landscape analysis, chosen because the first represents an initial 
exploratory act in evaluating a conspecific (similar to appetitive behaviors in mating), 
and the second representing the most active engagement allowed animals (closest to the 
consummatory act). For Time in Whole Arm (Figure 4.4) there was a significant effect of 
sex for the EB group, with the female and male landscape profiles differing significantly 
(p < 0.002). The other 3 treatment groups did not differ by sex. For the Number of Nose 
Touch Events, similar analysis revealed that the A1221 (0.5) group was the only one with 
a significant sex difference (p < 0.05; Figure 4.5). 
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Figure 4.4 Time in Whole Arm 
Time Spent in the Whole Arm, an appetitive behavior, is shown for females (left), males 
(middle), and the sex difference (right) as functional landscapes. For each sex, the height 
of each peak shows the absolute amount of time spent in the arm (seconds). For the sex 
difference, the y-axis shows the time differential, with an upward peak indicating F > M, 
and a downward valley indicating M > F. The only landscape profile that differed 
significantly between the sexes was the EB group. The positions of the four stimulus 
choices in each landscape are indicated by the inset.  
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Figure 4.5. Number of Nose Touch Events 
Number of Nose Touch Events (consummatory behavior) is shown for females (left), 
males (center), and the sex difference (right). Labels and analysis are the same as in 
Figure 4.4. A sex difference was found only for the A1221 (0.5) group.   
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DISCUSSION 
 
The concept that the EDCs are one of a number of potent environmental stressors 
has been gaining traction (Grandjean et al., 2015; Padmanabhan, Cardoso, & 
Puttabyatappa, 2016). The effects of these chemicals must be put in the broader context 
of the anthropogenic, natural, and social environments. Our focus on how prenatal PCB 
exposures change the trajectory of development adds to knowledge about a subset of 
these types of interactions, with an emphasis on evaluating outcomes in a more socially-
relevant system. This study adds to the small but growing body of literature showing 
social behavior can be altered through developmental exposure to these PCBs (Jolous-
Jamshidi, Cromwell, McFarland, & Meserve, 2010;  Bell et al., 2015).  
 
Effects of Prenatal PCBs on Biological and Social Outcomes in the FourPlex 
In nature, individuals differ by sex, reproductive status, age, and dominance 
hierarchy, among other traits. Rats are social animals living in communal settings with 
conspecifics of both sexes, a range of ages, health, and experiences. By expanding from 
the traditional two-choice to a four-choice test, we can systematically investigate the 
influence of more than one biologically-relevant factor on an experimental animal’s 
social decision-making. In our apparatus, the experimental animal engages in motivated 
behavior, presumably driven by a desire to increase or decrease the distance between 
themselves and a stimulus animal. The choice to spend time near one stimulus is also 
inversely related to time away from other stimulus animals. Observing these behaviors 
within the context of endocrine disruption due to PCBs enables us to better understand 
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how low dose exposure to these compounds can lead to functional behavioral changes in 
adulthood. 
In our study, there were no significant morphological differences observed 
throughout the development of these animals, consistent with prior work on similarly-
treated animals (Gillette et al., 2017; Reilly et al., 2015). Thus, any alterations in behavior 
of these animals are likely not due to changes in the animal’s health. In general, our 
results further show that irrespective of prenatal treatment, the experimental rats spent 
more time in parts of the apparatus in association with the OS+ stimulus animal. This 
result is consistent with the literature in two-choice models of a choice between same sex 
conspecifics of differing hormonal status: males prefer estrous (or estrogen-treated) 
females over non-estrous (or ovariectomized) females, and females prefer males with 
testosterone over castrated males (Xiao, Kondo, and Sakuma , 2004). Similarly, when 
presented with an opposite-sex binary choice, males prefer females, and females prefer 
males (Bakker, 2003; Carson, 2003; Henley, Nunez, & Clemens, 2011). Thus, the 
FourPlex is a sensitive tool for differentiating amongst multiple stimuli in a manner 
consistent with simpler systems.  
Although the patterns of behavior in the FourPlex were largely preserved across 
prenatal treatment groups, there were several small but significant effects of prenatal 
treatment when considered in relationship to specific stimulus rats. These are best viewed 
in Table 9, which summarizes significant differences and/or LARGE effect sizes for 
treatment effects. In females, the only overall treatment effects were in the SS- arm (i.e. 
towards ovariectomized females): time spent in the remote part of the arm, and number of 
arm entries, was greater in EDC-exposed (especially A1221 (1.0)) than in vehicle 
females. We interpret this to mean that there is increased likelihood of the EDC females 
to affiliate with what is normally the least-salient stimulus. For males, the only significant 
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treatment effect was towards the OS- animal (ovariectomized female), limited to the 
number of stimulus explore events. In this case, A1221 (0.5) males had increased 
exploration compared to vehicle and EB rats. Although not significant, there was a trend 
(p = 0.06) for these animals to spend more time near the OS- rat’s cage, and in the whole 
arm of that rat. It is noteworthy that the perception of and/or interaction with the 
ovariectomized female stimulus rat was the only one affected by treatment in both sexes. 
Finally, for experimental males in relationship to the OS+ rats (ovariectomized female 
plus estradiol) there were trends for total time, and time near the stimulus rat’s cage, to be 
greater in EB than vehicle males. Thus, although wholesale behavioral changes were not 
caused by prenatal treatments, there are subtle shifts in interactions revealed in the 
FourPlex. While we do not know the mechanisms for these EDC effects, the finding that 
A1221 and EB have differential outcomes suggests that the former compound is acting 
by a non-estrogenic pathway. Furthermore, we point out that the prenatal EB treatment 
did not masculinize feminine behaviors, nor feminize masculine behavior. This is not 
unexpected given the low dose of EB and the short duration of treatment; in fact, our 
prior studies (Dickerson, Cunningham, & Gore, 2011; Steinberg, Walker, Juenger, 
Woller, & Gore, 2008; Walker, Goetz, & Gore, 2013; Gillette et al., 2017; Reilly et al., 
2015) are consistent with the current finding of small EB effects on brain and behavior in 
this model. 
 
Prenatal EDCs Exacerbate Sex Differences in Behaviors 
The sexual dimorphism in behaviors in the FourPlex, or lack thereof, were 
influenced by prenatal EDC exposures (Table 9). When considering the OS+ rats – the 
most socially salient stimulus that was preferred by both sexes – prenatal EB treatment 
 107 
introduced a novel sexual dimorphism, with males spending more time in the whole arm, 
time in the remote arm, and engaging in more stimulus explore and nose touch events. 
Sex differences and similarities in behaviors toward the SS- animal were the second-most 
commonly observed. For the number of stimulus explore and nose touch events, A1221 
(0.5) treatment resulted in males having greater numbers of these events than females. In 
addition, numbers of stimulus explore events and arm entries toward the SS- rat was 
greater in EB females than males. The time spent in the remote portion of the SS- arm 
was only sexually dimorphic in the vehicle group. As for the SS+ group, a sex difference 
in time near the stimulus cage was found for vehicle and A1221 (1.0) rats (female > 
male) but not for the EB or A1221 (0.5) groups.  
It is notable that most of these effects are in relationship to the OS+ and SS- 
groups, as these differ most in sociosexual valence. This underscores that the sensitivity 
of the FourPlex to discriminate the hierarchy of preference in rats is greatest for a 
hormonally-treated (or potentially gonadally intact) opposite sex rat, and lowest for a 
same-sex hormonally-deficient rat.  
 
FourPlex Results do not Mirror the Binary Choice Paradigm 
It is informative to consider the results for the vehicle group vis-à-vis validation 
of the FourPlex in control animals. For both sexes, the numbers of arm entries, time 
spent, and interactions with (especially nose touches) stimulus rats were highest toward 
the opposite-sex, hormone-treated rat. This result, while not surprising, shows that the 
layout of the apparatus is adequate for a rat to discriminate, and for an investigator to 
discern that discrimination in a 10-minute trial. 
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It is also informative to contrast the current results to those of our prior binary 
choice study, in which rats received identical treatments to those used here, but were 
tested differently in adulthood (Reilly et al., 2015). There, rats were given the opportunity 
to distinguish between two same-sex gonadectomized rats (no hormone), one familiar and 
one unfamiliar. Under those conditions, while all experimental rats showed the expected 
preference for a novel over a familiar rat, the differential was much greater in males than 
females, with the exception of the male A1221 (0.5) group. These animals were more 
similar in their behaviors to the females, showing a loss of the sexual dimorphism. By 
contrast, sex differences in the FourPlex arena were more likely to have an exaggerated 
dimorphism with treatment. Moreover, the magnitudes of changes in the FourPlex were, 
in general, smaller than in the two-choice test, suggesting a tempering of the outcomes in 
a more complex social setting. 
 
Ethological Implications 
It has been a long-lasting endeavor to balance ethological significance and 
experimental feasibility when studying behavior in laboratory animals. In practice, 
controlling the environment in dyadic choice models is favored over settings more 
representative of an animal’s natural habitat due to the greater ease in simplifying 
behaviors in the former over the latter. However, advancements in technology have 
greatly aided efforts in creating environments capable of providing animals with more 
naturalistic setting. In particular, systems that allow for the automatic tracking of 
individual animals within a multi-animal, free-roaming environment have provided 
unique insights into the social hierarchy organization in a mouse model (So et al., 2015; 
Weissbrod et al., 2013)
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means of discovering novel and objective metrics of social behavior. Hong et al. used a 
simultaneous video and depth camera setup in combination with computerized vision and 
supervised machine learning methods to gain unprecedented resolution (30 
frames/second) of social interaction behavior between two strains of mice. This allowed 
the detection of extremely subtle differences in bout-length investigation previously 
undetectable through more standard methods (Hong et al., 2015).  
 It is notable that work in other fields have, on occasion, utilized 4+ choice 
paradigms. For example, a study on the effects of amphetamines on rat social behavior 
revealed that both treated and control rats would augment their aggregative tendency in 
proportion to the number of stimulus rats within the behavioral apparatus (Heimstra & 
McDonald, 1962). Studies on mate preference in rats have provided a female rat with 
four males and revealed differences in the dynamics of sexual selection when compared 
to binary choice models (Ferreira-Nuño et al., 2005). The field of cognitive neuroscience 
has many examples of learning-based tasks in radial arm mazes with multiple choices 
(Witty, Foster, Semple-Rowland, & Daniel, 2012), although in most cases the stimuli are 
objects or food rather than conspecifics. Nevertheless, the importance of mimicking the 
more realistic situation of multiple rather than binary possibilities underscores the 
potential application of the FourPlex to studies on endocrine disruption and other 
environmental perturbations. 
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CHAPTER 5: THE EFFECTS OF GESTATIONAL EXPOSURE TO 
POLYCHLORINATED BIPHENYLS ON THE PRESENCE OF 
OXYTOCIN AND VASOPRESSIN IN THE PARAVENTRICULAR 
AND SUPRAOPTIC NUCLEI OF THE ADULT HYPOTHALAMUS 
ABSTRACT 
Endocrine disrupting chemicals (EDCs) induce changes in hormone-sensitive 
tissues, causing responses that may lead to dysfunctional physiology. The effects of 
EDCs are especially influential during prenatal exposure, since the developing fetus is 
extremely sensitive to hormone-controlled tissue growth.  There is a critical period of 
fetal development during which sex-steroids are particularly crucial in organizing and 
sustaining a properly developing nervous system in a sexually dimorphic manner. 
Furthermore, a resurgence of these sex-steroids during puberty has an activational effect 
on this neural circuitry, which accounts for sex differences in the neuronal control of 
reproductive physiology and behaviors in adulthood. Preliminary data have shown that 
polychlorinated biphenyl (PCB) exposure abolishes the preference toward a novel 
conspecific in a sexually dimorphic manner. The actions of the neuropeptides oxytocin 
(OT) and Vasopressin (AVP), critical to the manifestation of rodent social behavior, are 
subject to mediation and modulation via estrogenic processes. These experiments, which 
used the brains from behaviorally characterized animals, tested hypothesis that early-life 
exposure to PCBs may lead to changes to the oxytocin- or vasopressin-producing neurons 
in the hypothalamus. Looking at both female and male rats, no significant effects of 
treatment were found in the number or density of OT- or AVP-positive neurons. These 
results suggest that the PCB-mediated alterations in adult social behavior are not due to 
changes in the amount of oxytocin or vasopressin neurons in the paraventricular or 
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supraoptic nucleus. Further experimentation will be required to uncover the neurological 
bases for the observed changes.  
 
INTRODUCTION 
Of the countless number of man-made chemicals that now exist in our 
environment, Endocrine disrupting chemicals (EDCs) pose a particularly persistent risk 
to those inhabiting the contaminated areas and beyond. The Endocrine Society’s updated 
statement (Gore et al, 2015) defines EDCs as “an exogenous chemical, or mixture of 
chemicals, that can interfere with any aspect of hormone action”, exposure to EDCs 
during critical periods of development have the potential to lead to lost-lasting effects. 
The developmental processes that occur during gestation, through birth, and into the early 
life are greatly influenced by both the presence or absence of endogenous sex steroids. 
Throughout all of life, but particularly during these sensitive periods, natural sex steroids 
organize and sustain a properly developing nervous system in a sexually dimorphic 
manner. Exposures to EDCs in early life can perturb these processes, changing how the 
brain develops, and causing functional behavioral changes later in adulthood.   
 
The present study focuses on a ubiquitous EDC mixture of polychlorinated 
biphenyls (PCBs), which is a manmade compound that has contaminated the 
environment. Although the production was banned in the United States in 1979, this 
persistence of PCBs pose a continued risk. Experiments with mice and rats reveal that 
early exposure to these organochlorides interfere with brain mechanisms that modulate 
anxiety, reproductive, and social behaviors in adulthood. (Reilly et al. 2015, Bell et al. 
2014, Gillette et al. 2017). 
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In mammals, social groups are characterized by high levels of complexity in the 
type/amount of social interactions amongst each other. In order for the manifestation of 
appropriate behavioral actions, the processing of social information needs to be precise 
for sociality to exist. This requires specific regulation of specific brain mechanisms 
associated with (1) recognition and (2) interpretation of various aspects of social 
information. Among the several neurobiological systems, neuroendocrine mechanisms 
appear to play a prominent role in social information processing. The brain distribution of 
oxytocin and vasopressin receptors and their genes have been linked to the presence or 
absence of monogamy and pair bonding in voles and peromyscus (Ross, HE, 2009). 
Oxytocin and vasopressin are, in turn, under the control of gonadal hormones. Sex steroid 
hormones mediate specific activation of different genes underlying a wide variety of 
social behaviors; even when these behaviors are ultimately regulated by different 
neurotransmitter systems in different brain regions (Choleris, 2008). One particular 
behavior essential for life in most social species is social recognition, which can be 
defined as the ability of an organism to distinguish between conspecifics such as a mate, 
an intruder, a subordinate or dominant member of the social hierarchy. Both oxytocin and 
vasopressin have been implicated in the processes governing social recognition (Lee HJ, 
2008; Takayanagi Y, 2005; Engelmann M, 1994; Bielsky IF, 2005).  
 
This manuscript aims to complement previously published findings that exposure 
to PCBs during gestation lead to sex- and dose-specific alterations of social behavior in 
adult rats (Reilly et al. 2016). Because the timing of gestational exposure in the present 
model coincides with the onset in the development of these two nonapeptides (Buijs, 
1980), we hypothesized that the changes in behavior previously reported in these animals 
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may have been due to differences in the production of oxytocin and vasopressin at the 
main sites of synthesis, the PVN and SON (Figure 5.1). Presented here is an 
immunohistological investigation to identify if any changes in the synthesis of these 
nonapeptides may correlate with the changes we’ve seen in the behavior of these animals. 
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Figure 5.1. Oxytocin and Vasopressin Cell Bodies in The Paraventricular and Supraoptic 
Nuclei 
Low-magnification coronal photomicrographs from a vehicle-treated male showing the 
two regions of interest: the paraventricular nucleus (dashed outline) and the supraoptic 
nucleus (dotted outline). This macro perspective shows the oxytocin(A)- and 
vasopressin(B)- positive cell bodies, detected by the DAB-peroxidase reaction. Tissues 
were counterstained with cresyl violet (nissl) staining. Scale bar = 500μm  
Figure 1. Low-magnification coronal photomicrographs from a vehicle-treated male showing the two regions of interest: the paraventricular
nucleus (dashed outline) and the supraoptic nucleus (dotted outline). This macro perspective shows the oxytocin(A)- and vasopressin(B)-
positive cell bodies, detected by the DAB-peroxidase reaction. Tissues were counterstained with cresyl violet (nissl) staining. Scale bar = 
500µm
Figure 1. Oxytocin and vasopressin cell bodies in the paraventricular and supraoptic nuclei
Oxytocin Vasopressin
A B
Figure 1. Low-magnification coronal photomicrographs from a vehicle-treated mal  showing the two regions of interest: the paraventricular
nucleus (dashed outline) and the supraoptic nucleus (dotted outline). This macro perspective shows the oxytocin(A)- and vasopressin(B)-
positive cell bodies, detected by the DAB-peroxidase reaction. Tissues were counterstained with cresyl violet (nissl) staining. Scale bar = 
500µm
Figure 1. Oxytocin and vasopressin cell bodies in the paraventricular and supraoptic nuclei
Oxytocin Vasopressin
A B
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METHODS 
Animals and Husbandry 
Young adult male and female Sprague-Dawley rats, aged approximately 3 
months, were purchased from Harlan (Indianapolis, IN) for use in this study, which was 
conducted under a protocol approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Texas at Austin, following NIH guidelines. All 
animals were housed in same-sex groups of 2-3 inside of polycarbonate cages with ad-
libitum access to water and a low-phytoestrogen chow (Harlan-Tekland Extruded 2019 
Global Rodent diet). The colony was maintained at room temperature (21-22 C) on a 
partially reversed 12:12 light cycle (lights on at 12:00 am). Following a one-week 
acclimation period, females were smeared daily to determine estrous cyclicity. On days 
of proestrus, the virgin female was placed in a cage with a sexually experienced male to 
confirm receptivity. Then, the pair was left together overnight and a vaginal smear 
containing sperm served as the marker for embryonic day 0 (E0). Males were removed 
and the females were left singly housed for the duration of their pregnancy; nestlet 
bedding was provided several days prior to parturition on E21.  
Gestational Exposure to Endocrine Disrupting Chemicals 
Pregnant dams were injected intraperitonally once on E16 and again with the 
same treatment on E18. The four experimental treatment groups were as follows: (a) 
vehicle (3% dimethylsulfoxide in sesame oil; negative control), (b) estradiol benzoate 
(EB  50 μg/kg; positive control for the estrogenic effects of PCBs), and the PCB mixture 
Aroclor 1221 at one of two concentrations: (c) (A1221, 0.5 mg/kg) or (d) (A1221, 1.0 
mg/kg). For the duration of this manuscript, the four treatment groups will be referred to 
as vehicle, EB, A1221 (0.5), or A1221 (1.0), respectively. On the day of parturition (E21, 
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subsequently referred to as postnatal Day 0(P0)), pups were weighed and the anogenital 
distance (AGD) measured. To maintain an equal sex ratio across all groups, the litters 
were weaned to 4 males and 4 females. In addition to daily monitoring for signs of eye 
opening, weekly weights and AGD measurements occurred through weaning at P21. 
Initially, the animals were placed into same-sex groups, 4 animals per cage while the 
animals were monitored for pubertal development (vaginal opening in females, preputial 
separation in males). Postpubertal females were smeared daily and vaginal cytology was 
inspected under a microscope to determine and record estrous cyclicity for the duration of 
their lifetime. On P49, the same-sex groups were further divided into same-sex dyads 
maintained through the completion of the study. On P60, one animal from each of these 
cages was randomly selected for behavioral analyses, detailed in the following 
publications: Reilly et al 2015, Gillette et al, 2017. The total number of animals used to 
generate tissues was: Vehicle – 11 females, 10 males; EB – 9 females, 10 males; A1221 
(0.5)- 9 females, 9 males; A1221 (1.0)- 8 females, 9 males. 
Euthanasia, Tissue Collection, and Processing.  
All animals were euthanized at ~P90; to control for cycle status, all females were 
euthanized on proestrus. Half of the animals were anesthetized with ketamine 
(AnimalHealth; 150 mg/kg) and xylazine (AnimalHealth; 30 mg/kg) and perfused with 
4% paraformaldehyde (PFA) in PBS following lab protocols (Dickerson et al. 2011, 
Naugle et al. 2014, Kermath et al. 2014). The brains were postfixed overnight in 4% PFA 
at 4C and then stored in a sucrose cryoprotectant buffer at -20 for long-term storage. 
Tissues were blocked coronally and the region containing the hypothalamus was glued to 
a stage and sectioned on a Leica VT1000 vibrating microtome from Bregma -0.6 through 
Bregma 2.0 (Paxinos et al. 2007)  
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Two separate immunohistochemistry experiments were conducted utilized DAB 
immunostaining to quantify the number of oxytocin (OT) and vasopressin (AVP) neurons 
in a 1:5 tissue series, resulting in 5 sections for each animal.  
 
Immunohistochemistry 
Free floating sections were washed in PBS and subsequently quenched of any 
endogenous peroxidase in a 3:1 solution of methanol and 3% hydrogen peroxide in PBS 
for 20 minutes. Tissues were then incubated for 1 hour in a blocking solution containing 
10% normal goal serum (NGS; Vector Laboratories), 0.5% Triton X (Vector 
Laboratories) in PBS. Incubation in primary antibody was done for oxytocin (Millipore 
MAB5296, mouse monoclonal at 1:20,000) or vasopressin (Immunostar 20069, rabbit 
polyclonal at 1:40,000) in 2% NGS at 4C for 48 hours. Tissues were washed in PBS and 
then incubated for 2 hours in a solution containing 2% NGS and secondary antibody 
(oxytocin: Vector Laboratories Biotinylated Goat Anti-Mouse IgG #BA-9200; 
vasopressin: Vector Laboratories Biotinylated Goat Anti-Rabbit IgG Cat#BA-1000) at 
1:400 in PBS. Tissues were then placed in an avidin-biotin solution (ABC kit, Vector) for 
1 hour, followed by 3,3′-Diaminobenzidine (DAB, Vector) reaction on ice for either 2 
minutes (oxytocin) or 4 minutes (vasopressin). Between every step, tissues were washed 
with PBS; all reactions occurred at room temperature unless otherwise noted. The 5 
section series per antibody per animal was mounted on a slide, counterstained with a 
cresyl violet (Nissl) solution,  covered in DPX mountant (Sigma, Aldrich), and 
coverslipped.  
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Cell counting.  
In order to assess the effects of treatment on the number of Oxytocin  and 
Vasopressin neurons, all mounted sections were visualized on an Olympus BX61 
microscope. Using Stereoinvestigator (MBF Bioscience, v10.0) the bilateral PVN and 
SON regional borders, as detected by the nissl stain, were outlined to calculate the area 
(μm); and all immunopositive neurons within the borders were counted. Analyses were 
done separately for the 5 sections collected from rostral to caudal (Representative series 
shown in Figure 5.2 and Figure 5.3 for oxytocin and vasopressin, respectively). For each 
section, based on the 40 μm tissue thickness, the regional density was calculated as:  
 
 
 
 
 
 
 
 
 
 
!"#$%&'(	*"&+$,-	.#	$001&%2%+$,$3"&"14%&+506 7 = [:%,'(	#	%;	$001&%2%+$,$3"	&"14%&+][(Total	area) ∗ 40	µm]  
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Figure 5.2. Oxytocin-positive Cell Bodies in the Paraventricular and Supraoptic Nuclei 
Representative photomicrographs from a vehicle-treated female rat showing the rostral-
to-caudal (left-to-right) distribution of oxytocin- positive cell bodies in the 
paraventricular nucleus (PVN; A-E) and supraoptic nucleus(SON; F-J), as detected by the 
DAB-peroxidase reaction. Both regions have been outlined. All tissues were 
counterstained with cresyl violet (nissl) staining. Abbreviations: 3v, third ventricle; ox, 
optic chiasm. Scale bar = 100μm  
Figure 5.3. Vasopressin-positive Cell Bodies in the Paraventricular and Supraoptic nuclei 
Representative photomicrographs from a vehicle-treated male rat showing the rostral-to-
caudal (left-to-right) distribution of vasopressin-positive cell bodies in the paraventricular 
nucleus (PVN; A-E) and supraoptic nucleus(SON; F-J), as detected by the DAB- 
peroxidase reaction. Both regions have been outlined. No vasopressin staining was seen 
in the first two PVN sections of the experiment (shown in panels A and B). All tissues 
were counterstained with a cresyl violet (nissl) stain. Abbreviations: 3v, third ventricle; 
ox, optic chiasm. Scale bar = 100μm. 
Figure 2: Representativ  photomicrographs from a vehicle-treated female rat showing the rostral-to-c udal (left-to-right) distribution of oxytocin-
positive cell bodies in the paraventricular nucleus (PVN; A-E) and supraoptic nucleus(SON; F-J), as detected by the DAB-peroxidase reaction. Both 
regions have been outlined. All tissues were counterstained with cresyl violet (nissl) staining. Abbreviations: 3v, third ventricle; ox, optic chiasm. 
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Figure 2. Oxytocin-positive cell bodies in the paraventricular and supraoptic nuclei
PVN
SON
Figure 3. Vasopressin-positive cell bodies in the paraventricular and supraoptic nuclei
Figure 2: Representative photomicrographs from a vehicle-treated male rat showing the rostral-to-caudal (left-to-right) distribution of 
vasopressin-positive cell bodies in the paraventricular nucleus (PVN; A-E) and supraoptic nucleus(SON; F-J), as detected by the DAB-
peroxidase reaction. Both regions have been outlined. No vasopressin staining was seen in the first two PVN sections of the experiment 
(shown in panels A and B). All tissues were counterstained with a cresyl violet (nissl) stain. Abbreviations: 3v, third ventricle; ox, optic 
chiasm. Scale bar = 100µm
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Statistical Analyses 
JMP Pro (v13.0) was used for statistical analyses. Datasets were examined for 
homogeneity of variance and normality, and ANOVA used when criteria were met. 
Because many data did not conform to the assumptions required for parametric analyses, 
the non-parametric Kruskal-Wallis test was performed to assess any treatment effects 
within the sexes, which were analyzed separately to evaluate any sex differences within 
each treatment via t-tests . The heterogeneity of the dataset limited the treatment 
comparisons to single rostral-caudal levels;  Effect sizes were calculated for all 
comparisons made: partial-η2 or ε2, respectively, accompany the ANOVA/Kruskal-Wallis 
tests while Cohen’s d effect sizes describe the sex differences within treatment. 
Interpretation of the effect size values for partial-η2 and ε2 were as follows: 0.01 = Small; 
0.09 = Medium; 0.25 = Large. For Cohen’s d: 0.2 = small; 0.5 = Medium; 0.8 = Large. 
RESULTS 
Total number of oxytocin- and vasopressin-immunoreactive cells for the entire 
series   
Oxytocin  
In the PVN of females (Table 5.1A) and males (Table 5.1B), there were no 
significant effects of treatment on the total number of oxytocin-positive cell bodies 
counted in the experiment (Figure 5.4A). A trend for a sex difference in oxytocin neuron 
numbers in the vehicle groups (female > male) was found (Table 5.1C; p = 0.06); this had 
a Large effect size.  For the SON, no significant effects of sex or treatment were observed 
(Figure 5.4B). A trend was found for a sex difference in the A1221(0.5) groups (male > 
female; p = 0.06), with a Large effect size. 
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Vasopressin 
There were no significant effects of treatment in the total number of vasopressin-
positive cell bodies within either the PVN or SON (Table 5.1; Figure 5.4C, 5.4D). One 
trend for a sex difference was found for vasopressin in PVN for the EB group (male > 
female; p = 0.06), with a Medium effect size. 
 
Figure 5.4. Total Number of Oxytocin- and Vasopressin-positive Cell Bodies in the 
Paraventricular and Supraoptic Nuclei 
The total number of oxytocin- and vasopressin-positive cells counted in the 
paraventricular (PVN) and supraoptic nuclei (SON). There were no effects of treatment 
on the total number of cells detected in either region. The full statistical report can be 
found in Table 1. Means and SEM are shown.  
 
Figure 4. Total number of oxytocin- and vasopressin- cell bodies in the paraventricular and supraoptic nuclei
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Figure 4: The total number of oxytocin- and vasopressin-positive cells counted in the paraventricular (PVN) and supraoptic nuclei 
(SON). There were no effects of treatment on the total number of cells detected in either region. The full statistical report can be found in 
Table 1. Means and SEM are shown. 
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(Table 5.1 continued on next page) 
Target Region Treatment
N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 11 371 ± 40
EB 9 320 ± 55
A1221 (0.5) 9 420 ± 33
A1221 (1.0) 8 365 ± 58
Vehicle 11 100 ± 21
EB 8 105 ± 41
A1221 (0.5) 9 87 ± 33
A1221 (1.0) 7 112 ± 38
Vehicle 11 199 ± 18
EB 9 165 ± 15
A1221 (0.5) 8 206 ± 22
A1221 (1.0) 8 186 ± 21
Vehicle 11 409 ± 20
EB 9 364 ± 41
A1221 (0.5) 8 341 ± 38
A1221 (1.0) 8 373 ± 53
A. Female Treatment Effects
0.08
SON ANOVA F(3,33) = 0.62
Oxytocin
Vasopressin
PVN ANOVA F(3,33) = 1.26
SON KW X2(3) = 0.90
0.61 0.05
0.45
SEM
0.83 0.03
PVN ANOVA F(3,34) = 0.74 0.54 0.06
Target Region Treatment
N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 233 ± 57
EB 10 360 ± 36
A1221 (0.5) 9 342 ± 56
A1221 (1.0) 9 274 ± 61
Vehicle 10 95 ± 35
EB 10 175 ± 48
A1221 (0.5) 9 192 ± 39
A1221 (1.0) 9 129 ± 45
Vehicle 9 188 ± 17
EB 8 210 ± 16
A1221 (0.5) 8 241 ± 19
A1221 (1.0) 6 183 ± 22
Vehicle 9 376 ± 39
EB 8 417 ± 58
A1221 (0.5) 8 376 ± 30
A1221 (1.0) 7 341 ± 40
B. Male Treatment Effects
0.19
SON ANOVA F(3,29) = 0.48
Oxytocin
Vasopressin
PVN ANOVA F(3,28) = 2.04
SON KW X2(3) = 3.62
0.70 0.05
0.13
SEM
0.31 0.10
PVN ANOVA F(3,35) = 1.30 0.29 0.10
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Table 5.1. Total Number of Cells Counted per Region 
Total number of cumulative oxytocin- and vasopressin- positive cell bodies across the 
entire series is shown for Females (A) and Males (B). Data here, and in subsequent 
Tables (5.2-5.9), are shown as mean + SEM. Statistical tests used, values and degrees of 
freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM = 0.09; LARGE = 
0.25). (C) The statistics for within-treatment sex differences and Cohen’s d effect sizes 
are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with directionality of the 
effect. There were no differences due to treatment or sex. 
 
 
 
 
 
Target Region Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.06 0.87 Large
EB 0.55 -0.28 Small
A1221 (0.5) 0.26 0.56 Medium
A1221 (1.0) 0.30 0.52 Medium
Vehicle 0.91 0.05 Small
EB 0.29 -0.51 Medium
A1221 (0.5) 0.06 -0.97 Large
A1221 (1.0) 0.78 -0.14 Small
Vehicle 0.66 0.20 Small
EB 0.06 -0.62 Medium
A1221 (0.5) 0.24 -0.62 Medium
A1221 (1.0) 0.94 0.04 Small
Vehicle 0.46 0.35 Small
EB 0.47 -0.36 Small
A1221 (0.5) 0.49 -0.36 Small
A1221 (1.0) 0.64 0.25 Small
Vasopressin
PVN
SON
Oxytocin
PVN
SON
C. Sex Effects within Treatment
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Rostral to caudal distribution of oxytocin- and vasopressin-immunoreactive cells 
Oxytocin  
Because of the heterogeneity of cell number and density, the analysis was broken down  
from rostral to caudal in the PVN (Figure 5.5A). There were no effects of treatment in the 
females (Table 5.2A). Males were also not significantly affected (Table 5.2B), although a 
trend at was found (p = 0.08; medium effect size) at Bregma -0.8, presumably driven by 
the EB group. There were several significant sex differences (Table 5.2C) at specific 
parts of the series. At Bregma = -0.8, the A1221 (1.0) sexes differed significantly (female 
> male; p = 0.02; Large effect size). At both Bregma = -1.1 and -1.7, a sex difference 
(female > male; p < 0.05; Large effect sizes) was detected for the vehicle group. Finally, 
EB-treated animals at Bregma = -1.7 had a significant sex difference (female > male, p = 
0.03; Large effect size). There were no significant effects of treatment in the density 
(Figure 5.6A) in the females (Table 5.3A) or males (Table 5.3B). Sex differences in the 
density of oxytocin-positive neurons within this region matched those for cell numbers, 
with the inclusion of an additional significant sex difference in the animals treated with 
A1221 (0.5) (Table 5.3C; p = 0.03; female > male; Large effect size). 
 
A similar analysis was done for oxytocin in the SON, where no effects of 
treatment were observed in either sex (Females: Table 5.4A; Males: Table 5.4B) for total 
cell numbers, as well as when considered from rostral to caudal (Figure 5.5B). One 
significant sex difference (Table 5.4C) was observed at Bregma = -1.7 in the A1221 (0.5) 
group (male > female; p = 0.02; Large effect size). Several other instances of Large effect 
sizes between the sexes were observed but these not accompanied by statistical 
differences.  When expressed as density (Figure 5.5B), there were no significant effects 
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of treatment in any of the females (Table 5.5A). In males (Table 5.5B), a significant 
effect of treatment was observed at Bregma = -2 (p = 0.03; Large effect size). Post hoc 
analysis indicated that this effect was driven by the difference between the A1221 (0.5) 
and A1221 (1.0) males (A1221(0.5) > A1221 (1.0); p < 0.05). The only sex difference 
(Table 5.5C) identified was also at Bregma -2.0 in the A1221 (0.5) group (male > female; 
p = 0.01; Large effect size). Any other instances of large effect sizes were not met with 
statistical significance.   
 
Vasopressin  
In the PVN was little-to-no immunolabeling in the rostral-most two sections of 
this series, therefore these data were not evaluated (Figure 5.5C). Analysis of the three 
remaining sections resulted in no significant differences due to treatment in females 
(Table 5.6A), although a trend (p = 0.09; large effect size) was found at Bregma = -2. For 
males (Table 6B), there were no treatment effects. There were also no significant sex 
differences in any of the treatment groups (Table 5.6C), despite several instances of an 
associated Large effect size. There were no significant effects of treatment on vasopressin 
density in females (Figure 5.6C; Table 75.A), and one trend for males at Bregma = -1.4; 
Large effect size; Table 5.7B). Analysis indicated a significant sex difference (Table 
5.7C) in the A1221 (0.5) group (male > female; p = 0.004; Large effect size).  
 
Unlike the PVN, vasopressin neurons in the SON were detectable across the 
entire rostral to caudal extent of the series (Figure 5.5D). In both female (Table 5.8A) and 
male (Table 5.8B) animals, there were no significant effects of treatment. Additionally, 
comparing the sexes within each treatment group yielded no significant sex differences in 
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any treatment groups across the series (Table 5.8C). Similar findings were made for 
vasopressin cell density in the SON (Table 5.9).  
 
 
 
 
 
Figure 5.5. Rostral-to-caudal Distribution of Oxytocin and Vasopressin Immunopositive 
Neurons in the Paraventricular and Supraoptic Nuclei: Total Count 
The total number of oxytocin- and vasopressin-positive cell bodies in the paraventricular 
(PVN) and supraoptic supraoptic nuclei (SON). Data are plotted rostral-to-caudal, 
respective to the 1:5 series, from Bregma -0.8 to -2.0. Full statistical report can be found 
in Tables 5.2, 5.4, 5.6, and 5.8. Means and SEM are shown.  
 
 
Figure 5. Rostal-to -Caudal  Distribution of Oxytocin and Vasopressin 
immunopositive neurons in Supraoptic and Paraventricular Nuclei : Total Count
Figure 5: The total number of oxytocin- and vasopressin-positive cell bodies in the paraventricular (PVN) and supraoptic supraoptic
nuclei (SON). Data are plotted rostral-to-caudal, respective to the 1:6 series, from Bregma -0.8 to -2.0. Full statistical report can be 
found in Tables 3, 5, 7, and 9. Means and SEM are shown. 
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(Table 5.2 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 65 ± 14
EB 8 75 ± 12
A1221 (0.5) 9 69 ± 12
A1221 (1.0) 7 87 ± 13
Vehicle 10 52 ± 8
EB 9 37 ± 13
A1221 (0.5) 8 56 ± 24
A1221 (1.0) 7 60 ± 18
Vehicle 11 106 ± 25
EB 9 120 ± 29
A1221 (0.5) 9 149 ± 26
A1221 (1.0) 8 117 ± 32
Vehicle 11 121 ± 21
EB 9 71 ± 25
A1221 (0.5) 9 108 ± 20
A1221 (1.0) 7 101 ± 33
Vehicle 11 38 ± 8
EB 7 32 ± 13
A1221 (0.5) 9 44 ± 20
A1221 (1.0) 7 34 ± 16
-2 KW X2(3) = 1.14 0.77 0.03
-1.4 KW X2(3) = 1.56 0.67 0.04
-1.7 KW X2(3) = 3.06 0.31 0.10
-1.1 KW X2(3) = 2.43 0.49 0.07
-0.8 KW X2(3) = 1.26 0.74 0.04
SEM
A. Female Treatment Effects
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 49 ± 15
EB 10 46 ± 9
A1221 (0.5) 8 74 ± 16
A1221 (1.0) 7 35 ± 13
Vehicle 9 24 ± 7
EB 10 51 ± 14
A1221 (0.5) 9 34 ± 7
A1221 (1.0) 9 61 ± 14
Vehicle 8 100 ± 32
EB 10 95 ± 22
A1221 (0.5) 9 90 ± 26
A1221 (1.0) 7 47 ± 12
Vehicle 10 56 ± 17
EB 10 126 ± 28
A1221 (0.5) 9 95 ± 42
A1221 (1.0) 9 38 ± 17
Vehicle 7 37 ± 24
EB 9 47 ± 16
A1221 (0.5) 8 65 ± 14
A1221 (1.0) 9 111 ± 35
KW X2(3) = 3.94 0.27 0.12
-0.8
-1.1
-1.4
-1.7
-2
B. Male Treatment Effects
0.24 0.12
KW X2(3) = 0.99 0.80 0.03
X2(3) = 6.78 0.08 0.18KW
X2(3) = 2.86 0.41 0.08
KW X2(3) = 4.209
KW
SEM
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Table 5.2. Number of Oxytocin-positive Cell Bodies in the Paraventricular Nucleus 
Across the Series 
Total number of oxytocin- positive cell bodies counted in the paraventricular nucleus 
with respect to each section in the series is shown for Females (A) and Males (B). Data 
here, and in subsequent Tables 5.3-5.9, are shown as mean + SEM. Statistical tests used, 
values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM 
= 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences and 
Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 10 65 ± 14 Vehicle 0.43 0.36 Small
EB 8 75 ± 12 EB 0.08 0.90 Large
A1221 (0.5) 9 69 ± 12 A1221 (0.5) 0.81 -0.12 Medium
A1221 (1.0) 7 87 ± 13 A1221 (1.0) 0.02 1.52 Large F>M
Vehicle 10 52 ± 8 Vehicle 0.02 1.20 Large F>M
EB 9 37 ± 13 EB 0.48 -0.33 Small
A1221 (0.5) 8 56 ± 24 A1221 (0.5) 0.39 0.45 Small
A1221 (1.0) 7 60 ± 18 A1221 (1.0) 0.98 -0.01 Small
Vehicle 11 106 ± 25 Vehicle 0.88 0.07 Small
EB 9 120 ± 29 EB 0.50 0.32 Small
A1221 (0.5) 9 149 ± 26 A1221 (0.5) 0.13 0.75 Medium
A1221 (1.0) 8 117 ± 32 A1221 (1.0) 0.07 1.03 Large
Vehicle 11 121 ± 21 Vehicle 0.03 1.04 Large F>M
EB 9 71 ± 25 EB 0.17 -0.66 Medium
A1221 (0.5) 9 108 ± 20 A1221 (0.5) 0.78 0.13 Small
A1221 (1.0) 7 101 ± 33 A1221 (1.0) 0.12 0.88 Large
Vehicle 11 38 ± 8 Vehicle 0.97 0.02 Small
EB 7 32 ± 13 EB 0.48 -0.36 Small
A1221 (0.5) 9 44 ± 20 A1221 (0.5) 0.40 -0.42 Small
A1221 (1.0) 7 34 ± 16 A1221 (1.0) 0.07 -0.95 Large
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 49 ± 15
EB 10 46 ± 9
A1221 (0.5) 8 74 ± 16
A1221 (1.0) 7 35 ± 13
Vehicle 9 24 ± 7
EB 10 51 ± 14
A1221 (0.5) 9 34 ± 7
A1221 (1.0) 9 61 ± 14
Vehicle 8 100 ± 32
EB 10 95 ± 22
A1221 (0.5) 9 90 ± 26  
A1221 (1.0) 7 47 ± 12
Vehicle 10 56 ± 17
EB 10 126 ± 28
A1221 (0.5) 9 95 ± 42
A1221 (1.0) 9 38 ± 17
Vehicle 7 37 ± 24
EB 9 47 ± 16
A1221 (0.5) 8 65 ± 14
A1221 (1.0) 9 111 ± 35
-0.8
-1.1
-1.4
-1.7
-2
KW X2(3) = 3.94 0.27 0.12
-2 KW X2(3) = 1.14 0.77 0.03
-0.8
-1.1
-1.4
-1.7
-2
B. Male Treatment Effects
0.24 0.12
KW X2(3) = 0.99 0.80 0.03
X2(3) = 6.78 0.08 0.18
-1.4 KW X2(3) = 1.56 0.67 0.04
-1.7 KW X2(3) = 3.06 0.31 0.10
KW
X2(3) = 2.86 0.41 0.08
-1.1 KW X2(3) = 2.43 0.49 0.07
KW X2(3) = 4.209
-0.8 KW X2(3) = 1.26 0.74 0.04
KW
SEM
SEM
Table 2. Number of Oxytocin-positive cell bodies in the paraventricular nucleus across the series
A. Female Treatment Effects C. Sex Effects within Treatment
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directionality of the effect. There were no differences due to treatment. Three significant 
sex differences were found and are indicated. M=male, F=female.   
 
 
 
Figure 5.6. Rostral-to-caudal Distribution of Oxytocin and Vasopressin Immunopositive 
Neurons in the Paraventricular and Supraoptic Nuclei: Density 
The density of oxytocin- and vasopressin-positive cell bodies per regional volume (per 
μ3) in the paraventricular (PVN) and supraoptic supraoptic nuclei (SON). Data are plotted 
rostral-to-caudal, respective to the 1:5 series, from Bregma -0.8 to -2.0. Full statistical 
report can be found in Tables 5.3, 5.5, 5.7, and 5.9. Means and SEM are shown.  
 
 
 
 
 
Figure 6. Rostal-to -Caudal  Distribution of Oxytocin and Vasopressin 
immunopositive neurons in Supraoptic and Paraventricular Nuclei : Density
Oxytocin Vasopressin
SON
PVN
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f A
V
P
-ir
 n
eu
ro
ns
/µ
m
3)
DMSO
EB
A1221 (0.5mg/kg)
A1221 (1.0 mg/kg)
Males
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f O
T-
ir 
ne
ur
on
s/
µ
m
3)
Females
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f O
T-
ir 
ne
ur
on
s/
µ
m
3)
DMSO
EB
A1221 (0.5mg/kg)
A1221 (1.0 mg/kg)
Males
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
2.5×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f O
T-
ir 
ne
ur
on
s/
µ
m
3)
Females
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
2.5×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f O
T-
ir 
ne
ur
on
s/
µ
m
3)
DMSO
EB
A1221 (0.5mg/kg)
A1221 (1.0 mg/kg)
Males
-0.8 -1.1 -1.4 -1.7 -2.0
0
1×10-5
2×10-5
3×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f A
V
P
-ir
 n
eu
ro
ns
/µ
m
3)
Males
A1221 (1.0 mg/kg)
A1221 (0.5mg/kg)
EB
DMSO
-0.8 -1.1 -1.4 -1.7 -2.0
0
1×10-5
2×10-5
3×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f A
V
P
-ir
 n
eu
ro
ns
/µ
m
3)
Females
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f A
V
P
-ir
 n
eu
ro
ns
/µ
m
3)
Females
-0.8 -1.1 -1.4 -1.7 -2.0
0.0
5.0×10-6
1.0×10-5
1.5×10-5
2.0×10-5
Distance from Bregma
D
en
sit
y
(#
 o
f A
V
P
-ir
 n
eu
ro
ns
/µ
m
3)
DMSO
EB
A1221 (0.5mg/kg)
A1221 (1.0 mg/kg)
Males
Vehicle
Figure 6: The density of oxytocin- and vasopressin-positive cell bodies per regional volume (per µ3) in the paraventricular (PVN) and 
supraoptic supraoptic nuclei (SON). Data are plotted rostral-to-caudal, respective to the 1:6 series, from Bregma -0.8 to -2.0. Full 
statistical report can be found in Tables 3, 5, 7, and 9. Means and SEM are shown. 
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(Table 5.3 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 7.6E-06 ± 2.1E-06
EB 8 7.5E-06 ± 1.5E-06
A1221 (0.5) 8 7.1E-06 ± 1.6E-06
A1221 (1.0) 6 7.5E-06 ± 1.3E-06
Vehicle 10 5.0E-06 ± 0.8E-06
EB 9 3.1E-06 ± 1.3E-06
A1221 (0.5) 7 6.1E-06 ± 2.5E-06
A1221 (1.0) 7 6.1E-06 ± 2.1E-06
Vehicle 11 9.3E-06 ± 2.1E-06
EB 9 1.0E-05 ± 1.8E-06
A1221 (0.5) 9 1.4E-05 ± 2.0E-06
A1221 (1.0) 8 1.1E-05 ± 3.6E-06
Vehicle 11 9.3E-06 ± 1.8E-06
EB 9 5.1E-06 ± 1.7E-06
A1221 (0.5) 9 6.8E-06 ± 1.2E-06
A1221 (1.0) 7 7.3E-06 ± 2.2E-06
Vehicle 10 2.8E-06 ± 0.6E-06
EB 7 2.1E-06 ± 0.8E-06
A1221 (0.5) 9 3.1E-06 ± 1.5E-06
A1221 (1.0) 7 2.7E-06 ± 1.0E-06
-2 KW X2(3) =1.35 0.72 0.04
-1.7 KW X2(3) = 2.89 0.41 0.08
-1.4 KW X2(3) = 3.20 0.36 0.09
-1.1 KW X2(3) = 4.30 0.23 0.13
-0.8 KW X2(3) = 0.18 0.98 0.01
SEM
A. Female Treatment Effects
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 10 4.3E-06 ± 1.4E-06
EB 9 3.6E-06 ± 0.8E-06
A1221 (0.5) 8 7.4E-06 ± 1.5E-06
A1221 (1.0) 7 2.8E-06 ± 1.3E-06
Vehicle 8 1.8E-06 ± 0.5E-06
EB 9 5.1E-06 ± 1.3E-06
A1221 (0.5) 8 4.1E-06 ± 1.3E-06
A1221 (1.0) 9 5.2E-06 ± 1.3E-06
Vehicle 8 7.57E-06 ± 2.3E-06
EB 10 8.21E-06 ± 1.9E-06
A1221 (0.5) 9 7.23E-06 ± 1.9E-06
A1221 (1.0) 7 2.83E-06 ± 0.2E-06
Vehicle 10 4.1E-06 ± 1.4E-06
EB 10 1.0E-05 ± 3.1E-06
A1221 (0.5) 9 7.7E-06 ± 3.1E-06
A1221 (1.0) 9 3.5E-06 ± 1.7E-06
Vehicle 7 2.5E-06 ± 1.4E-06
EB 9 3.0E-06 ± 0.9E-06
A1221 (0.5) 8 4.8E-06 ± 0.8E-06
A1221 (1.0) 9 7.2E-06 ± 2.4E-06
-2 KW X2(3) =3.99 0.26 0.12
-1.7 KW X2(3) =4.72 0.19 0.13
-1.4 KW X2(3) =1.72 0.63 0.05
-1.1 KW X2(3) =4.11 0.25 0.12
-0.8 KW X2(3) =3.94 0.27 0.12
SEM
B. Male Treatment Effects
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Table 5.3. Oxytocin Staining Density in the Paraventricular Nucleus Across the Series 
The density of ocytocin-positive cell bodies by regional volume (per µ3)  in the 
paraventricular nucleus with respect to each section in the series is shown here. Data 
here, and in subsequent Tables 5.4-5.9, are shown as mean + SEM. Statistical tests used, 
values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM 
= 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences and 
Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. There were no differences due to treatment. The four 
significant sex differences found are indicated . M=male, F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.21 0.58 Medium
EB 0.04 1.12 Large
A1221 (0.5) 0.90 -0.06 Small
A1221 (1.0) 0.03 1.36 Large F>M
Vehicle 0.004 1.57 Large F>M
EB 0.28 -0.53 Medium
A1221 (0.5) 0.51 0.36 Small
A1221 (1.0) 0.73 0.71 Medium
Vehicle 0.59 0.18 Small
EB 0.51 0.31 Small
A1221 (0.5) 0.03 1.15 Large F>M
A1221 (1.0) 0.07 1.15 Large
Vehicle 0.04 0.98 Large F>M
EB 0.16 -0.62 Medium
A1221 (0.5) 0.79 -0.13 Small
A1221 (1.0) 0.19 0.71 Medium
Vehicle 0.87 0.08 Small
EB 0.45 -0.38 Small
A1221 (0.5) 0.35 -0.46 Small
A1221 (1.0) 0.11 -0.84 Large
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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(Table 5.4 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 6 20 ± 3
EB 5 56 ± 17
A1221 (0.5) 6 34 ± 17
A1221 (1.0) 6 35 ± 10
Vehicle 10 28 ± 8
EB 7 35 ± 14
A1221 (0.5) 6 25 ± 6
A1221 (1.0) 5 49 ± 19
Vehicle 11 31 ± 8
EB 7 30 ± 13
A1221 (0.5) 7 42 ± 16
A1221 (1.0) 7 28 ± 12
Vehicle 10 28 ± 6
EB 2 27 ± 16
A1221 (0.5) 6 17 ± 5
A1221 (1.0) 5 22 ± 10
Vehicle 4 19 ± 6
EB 2 27 ± 22
A1221 (0.5) 3 10 ± 3
A1221 (1.0) 2 13 ± 1
-2 KW X2(3) =0.94 0.81 0.09
-1.7 KW X2(3) = 1.40 0.71
-1.4 KW X2(3) = 0.61 0.89 0.02
-1.1 KW X2(3) = 1.13 0.77
-0.8 KW X2(3) = 1.26 0.42 0.13
SEM
A. Female Treatment Effects
0.06
0.04
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 6 32 ± 14
EB 8 34 ± 18
A1221 (0.5) 4 24 ± 12
A1221 (1.0) 5 19 ± 13
Vehicle 5 48 ± 16
EB 9 47 ± 15
A1221 (0.5) 7 47 ± 19
A1221 (1.0) 7 44 ± 15
Vehicle 8 33 ± 13
EB 10 63 ± 14
A1221 (0.5) 9 61 ± 16
A1221 (1.0) 5 65 ± 22
Vehicle 7 29 ± 12
EB 7 47 ± 12
A1221 (0.5) 7 57 ± 13
A1221 (1.0) 3 80 ± 39
Vehicle 2 25 ± 18
EB 7 15 ± 4
A1221 (0.5) 7 50 ± 18
A1221 (1.0) 6 31 ± 10
-2 KW X2(3) =3.26 0.35 0.16
-1.7 KW X2(3) =3.78 0.29
-1.4 KW X2(3) =3.06 0.38 0.10
-1.1 KW X2(3) =0.42 0.94
-0.8 KW X2(3) = 1.19 0.76 0.05
SEM
B. Male Treatment Effects
0.16
0.02
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Table 5.4. Number of Oxytocin-positive Cell Bodies in the Supraoptic Nucleus Across 
the Series 
Table 4. Total number of oxytocin- positive cell bodies counted in the supraoptic nucleus 
with respect to each section in the series is shown for Females (A) and Males (B). Data 
here, and in subsequent Tables 5.5-5.9, are shown as mean + SEM. Statistical tests used, 
values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM 
= 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences and 
Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. There were no differences due to treatment. The one 
significant sex difference that was found is indicated. M=male, F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.41 -0.51 Medium
EB 0.40 0.49 Small
A1221 (0.5) 0.62 0.31 Small
A1221 (1.0) 0.39 0.56 Medium
Vehicle 0.29 -0.67 Medium
EB 0.57 -0.28 Small
A1221 (0.5) 0.30 -0.59 Medium
A1221 (1.0) 0.84 0.12 Small
Vehicle 0.90 -0.06 Small
EB 0.10 -0.84 Large
A1221 (0.5) 0.42 -0.41 Small
A1221 (1.0) 0.19 -0.90 Large
Vehicle 0.96 -0.03 Small
EB 0.42 -0.72 Medium
A1221 (0.5) 0.02 -1.56 Large M>F
A1221 (1.0) 0.27 -1.16 Large
Vehicle 0.80 -0.31 Small
EB 0.68 0.52 Medium
A1221 (0.5) 0.07 -1.18 Large
A1221 (1.0) 0.12 -1.09 Large
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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(Table 5.5 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 6 1.0E-05 ± 3.3E-06
EB 5 1.7E-05 ± 3.6E-06
A1221 (0.5) 6 9.6E-06 ± 3.3E-06
A1221 (1.0) 6 1.2E-05 ± 2.2E-06
Vehicle 10 7.5E-06 ± 2.2E-06
EB 7 1.0E-05 ± 2.9E-06
A1221 (0.5) 6 8.9E-06 ± 2.7E-06
A1221 (1.0) 5 1.2E-05 ± 4.0E-06
Vehicle 11 9.1E-06 ± 2.0E-06
EB 7 9.9E-06 ± 3.6E-06
A1221 (0.5) 7 9.2E-06 ± 3.0E-06
A1221 (1.0) 7 7.0E-06 ± 2.2E-06
Vehicle 10 9.3E-06 ± 1.6E-06
EB 2 8.5E-06 ± 4.7E-06
A1221 (0.5) 6 8.4E-06 ± 2.2E-06
A1221 (1.0) 5 8.3E-06 ± 2.7E-06
Vehicle 4 1.2E-05 ± 3.1E-06
EB 2 1.1E-05 ± 8.1E-06
A1221 (0.5) 2 3.4E-06 ± 2.2E-06
A1221 (1.0) 2 2.6E-06 ± 0.4E-06
-1.7 KW X2(3) = 0.29 0.96
-2 KW X2(3) = 3.79 0.28 0.04
-1.4 KW X2(3) = 0.61 0.89 0.02
SEM
-1.1 KW X2(3) = 1.38 0.71
-0.8 KW X2(3) = 2.63 0.45 0.12
A. Female Treatment Effects
0.05
0.01
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 6 9.5E-06 ± 4.9E-06
EB 8 9.2E-06 ± 3.6E-06
A1221 (0.5) 4 8.9E-06 ± 3.2E-06
A1221 (1.0) 5 5.1E-06 ± 2.5E-06
Vehicle 5 1.3E-05 ± 3.6E-06
EB 9 9.9E-06 ± 2.6E-06
A1221 (0.5) 7 1.2E-05 ± 3.8E-06
A1221 (1.0) 7 1.3E-05 ± 4.3E-06
Vehicle 8 6.63E-06 ± 2.2E-06
EB 10 11.0E-06 ± 2.1E-06
A1221 (0.5) 9 14.0E-06 ± 2.5E-06
A1221 (1.0) 5 15.0E-06 ± 3.3E-06
Vehicle 7 9.9E-06 ± 2.4E-06
EB 7 13.0E-06 ± 1.7E-06
A1221 (0.5) 7 15.0E-06 ± 2.8E-06
A1221 (1.0) 3 15.0E-06 ± 4.6E-06
Vehicle 2 11.0E-06 ± 3.2E-06
EB 7 11.0E-06 ± 1.7E-06
A1221 (0.5) 7 18.0E-06 ± 2.2E-06
A1221 (1.0) 6 6.9E-06 ± 2.6E-06
-1.7 KW X2(3) =2.07 0.56
-2 KW X2(3) =8.93 0.03 0.43
-1.4 KW X2(3) =5.69 0.13 0.18
SEM
-1.1 KW X2(3) =0.89 0.83
-0.8 KW X2(3) =0.82 0.85 0.04
B. Male Treatment Effects
0.03
0.09
 135 
 
Table 5.5. Oxytocin Staining Density in the Supraoptic Nucleus Across the Series 
Table 5. The density of oxytocin-positive cell bodies by regional volume (per µ3)  in the 
supraoptic nucleus with respect to each section in the series is shown here. Data here, and 
in subsequent Tables 5.6-5.9, are shown as mean + SEM. Statistical tests used, values and 
degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM = 0.09; 
LARGE = 0.25). (C) The statistics for within-treatment sex differences and Cohen’s d 
effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. One significant effect of treatment was found in males in the 
last section (Bregma -2.0). The one significant sex difference found is indicated. 
M=male, F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.92 0.05 Small
EB 0.16 0.86 Large
A1221 (0.5) 0.89 0.09 Small
A1221 (1.0) 0.07 1.24 Large
Vehicle 0.23 -0.74 Medium
EB 0.88 0.02 Small
A1221 (0.5) 0.57 -0.37 Small
A1221 (1.0) 0.89 -0.10 Small
Vehicle 0.42 0.39 Small
EB 0.71 -0.14 Small
A1221 (0.5) 0.28 -0.62 Medium
A1221 (1.0) 0.10 -1.20 Large
Vehicle 0.83 -0.11 Small
EB 0.50 -0.81 Large
A1221 (0.5) 0.09 -1.01 Large
A1221 (1.0) 0.26 -0.94 Large
Vehicle 0.76 0.19 Small
EB 0.99 0.00 Small
A1221 (0.5) 0.01 -3.08 Large M > F
A1221 (1.0) 0.16 -0.97 Large
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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(Table 5.6 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 7 71 ± 18
EB 8 46 ± 13
A1221 (0.5) 7 48 ± 17
A1221 (1.0) 7 33 ± 9
Vehicle 11 108 ± 24
EB 9 102 ± 18
A1221 (0.5) 8 53 ± 21
A1221 (1.0) 8 89 ± 30
Vehicle 6 47 ± 23
EB 5 21 ± 14
A1221 (0.5) 4 6 ± 2
A1221 (1.0) 4 24 ± 16
SEM
A. Female Treatment Effects
-1.1 N/A N/A N/A N/A
-0.8 N/A N/A N/A N/A
-1.4 KW X2(3) = 2.31 0.51 0.08
-1.7 KW X2(3) =4.24 0.24 0.12
-2 KW X2(3) =6.60 0.09 0.37
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 7 75 ± 25
EB 6 69 ± 12
A1221 (0.5) 3 153 ± 35
A1221 (1.0) 4 87 ± 24
Vehicle 7 102 ± 35
EB 7 135 ± 27
A1221 (0.5) 8 115 ± 28
A1221 (1.0) 4 149 ± 48
Vehicle 3 55 ± 34
EB 5 51 ± 29
A1221 (0.5) 4 53 ± 36
A1221 (1.0) 1 151 ± N/A
SEM
B. Male Treatment Effects
-1.1 N/A N/A N/A N/A
-0.8 N/A N/A N/A N/A
-1.4 KW X2(3) = 4.17 0.24 0.22
-1.7 KW X2(3) = 1.35 0.72 0.05
-2 KW X2(3) = 2.46 0.48 0.22
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Table 5.6. Number of Vasopressin-positive Cell Bodies in the Paraventricular Nucleus 
Across the Series 
Total number of vasopressin- positive cell bodies counted in the paraventricular nucleus 
with respect to each section in the series is shown for Females (A) and Males (B). Data 
here, and in subsequent Tables 5.7-5.9, are shown as mean + SEM. Statistical tests used, 
values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM 
= 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences and 
Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. There were no differences due to treatment or sex. M=male, 
F=female.   
 
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle N/A N/A N/A N/A
EB N/A N/A N/A N/A
A1221 (0.5) N/A N/A N/A N/A
A1221 (1.0) N/A N/A N/A N/A
Vehicle N/A N/A N/A N/A
EB N/A N/A N/A N/A
A1221 (0.5) N/A N/A N/A N/A
A1221 (1.0) N/A N/A N/A N/A
Vehicle 0.90 -0.07 Small
EB 0.23 -0.67 Medium
A1221 (0.5) 0.07 -1.99 Large
A1221 (1.0) 0.11 -1.43 Large
Vehicle 0.89 0.07 Small
EB 0.32 -0.53 Medium
A1221 (0.5) 0.10 -0.89 Medium
A1221 (1.0) 0.33 -0.67 Medium
Vehicle 0.86 -0.14 Small
EB 0.38 -0.60 Medium
A1221 (0.5) 0.28 -0.93 Large
A1221 (1.0) N/A N/A N/A N/A
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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(Table 5.7 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 7 7.7E-06 ± 1.5E-06
EB 8 6.0E-06 ± 1.2E-06
A1221 (0.5) 7 5.8E-06 ± 1.4E-06
A1221 (1.0) 6 4.6E-06 ± 1.4E-06
Vehicle 11 8.1E-06 ± 1.5E-06
EB 9 8.6E-06 ± 1.4E-06
A1221 (0.5) 8 4.7E-06 ± 1.7E-06
A1221 (1.0) 8 6.7E-06 ± 2.2E-06
Vehicle 6 4.6E-06 ± 1.8E-06
EB 4 3.3E-06 ± 1.3E-06
A1221 (0.5) 3 0.8E-06 ± 0.1E-06
A1221 (1.0) 4 2.7E-06 ± 1.0E-06
SEM
A. Female Treatment Effects
-1.1 KW N/A N/A N/A
-0.8 KW N/A N/A N/A
-1.4 KW X2(3) = 1.34 0.72 0.05
-1.7 KW X2(3) = 4.01 0.26 0.11
-2 KW X2(3) = 4.01 0.16 0.29
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 0 N/A ± N/A
EB 0 N/A ± N/A
A1221 (0.5) 0 N/A ± N/A
A1221 (1.0) 0 N/A ± N/A
Vehicle 7 6.97E-06 ± 1.5E-06
EB 6 7.76E-06 ± 0.7E-06
A1221 (0.5) 3 14.0eE06 ± 1.2E-06
A1221 (1.0) 4 7.96E-06 ± 1.2E-06
Vehicle 6 8.5E-06 ± 2.3E-06
EB 7 9.8E-06 ± 1.8E-06
A1221 (0.5) 8 9.8E-06 ± 1.9E-06
A1221 (1.0) 4 10.0E-06 ± 3.0E-06
Vehicle 3 4.6E-06 ± 1.8E-06
EB 4 5.3E-06 ± 2.3E-06
A1221 (0.5) 4 5.2E-06 ± 1.9E-06
A1221 (1.0) 1 12.0E-06 ± N/A
SEM
B. Male Treatment Effects
-1.1 N/A N/A N/A N/A
-0.8 N/A N/A N/A N/A
-1.4 KW X2(3) = 7.30 0.06 0.38
-1.7 KW X2(3) =0.41 0.94 0.02
-2 KW X2(3) =2.72 0.44 0.25
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Table 5.7. Vasopressin Staining Density in the Paraventricular Nucleus Across the Series 
The density of vasopressin-positive cell bodies by regional volume (per µ3)  in the 
paraventricular nucleus with respect to each section in the series is shown here. Data 
here, and in subsequent Tables 5.8 and 5.9, are shown as mean + SEM. Statistical tests 
used, values and degrees of freedom, and effect sizes are indicated (SMALL = 0.01; 
MEDIUM = 0.09; LARGE = 0.25). (C) The statistics for within-treatment sex differences 
and Cohen’s d effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) 
with directionality of the effect. No significant effects of treatment were found. The one 
significant sex difference is indicated. M=male, F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle N/A N/A N/A
EB N/A N/A N/A
A1221 (0.5) N/A N/A N/A
A1221 (1.0) N/A N/A N/A
Vehicle N/A N/A N/A
EB N/A N/A N/A
A1221 (0.5) N/A N/A N/A
A1221 (1.0) N/A N/A N/A
Vehicle 0.73 0.19 Small
EB 0.23 -0.66 Medium
A1221 (0.5) 0.004 -2.69 Large M>F
A1221 (1.0) 0.11 -1.13 Large
Vehicle 0.89 -0.07 Small
EB 0.60 -0.27 Small
A1221 (0.5) 0.06 -1.01 Large
A1221 (1.0) 0.38 -0.54 Medium
Vehicle 0.99 0.00 Small
EB 0.50 -0.52 Medium
A1221 (0.5) 0.11 -1.59 Large
A1221 (1.0) N/A N/A N/A
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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(Table 5.8 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 9 68 ± 14
EB 8 72 ± 14
A1221 (0.5) 8 47 ± 11
A1221 (1.0) 7 77 ± 22
Vehicle 9 121 ± 14
EB 8 106 ± 23
A1221 (0.5) 8 97 ± 12
A1221 (1.0) 7 102 ± 26
Vehicle 9 106 ± 16
EB 8 131 ± 15
A1221 (0.5) 8 108 ± 12
A1221 (1.0) 7 100 ± 20
Vehicle 9 63 ± 9
EB 8 86 ± 16
A1221 (0.5) 8 85 ± 15
A1221 (1.0) 7 42 ± 16
Vehicle 9 17 ± 5
EB 8 22 ± 9
A1221 (0.5) 8 39 ± 16
A1221 (1.0) 7 20 ± 15
B. Male Treatment Effects
SEM
-1.1 KW X2(3) =1.14 0.77 0.04
-1.4 KW X2(3) =1.51
-0.8 KW X2(3) = 2.21 0.53 0.07
0.68 0.05
-1.7 KW
0.40-2 KW X2(3) =4.88 0.09
X2(3) =4.88 0.18 0.16
Distance 
from 
Bregma Treatment N Mean (#) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 11 62 ± 9
EB 9 60 ± 17
A1221 (0.5) 8 51 ± 14
A1221 (1.0) 8 66 ± 9
Vehicle 11 113 ± 9
EB 9 112 ± 17
A1221 (0.5) 8 103 ± 15
A1221 (1.0) 8 105 ± 25
Vehicle 11 119 ± 11
EB 9 108 ± 12
A1221 (0.5) 8 103 ± 8
A1221 (1.0) 8 110 ± 17
Vehicle 11 83 ± 11
EB 9 70 ± 13
A1221 (0.5) 8 70 ± 12
A1221 (1.0) 8 76 ± 14
Vehicle 11 32 ± 12
EB 9 14 ± 6
A1221 (0.5) 8 13 ± 5
A1221 (1.0) 8 16 ± 5
A. Female Treatment Effects
SEM
-1.1 KW X2(3) = 0.45 0.93 0.01
-1.4 KW X2(3) = 2.11
-0.8 KW X2(3) = 2.31 0.86 0.02
0.55 0.06
-1.7 KW
0.86-2 KW X2(3) = 0.74 0.02
X2(3) = 1.01 0.80 0.03
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Table 5.8. Number of Vasopressin-positive Cell Bodies in the Supraoptic Nucleus Across 
the Series 
Total number of vasopressin- positive cell bodies counted in the supraoptic nucleus with 
respect to each section in the series is shown for Females (A) and Males (B). Data here, 
and in subsequent Table 5.9, are shown as mean + SEM. Statistical tests used, values and 
degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM = 0.09; 
LARGE = 0.25). (C) The statistics for within-treatment sex differences and Cohen’s d 
effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. There were no differences due to treatment or sex. M=male, 
F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.72 -0.17 Small
EB 0.56 -0.29 Small
A1221 (0.5) 0.83 0.11 Small
A1221 (1.0) 0.65 -0.25 Small
Vehicle 0.63 -0.22 Small
EB 0.83 0.11 Small
A1221 (0.5) 0.76 0.16 Small
A1221 (1.0) 0.93 0.05 Small
Vehicle 0.50 0.31 Small
EB 0.25 -0.58 Medium
A1221 (0.5) 0.77 -0.15 Small
A1221 (1.0) 0.71 0.20 Small
Vehicle 0.19 0.61 Medium
EB 0.46 -0.37 Small
A1221 (0.5) 0.46 -0.38 Small
A1221 (1.0) 0.14 0.82 Large
Vehicle 0.28 0.48 Small
EB 0.48 -0.36 Small
A1221 (0.5) 0.15 -0.79 Medium
A1221 (1.0) 0.83 -0.12 Small
-2
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
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(Table 5.9 continued on next page) 
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 8 1.7E-05 ± 2.3E-06
EB 8 1.5E-05 ± 1.4E-06
A1221 (0.5) 8 1.2E-05 ± 2.7E-06
A1221 (1.0) 7 1.6E-05 ± 1.5E-06
Vehicle 9 1.7E-05 ± 1.6E-06
EB 8 1.7E-05 ± 1.5E-06
A1221 (0.5) 8 1.7E-05 ± 2.2E-06
A1221 (1.0) 7 1.6E-05 ± 4.2E-06
Vehicle 9 1.70E-05 ± 1.4E-06
EB 8 1.80E-05 ± 1.6E-06
A1221 (0.5) 8 2.20E-05 ± 2.9E-06
A1221 (1.0) 6 2.00E-05 ± 3.3E-06
Vehicle 9 1.5E-05 ± 1.5E-06
EB 8 1.9E-05 ± 2.3E-06
A1221 (0.5) 8 1.8E-05 ± 1.9E-06
A1221 (1.0) 5 2.1E-05 ± 1.8E-06
Vehicle 7 1.2E-05 ± 1.5E-06
EB 7 1.3E-05 ± 1.9E-06
A1221 (0.5) 6 1.8E-05 ± 4.4E-06
A1221 (1.0) 3 1.5E-05 ± 8.5E-06
SEM
B. Male Treatment Effects
-1.1 KW X2(3) = 0.33 0.95 0.01
-0.8 KW X2(3) = 3.82 0.28 0.13
-1.4 KW X2(3) = 1.19 0.76 0.04
-1.7 KW X2(3) = 4.86 0.18 0.17
-2 KW X2(3) = 1.42 0.70 0.06
Distance 
from 
Bregma Treatment N Mean (#/µ3) Test
F (df) for 
ANOVA; X2 (df) 
for KW
P-value ηp
2 for ANOVA; 
ε2 for KW
Vehicle 11 1.3E-05 ± 0.9E-06
EB 7 1.5E-05 ± 1.6E-06
A1221 (0.5) 7 1.3E-05 ± 2.0E-06
A1221 (1.0) 8 1.3E-05 ± 1.6E-06
Vehicle 11 1.8E-05 ± 1.1E-06
EB 9 1.8E-05 ± 1.8E-06
A1221 (0.5) 8 1.6E-05 ± 1.8E-06
A1221 (1.0) 8 1.6E-05 ± 3.5E-06
Vehicle 11 2.0E-05 ± 1.8E-06
EB 9 1.8E-05 ± 1.0E-06
A1221 (0.5) 8 1.8E-05 ± 1.4E-06
A1221 (1.0) 7 1.6E-05 ± 2.7E-06
Vehicle 11 2.2E-05 ± 2.6E-06
EB 8 1.6E-05 ± 1.5E-06
A1221 (0.5) 8 1.6E-05 ± 1.8E-06
A1221 (1.0) 8 1.7E-05 ± 2.6E-06
Vehicle 9 2.0E-05 ± 7.7E-06
EB 7 1.0E-05 ± 3.0E-06
A1221 (0.5) 6 1.4E-05 ± 2.1E-06
A1221 (1.0) 6 1.8E-05 ± 5.9E-06
SEM
A. Female Treatment Effects
-1.1 KW X2(3) = 1.14 0.67 0.04
-0.8 KW X2(3) = 1.14 0.77 0.04
-1.4 KW X2(3) = 2.28 0.51 0.07
-1.7 KW X2(3) = 3.11 0.37 0.09
-2 KW X2(3) = 1.38 0.71 0.05
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Table 5.9. Vasopressin Staining Density in the Supraoptic Nucleus Across the Series 
The density of vasopressin-positive cell bodies by regional volume (per µ3)  in the 
supraoptic nucleus with respect to each section in the series is shown here. Data here, and 
in subsequent Tables x-x, are shown as mean + SEM. Statistical tests used, values and 
degrees of freedom, and effect sizes are indicated (SMALL = 0.01; MEDIUM = 0.09; 
LARGE = 0.25). (C) The statistics for within-treatment sex differences and Cohen’s d 
effect sizes are shown (SMALL = 0.2; MEDIUM = 0.5; LARGE = 0.8) with 
directionality of the effect. No significant effects of treatment or sex were found. 
M=male, F=female.   
Distance 
from 
Bregma Treatment P-Value Cohen's d Effect Size Directionality
Vehicle 0.14 -0.79 Medium
EB 0.93 0.00 Small
A1221 (0.5) 0.73 0.15 Small
A1221 (1.0) 0.18 -0.71 Medium
Vehicle 0.675 0.24 Small
EB 0.63 0.21 Small
A1221 (0.5) 0.66 -0.18 Small
A1221 (1.0) 0.88 0.00 Small
Vehicle 0.33 0.57 Medium
EB 0.95 0.00 Small
A1221 (0.5) 0.25 -0.63 Medium
A1221 (1.0) 0.30 -0.52 Medium
Vehicle 0.06 1.00 Large
EB 0.37 -0.55 Medium
A1221 (0.5) 0.37 -0.38 Small
A1221 (1.0) 0.23 -0.68 Medium
Vehicle 0.34 0.48 Small
EB 0.46 -0.47 Small
A1221 (0.5) 0.42 -0.47 Small
A1221 (1.0) 0.23 0.20 Small
C. Sex Effects within Treatment
-0.8
-1.1
-1.4
-1.7
-2
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DISCUSSION 
 
The purpose of the present study was to evaluate the effects of gestational 
exposure to PCBs on the oxytocin- and -vasopressin producing neurons within two 
hypothalamic brain regions, the paraventricular and supraoptic nuclei. Previous work in 
the lab identified changes in the social and anxiety-related behavior of these same 
animals (Reilly, 2015; Gillette 2017). In tests of sociality, the binary choice model 
identified that females in the EB and A1221 groups did not display the expected 
preference for the novel stimulus animal; this was also seen in the male A1221 (0.5 
mg/kg) group. Although it is not possible to attribute this outcome to any one specific 
mechanism, there exists precedent in the literature to suggest that an animal’s ability to 
recognize a conspecific is impaired by deficiencies in the oxytocin and vasopressin 
signaling system.  
 
In this report, we present evidence of no significant differences in the expression 
of oxytocin- or vasopressin-positive cell bodies within the paraventricular or supraoptic 
nucleus in animals exposed to low dosages of the PCB mixture A1221. Although the 
timing of exposure coincided with the ontogeny of these two peptides, the exogenous 
effects during gestation did not drive any changes to the production of either peptide in 
the adult brain. Thus, the sex- and dose-specific changes observed in the social behavior 
of these animals (Reilly, 2016) may exist downstream of the peptidergic activity of these 
two regions.  
 
Many experiments identifying the role of oxytocin (OT) and vasopressin (AVP) 
in social recognition have done so through the manipulation of the respective receptors 
 145 
away from the sites of production. For example, the actions of OT on it’s receptor (OTR) 
in the medial amygdala (MeA) has been determined to play a critical role in an animal’s 
ability to display behavior consistent with social recognition (Ferguson, 2000). The MeA 
is the site of convergence of socially-relevant olfactory systems. Infusion of OT into the 
MeA of OT-knockout mice restored social recognition (Beauchamp, 2003). Studies in 
AVP-deficient Battleboro rats have shown changes in social recognition as well (Feifel, 
2009). In contrast to the actions of OT on this behavior, knockout studies in mice have 
determined that the actions of AVP on social recognition lie at the level of the lateral 
septum (LS), where vasopressin receptor subtype 1a (AVP1aR)-KO mice fail to display 
behavior suggesting familiarity to a stimulus animal (Bielsky 2004). Re-expression of the 
gene encoding for AVP1aR in the LS was sufficient to reinstate social recognition in the 
knockout mice (Bielsky, 2005). Moreover, sex steroid hormones modulate the activity of 
the peptides at these regions and, in the case of OT’s action at the MeA, serve as a 
requirement for normal function. Although both estrogen receptor alpha (ERα) and beta 
(ERβ) have been implicated in social behavior (Clipperton, 2006), ERα is required for 
the induction of the OTR at the MeA (Cushing, 2008; Spiteri, 2011).  
 
Without evidence of changes in the synthesis of oxytocin or vasopressin in the 
PVN or SON, it’s possible that the alterations in behavior observed in our animals were 
mediated by changes to the target regions of the peptides, such as the LS or MeA. The 
degree of estrogenic modulation in these regions presents a sensitivity to endocrine 
disruption by PCBs; particularly if exposure occurs during development of these regions 
during gestation.   Having no reliable antibody against the specific OT or AVP receptors, 
such a theory is not feasibly addressed through immunohistochemical methods. Rather, 
future work will investigate the MeA for changes in oxytocin, vasopressin, and the 
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receptors to see if changes to the genes that encode for these proteins is altered by 
gestational exposure to PCBs, presumably via estrogenic mechanisms. 
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CHAPTER 6: SUMMARY, IMPLICATIONS, AND FUTURE 
DIRECTIONS 
The purpose of this dissertation was to develop an in-depth behavioral analysis of 
animals exposed to EDCs during gestation. By observing both sexes in an assortment of 
paradigms that model social behavior, I was able to determine how the sexes differed in 
their behavior and whether these differences presented differential susceptibilities to 
endocrine disruption. In general, each chapter had at least one experimental factor that 
was shared with another chapter. This internal consistency presented the opportunity to 
compare and contrast the results, aiding in the interpretation of the outcomes.  
SUMMARY OF FINDINGS 
Gestational EDCs do Not Alter the Social Preference  
 The results of chapters 2 and 3 give me confidence in determining that 
gestational exposure to PCBs or VIN do not alter the general affiliative behaviors of the 
animals. Regardless of sex or treatment, all animals displayed a clear-cut preference to 
spent time investigating and interacting with the stimulus cage containing a stimulus 
animal compared to the empty stimulus cage, as is consistent with the literature in rats. 
Interestingly, sex differences that were present in Chapter 2 were either absent or 
reversed in Chapter 3. Specifically, Chapter 2 determined that, although there were no 
alterations of the Social Preference due to treatment, there was a main effect of sex in the 
(1) latency to explore the stimulus animal (M>F) and (2) the total amount of time spent 
nose touching (M>F). In chapter 3, we did not see a significant effect of sex in the total 
time spent nose touching. Comparing the outcomes of the two chapters, I noticed that this 
was driven by the females of Chapter 3 engaging in more nose touching behavior with 
the stimuli used. In contrast to the same-sex gonadectomized stimulus animals used in 
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Chapter 2, Chapter 3 used same-sex intact stimulus animals for the binary choice test. 
This suggests that the intact stimulus elicited more nose touching from the females in all 
treatment groups within this social setting. An alternate, though not definitively mutually 
exclusive, explanation between the discordance in this sex difference may also lie in the 
difference in exposure durations. While Chapter 2 animals were subject to the effects of 
EDC during the time when the hypothalamus was going through sexual differentiation 
(E16 and E18), the animals in Chapter 3 received treatment much earlier (beginning on 
E08) and for a longer duration (daily until E18). This paradigm also encompasses the 
development of the fetal gonads, which play a crucial role in the subsequent sexual 
differentiation of the brain. It is tempting to suggest that exposure to PCBs at an a point 
prior to the sexual differentiation of the brain altered the developmental trajectory such 
that the processes mediating the sex differences were altered. 
Gestational EDCs alter the Novelty Preference in a Sex- Dose- and Duration-
Specific Manner 
In contrast to the unaffected Social Preference as determined by the Sociability 
test, Chapters 2 and 3 both saw sex- and dose-specific alterations to Novelty Preference. 
In Chapter 2, A1221 disrupted the novelty preference in females at the 1.0 mg/kg dose 
and males at the 0.5 mg/kg dose; this phenotype was observed in the three most salient 
measures: Time in Proximity to Stimulus Cage, Time Spent Exploring Stimulus Cage, 
and Time Spent Nose Touching. Looking at the exact same behavioral outcomes in 
Chapter 3, it was only the VIN-treated males who did not display a novelty preference. 
While A1221 appeared to disrupt the ability for both sexes to display a novelty 
preference in the 2-day dose paradigm, the 11-day dosed animals displayed the expected 
phenotype consistent with an ability to discriminate the two options. Similarly, the 
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significant lowering of male Nose Touching due to PCB treatment was unique to Chapter 
2. As previously stated, it appears that differences in the dose- and/or behavioral- 
paradigms of Chapter 2 and 3 ameliorated the PCB-mediated disruption to Novelty 
Preference. It bears repeating that, in either of these two chapters (2 and 3) which utilizes 
Novelty Preference as a means of understanding the discriminatory abilities of the 
animals, caution must be taken when interpreting the meaning behind animals who failed 
to display the expected (novel) preference. In order to have a preference, an animal must 
first be able to discriminate between two options. Therefore, it can be stated with 
certainty that animals who showed this preference are, at least in part, unaffected in the 
processed that are involved in social recognition. Conversely, animals who fail to display 
a clear preference cannot be as-easily characterized. To say that these animals have an 
alteration in their ability to discriminate between the two options assumes that a 
preference must follow the ability to discriminate. Given the behavioral methods used in 
these chapters, such a distinction cannot be made with certainty.  
Simple Models of Social Behavior Should Not Be Used to Anticipate how An Animal 
Will Behave in More Complex Models of Social Interaction 
Aside from a small number of subtle effects of treatment observed in Chapter 4, 
the most interesting finding was that, when presented with four stimulus options (one 
option tantamount to a reproductively active member of the opposite sex), the preferences 
were not as clearly defined as they were in the binary models used in Chapters 2 and 3. 
This is in contrast to binary choice models of mate preference that indicate a significant 
preference for females to spend more time affiliating with a male castrate with 
testosterone replacement over a castrate without testosterone. The implications of this 
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finding suggest that caution must be made when extrapolating the biological implications 
of binary choice models.   
PCBS Given During Late Gestation Do Not Alter the Total Number of Oxytocin- or 
Vasopressin-Producing Neurons in the Paraventricular or Supraoptic Nuclei 
Although the behaviors of these animals, as shown in Chapter 2, indicate that 
there was a sex- and dose-specific alteration of the novelty preference, there was no 
morphological indication that PCBs altered the amount of OT or AVP at the main sites of 
production within the hypothalamus. Looking at the rostral-to-caudal distribution of these 
OT/AVP-positive cells, however, there is an appreciable shift in the pattern. Using both 
count and density as a metric, the waxing and waning of the neurons throughout this 
region is not concordant between all treatment groups; this is especially apparent in 
A1221 (1.0) male OT distribution in the PVN and A1221 (0.5) female AVP distribution 
in the PVN. Though the relatively high degree of variability and low number of subjects 
(7-8 per group) it is possible that the subtle effects of PCBs were unable to be resolved by 
limited statistical power.  
 
 
IMPLICATIONS AND FUTURE DIRECTIONS 
Though this dissertation has established that gestational exposes to EDCs can and 
do result in significant differences in the adult social behavior of animals, the mechanistic 
underpinnings of these observations remain unclear. Specifically, what serves as the 
motivational or perceptual antecedent in the groups that fail to display a novelty 
preference?  In order to pursue further investigation of the proximate factors involved in 
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the altered phenotype, it is crucial to place the present findings within the context of what 
is known about how social information is processed in the brain.  
Although the exhibition of a behavior cannot be attributed to any one part of the 
brain, there have been key distinct (but interconnected) regions identified in mammals 
that work together to create and regulate social behavior. Sex differences in behavior 
have also been attributed to sexually dimorphic features of these regions, quantified by 
differences in cell number, gene expression, or epigenetic characteristics. Furthermore, 
gonadal sex hormones produce a profound influence on the male- or female-typical 
behaviors in which these regions have been implicated.  
The limbic system of the brain is predominately associated with the integration of 
external stimuli of social and/or sexual salience which results in the manifestation of 
appropriate behaviors that function to facilitate the protection of the individual and 
subsequent preservation of the species.   Environmental sensory information is 
transmitted via the olfactory bulb and tract systems to the medial amygdala (MeA), which 
plays a critical role in the processing of the signals that trigger social behaviors. Although 
the exact mechanisms underlying these processes are not well understood, experiments in 
rats and mice have determined the importance of the MeA in affiliative and, more 
specifically, discriminatory capabilities of the animal within a social context. 
Exceptionally important in social recognition is the estrogen-dependent actions of 
oxytocin in this brain region. It is tempting to speculate that the hormone-sensitive 
organization of this region serves as the conduit by which the sexes were differentially 
altered by gestational EDCs. In light of no observable changes to the source of oxytocin 
in Chapter 5, the extrahypothalamic actions of this peptide remain uninvestigated. 
Moreover, projections from the MeA feed into the hypothalamic portion of the limbic 
system, also crucial in social behaviors.   
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Classically, the ventral medial nucleus of the hypothalamus (VMN) and medial 
preoptic area (mPOA) have been implicated in the female- or male-typical social and 
sexual behaviors, respectively.  More recently, it has been proposed that both of these 
regions are of equal importance in the organization and activation of sex-specific 
behaviors. Rather than two separate neural circuits responsible for sexually dimorphic 
(but complimentary) copulatory behavior, attention has turned to a common network that, 
through sex differences in cell number, hormone and neuropeptide receptors, 
steroidogenic or epigenetic factors, result in the observed behavioral phenotypes. A 
growing body of evidence that EDCs can interfere with any one of these outcomes 
suggests that the sex-specific effects of gestational EDCs may be mediated by alterations 
to these processes. Present in the EDC literature and corroborated in this dissertation is 
the common occurrence of exacerbated sex differences; either induced or abolished. 
Future work focusing on these three brain regions in particular will provide crucial 
insight into how EDCs can alter the social information processing in a sexually 
dimorphic manner.  
Ongoing work in the Gore lab will use the brains of the behaviorally characterized 
animals from Chapter 3 and employ the use of a TaqMan Low-Density qPCR Array 
(TLDA; Life Technologies) to explore the effects of EDCs in these three brain regions by 
determining the relative expression of 48 genes involved in hormone or neuropeptide 
signaling, steroidogenesis, epigenetic modifications, neurotransmission, and the 
expression of neurotrophic factors (Table 6.1). This will provide a unique and holistic 
perspective in how gestational exposure to PCBs or VIN may alter the behavioral 
phenotype. It will be interesting to see if changes in the medial amygdala, specifically in 
the genes involved in oxytocin or estrogen signaling, correlate with the loss of novelty 
preference in VIN males. The results from these experiments will also provide 
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information which may provide a reasoning behind the restoration of the expected 
novelty preference in the PCB-treated females (in contrast to the results of Chapter 2). It 
is not surprising that exposure to EDCs at different stages of gestation differentially alter 
the developmental trajectory in a manner that results in dissimilar behavioral outcomes. It 
will also be interesting to compare and contrast the effects of PCB and VIN treatment as 
determined by the TLDA study.  
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Table 6.1. TLDA Genes 
A list of the 48 genes comprising the custom-designed microfluidic TaqMan Low 
Density Array with the gene product and general role indicated.  
Gene Product Function
1 Dnmt1 DNA methyltransferase 1 Epigenetics
2 Dmnt3a DNA methyltransferase 3 alpha Epigenetics
3 Dnmt3b DNA methyltransferase 3 beta Epigenetics
4 Hdac2 Histone deacetylase 2 Epigenetics
5 Hdac4 Histone deacetylase 4 Epigenetics
6 Esr1 Estrogen receptor alpha Hormone signaling
7 Esr2 Estrogen receptor  beta Hormone signaling
8 Ar Androgen receptor Hormone signaling
9 Gper GpProtein-coupled estrogen receptor Hormone signaling
10 Pgr Progesterone receptor Hormone signaling
11 Nr3c1 Glucocorticoid receptor Hormone signaling
12 Esrra Estrogen-related receptor alpha Hormone signaling
13 Esrrb Estrogen-related receptor beta Hormone signaling
14 Esrrg Estrogen-related receptor gamma Hormone signaling
15 Crh Corticotropin-releasing hormone Hormone signaling
16 Crhr1 Corticotropin-releasing hormone receptor 1 Hormone signaling
17 Gnrh1 Gonadotropin-releasing hormone Hormone signaling
18 Per2 Period circadian protein 2 Hormone signaling
19 Oxt Oxytocin Neuropeptide Signaling
20 Oxtr Oxytocin receptor Neuropeptide Signaling
21 Avp Argenine vasopressin Neuropeptide Signaling
22 Avpr1a Argenine vasopressin receptor subtype 1a Neuropeptide Signaling
23 Kiss1 Kisspeptin 1 Neuropeptide Signaling
24 Kiss1r Kisspeptin 1 receptor Neuropeptide Signaling
25 Tac2 Tachykinin 2 Neuropeptide Signaling
26 Tac3 Tachykinin 3 Neuropeptide Signaling
27 Gabbr1 GABA-B receptor 1 Neurotransmission
28 Drd1 Dopamine receptor D1 Neurotransmission
29 Drd2 Dopamine receptor D2 Neurotransmission
30 Grin1 NMDA receptor Neurotransmission
31 Grin2b NMDA receptor Neurotransmission
32 Gad1 Glutamate decarboxylase Neurotransmission
33 Bdnf Brain derived neurotrophic factor Neurotrophic factor
34 Igf1 Insulin-like growth factor 1 Neurotrophic factor
35 Igf1r Insulin-like growth factor 1 receptor Neurotrophic factor
36 Cyp19a1 Aromatase Steroidogenesis
37 Srd5a1 5 alpha reductase 1 Steroidogenesis
38 Hsd3b1 3 beta hydroxysteroid dehydrogenase 3b1 Steroidogenesis
39 Star Steroidogenic acute regulatory protein Steroidogenesis
40 Cyp11a1 Cytochrome P450 family 11 subfamily a Steroidogenesis
41 Hsd17b1 17 beta hydroxysteroid dehydrogenase 1 Steroidogenesis
42 Ahr Arylhydrocarbon receptor Transcription factor
43 Egr1 Early growth response 1 Transcription factor
44 Foxp1 Forkhead box protein 1 Transcription factor
45 Foxp2 Forkhead box protein 2 Transcription factor
46 Arntl Aryl hydrocarbon receptor nuclear translocator-like protein Transcription factor
47 Gapdh/Rpl1 Glyceraldehyde-3- Phosphate Dehydrogenase Housekeeping
48 18s 18S ribosomal RNA Housekeeping
Gene 
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CLOSING REMARKS 
The use of behavior as a tool has proven an invaluable means of identifying the 
biological significance of environmental contamination. This dissertation adds to a 
growing body of literature that exposure to EDCs during critical periods of development 
forever alter the developmental trajectory of the individual. While we have established 
the behavioral implications of such interference, further experimentation on the 
mechanisms and brain regions underlying the manifestations of these sexually dimorphic 
behaviors will provide much-needed insight into the nature of this disruption. 
Determining the mechanisms by which past-and-presently known EDCs interfere with 
homeostasis can and should be used to inform the identification of other potential EDCs 
that have contaminated the environment. Moving into the future, there is no reason to 
believe that the production and subsequent environmental release of novel synthetic 
chemicals will be halted. Being able to establish and quantify known EDCs and their 
actions may lead to more stringent regulations that may identify and condemn 
particularly harmful compounds before, rather than after, their widespread use. 
 
 
 
 
 
 
 
 
 156 
Bibliography 
Acher, R., & Chauvet, J. (1995). The neurohypophysial endocrine regulatory cascade: 
precursors, mediators, receptors, and effectors. Frontiers in Neuroendocrinology, 
16, 237–289. https://doi.org/10.1006/frne.1995.1009 
Aiello, T. P., & Whitaker-Azmitia, P. M. (2011). Sexual differentiation and the 
neuroendocrine hypothesis of autism. Anatomical Record (Hoboken, N.J. : 2007), 
294(10), 1663–70. https://doi.org/10.1002/ar.21251 
Altstein, M., Whitnall, M. H., House, S., Key, S., & Gainer, H. (1988). An 
immunochemical analysis of oxytocin and vasopressin prohormone processing in 
vivo. Peptides, 9(1), 87–105. https://doi.org/10.1016/0196-9781(88)90014-9 
Alves, S. E., Lopez, V., McEwen, B. S., & Weiland, N. G. (1998). Differential 
colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin 
in the paraventricular and supraoptic nuclei of the female rat brain: an 
immunocytochemical study. Proceedings of the National Academy of Sciences of 
the United States of America, 95, 3281–3286. 
https://doi.org/10.1073/pnas.95.6.3281 
Andrews, O., Buffington, S. A., Viana, G., Prisco, D., Auchtung, T. A., Ajami, N. J., … 
Sakuma, Y. (2003). Sex-specific effects of gonadal steroids on conspecific odor 
preference in the rat. Hormones and Behavior, 466(August), 356–361. 
https://doi.org/10.1016/j.yhbeh.2004.05.008 
Arcaro, K. F., Yi, L., Seegal, R. F., Vakharia, D. D., Yang, Y., Spink, D. C., … Gierthy, 
J. F. (1999). 2,2′,6,6′-Tetrachlorobiphenyl is estrogenic in vitro and in vivo. 
Journal of Cellular Biochemistry, 72(1), 94–102. 
https://doi.org/10.1002/(SICI)1097-4644(19990101)72:1<94::AID-
JCB10>3.0.CO;2-Y 
Arnold, A. P. (2009). The organizational-activational hypothesis as the foundation for a 
unified theory of sexual differentiation of all mammalian tissues. Hormones and 
Behavior, 55, 570–578. https://doi.org/10.1016/j.yhbeh.2009.03.011 
Arnold, A. P., & Breedlove, S. M. (1985). Organizational and activational effects of sex 
steroids on brain and behavior: A reanalysis. Hormones and Behavior, 19(4), 
469–498. https://doi.org/10.1016/0018-506X(85)90042-X 
Aron, C. (1979). Mechanisms of Control of the Reproductive Function by Olfactory 
Stimuli in Female Mammals. Physiological Reviews, 52(2), 229–284. 
Bakker, J. (2003). Sexual differentiation of the neuroendocrine mechanisms regulating 
mate recognition in mammals. Journal of Neuroendocrinology, 15(6), 615–621. 
https://doi.org/10.1046/j.1365-2826.2003.01099.x 
 
 157 
Bale, T. L., Davis, A. M., Auger, A. P., Dorsa, D. M., & McCarthy, M. M. (2001). CNS 
region-specific oxytocin receptor expression: importance in regulation of anxiety 
and sex behavior. The Journal of Neuroscience, 21(7), 2546–52. 
https://doi.org/21/7/2546 [pii] 
Bellingham, M., Fiandanese, N., Byers, A., Cotinot, C., Evans, N. P., Pocar, P., … 
Fowler, P. a. (2012). Effects of exposure to environmental chemicals during 
pregnancy on the development of the male and female reproductive axes. 
Reproduction in Domestic Animals = Zuchthygiene, 47 Suppl 4, 15–22. 
https://doi.org/10.1111/j.1439-0531.2012.02050.x 
Belloni, V., Dessì-Fulgheri, F., Zaccaroni, M., Di Consiglio, E., De Angelis, G., Testai, 
E., … Santucci, D. (2011). Early exposure to low doses of atrazine affects 
behavior in juvenile and adult CD1 mice. Toxicology, 279, 19–26. 
https://doi.org/10.1016/j.tox.2010.07.002 
Bergvall, Å. H., Vega Matuszczyk, J., Dahlöf, L. G., & Hansen, S. (1991). Peripheral 
anosmia attenuates female-enhanced aggression in male rats. Physiology and 
Behavior, 50(1), 33–40. https://doi.org/10.1016/0031-9384(91)90494-9 
Betz, A. J., Jayatilaka, S., Joshi, J., Ramanan, S., Debartolo, D., Pylypiw, H., & Franke, 
E. (2013). Chronic exposure to benzyl butyl phthalate (BBP) alters social 
interaction and fear conditioning in male adult rats: Alterations in amygdalar 
MeCP2, ERK1/2 and ERα. Neuroendocrinology Letters, 34(5), 347–358. 
Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004). Profound 
impairment in social recognition and reduction in anxiety-like behavior in 
vasopressin V1a receptor knockout mice. Neuropsychopharmacology : Official 
Publication of the American College of Neuropsychopharmacology, 29, 483–493. 
https://doi.org/10.1038/sj.npp.1300360 
Bielsky, I. F., Hu, S. B., Ren, X., Terwilliger, E. F., & Young, L. J. (2005). The V1a 
vasopressin receptor is necessary and sufficient for normal social recognition: A 
gene replacement study. Neuron, 47, 503–513. 
https://doi.org/10.1016/j.neuron.2005.06.031 
Boer, G. J., Gash, D. M., Dick, L., & Schluter, N. (1985). Vasopressin neuron survival in 
neonatal brattleboro rats; critical factors in graft development and innervation of 
the host brain. Neuroscience, 15, 1087–1109. https://doi.org/10.1016/0306-
4522(85)90255-6 
Böttner, M., & Wuttke, W. (2005). Chronic treatment with low doses of estradiol affects 
pituitary and thyroid function in young and middle-aged ovariectomized rats. 
Biogerontology, 6(4), 261–9. https://doi.org/10.1007/s10522-005-2623-2 
 
 
 158 
Buckley, J., Willingham, E., Agras, K., & Baskin, L. S. (2006). Embryonic exposure to 
the fungicide vinclozolin causes virilization of females and alteration of 
progesterone receptor expression in vivo: An experimental study in mice. 
Environmental Health: A Global Access Science Source, 5. 
https://doi.org/10.1186/1476-069X-5-4 
Cabras, P., & Angioni, A. (2000). Pesticide residues in grapes, wine, and their processing 
products. Journal of Agricultural and Food Chemistry. 
https://doi.org/10.1021/jf990727a 
Cao, J., Rebuli, M. E., Rogers, J., Todd, K. L., Leyrer, S. M., Ferguson, S. a, & Patisaul, 
H. B. (2013). Prenatal bisphenol a exposure alters sex-specific estrogen receptor 
expression in the neonatal rat hypothalamus and amygdala. Toxicological 
Sciences : An Official Journal of the Society of Toxicology, 133(1), 157–73. 
https://doi.org/10.1093/toxsci/kft035 
Carrier, N., & Kabbaj, M. (2012). Sex differences in social interaction behaviors in rats 
are mediated by extracellular signal-regulated kinase 2 expression in the medial 
prefrontal cortex. Neuroscience, 212, 86–92. 
https://doi.org/10.1016/j.neuroscience.2012.03.041 
Carson, H. L. (2003). Mate choice theory and the mode of selection in sexual 
populations. Pnas, 100(11), 6584–6587. https://doi.org/10.1073/pnas.0732174100 
Carter, C. S., Boone, E. M., Pournajafi-Nazarloo, H., & Bales, K. L. (2009). 
Consequences of early experiences and exposure to oxytocin and vasopressin are 
sexually dimorphic. Developmental Neuroscience. 
https://doi.org/10.1159/000216544 
Choleris, E., Gustafsson, J.-A., Korach, K. S., Muglia, L. J., Pfaff, D. W., & Ogawa, S. 
(2003). An estrogen-dependent four-gene micronet regulating social recognition: 
A study with oxytocin and estrogen receptor-  and -  knockout mice. Proceedings 
of the National Academy of Sciences, 100(10), 6192–6197. 
https://doi.org/10.1073/pnas.0631699100 
Choleris, E., Ogawa, S., Kavaliers, M., Gustafsson, J. Å., Korach, K. S., Muglia, L. J., & 
Pfaff, D. W. (2006). Involvement of estrogen receptor α, β and oxytocin in social 
discrimination: A detailed behavioral analysis with knockout female mice. Genes, 
Brain and Behavior, 5, 528–539. https://doi.org/10.1111/j.1601-
183X.2006.00203.x 
Choleris, E., Ogawa, S., Kavaliers, M., Gustafsson, J. Å., Korach, K. S., Muglia, L. J., & 
Pfaff, D. W. (2006). Involvement of estrogen receptor α, β and oxytocin in social 
discrimination: A detailed behavioral analysis with knockout female mice. Genes, 
Brain and Behavior, 5, 528–539. https://doi.org/10.1111/j.1601-
183X.2006.00203.x 
 159 
Cooke, B. M., Tabibnia, G., & Breedlove, S. M. (1999). A brain sexual dimorphism 
controlled by adult circulating androgens. Proceedings of the National Academy 
of Sciences, 96(13), 7538–7540. https://doi.org/10.1073/pnas.96.13.7538 
Cox, K. H., & Rissman, E. F. (2011). Sex differences in juvenile mouse social behavior 
are influenced by sex chromosomes and social context. Genes, Brain and 
Behavior, 10, 465–472. https://doi.org/10.1111/j.1601-183X.2011.00688.x 
Crews, D., Gillette, R., Scarpino, S. V., Manikkam, M., Savenkova, M. I., & Skinner, M. 
K. (2012). Epigenetic transgenerational inheritance of altered stress responses. 
Proceedings of the National Academy of Sciences. 
https://doi.org/10.1073/pnas.1118514109 
Crews, D., & Gore, A. C. (2011). Life imprints: Living in a contaminated world. 
Environmental Health Perspectives. https://doi.org/10.1289/ehp.1103451 
Crews, D., Lou, W., Fleming, A., & Ogawa, S. (2006). From gene networks underlying 
sex determination and gonadal differentiation to the development of neural 
networks regulating sociosexual behavior. Brain Research, 1126(1), 109–121. 
https://doi.org/10.1016/j.brainres.2006.07.031 
Cromwell, H. C., Johnson, A., McKnight, L., Horinek, M., Asbrock, C., Burt, S., … 
Meserve, L. A. (2007). Effects of polychlorinated biphenyls on maternal odor 
conditioning in rat pups. Physiology and Behavior, 91(5), 658–666. 
https://doi.org/10.1016/j.physbeh.2007.03.029 
Davis, E. C., Popper, P., & Gorski, R. A. (1996). The role of apoptosis in sexual 
differentiation of the rat sexually dimorphic nucleus of the preoptic area. Brain 
Research, 734, 10–18. 
Davis, E. C., Shryne, J. E., & Gorski, R. A. (1996). Structural sexual dimorphisms in the 
anteroventral periventricular nucleus of the rat hypothalamus are sensitive to 
gonadal steroids perinatally, but develop peripubertally. Neuroendocrinology, 
63(2), 142–148. https://doi.org/10.1159/000126950 
De Jesús-Burgos, M., Torres-Llenza, V., & Pérez-Acevedo, N. L. (2012). Activation of 
amygdalar metabotropic glutamate receptors modulates anxiety, and risk 
assessment behaviors in ovariectomized estradiol-treated female rats. 
Pharmacology, Biochemistry, and Behavior, 101(3), 369–78. 
https://doi.org/10.1016/j.pbb.2012.01.016 
de Vries, G. J., Duetz, W., Buijs, R. M., van Heerikhuize, J., & Vreeburg, J. T. (1986). 
Effects of androgens and estrogens on the vasopressin and oxytocin innervation of 
the adult rat brain. Brain Research, 399, 296–302. https://doi.org/10.1016/0006-
8993(86)91519-2 
De Vries, G. J., & Al-Shamma, H. A. (1990). Sex differences in hormonal responses of 
vasopressin pathways in the rat brain. Journal of Neurobiology, 21, 686–693. 
https://doi.org/10.1002/neu.480210503 
 160 
de Vries, G. J. (2008). Sex differences in vasopressin and oxytocin innervation of the 
brain. Progress in Brain Research. https://doi.org/10.1016/S0079-
6123(08)00402-0 
DeKoning, E. P., & Karmaus, W. (2000). PCB exposure in utero and via breast milk. A 
review. Journal of Exposure Analysis and Environmental Epidemiology, 10(3), 
285–93. https://doi.org/10.1038/sj.jea.7500090 
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., 
Soto, A. M., … Gore, A. C. (2009). Endocrine-Disrupting Chemicals: An 
Endocrine Society Scientific Statement. Endocrine Reviews, 30(4), 293–342. 
Retrieved from 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2726844&tool=pmce
ntrez&rendertype=abstract 
Dickerson, S. M., Cunningham, S. L., & Gore, A. C. (2011). Prenatal PCBs disrupt early 
neuroendocrine development of the rat hypothalamus. Toxicology and Applied 
Pharmacology, 252, 36–46. https://doi.org/10.1016/j.taap.2011.01.012 
Dickerson, S. M., Cunningham, S. L., Patisaul, H. B., Woller, M. J., & Gore, A. C. 
(2011). Endocrine disruption of brain sexual differentiation by developmental 
PCB exposure. Endocrinology, 152, 581–594. https://doi.org/10.1210/en.2010-
1103 
Dickerson, S. M., & Gore, A. C. (2007). Estrogenic environmental endocrine-disrupting 
chemical effects on reproductive neuroendocrine function and dysfunction across 
the life cycle. Reviews in Endocrine and Metabolic Disorders. 
https://doi.org/10.1007/s11154-007-9048-y 
Dickerson, S. M., Guevara, E., Woller, M. J., & Gore, A. C. (2009). Cell death 
mechanisms in GT1-7 GnRH cells exposed to polychlorinated biphenyls PCB74, 
PCB118, and PCB153. Toxicology and Applied Pharmacology, 237, 237–245. 
https://doi.org/10.1016/j.taap.2009.04.001 
Donaldson, Z. R., & Young, L. J. (2008). Oxytocin, vasopressin, and the neurogenetics of 
sociality. Science (New York, N.Y.), 322, 900–904. 
https://doi.org/10.1126/science.1158668 
Ebstein, R. P., Israel, S., Lerer, E., Uzefovsky, F., Shalev, I., Gritsenko, I., … Yirmiya, 
N. (2009). Arginine vasopressin and oxytocin modulate human social behavior. In 
Annals of the New York Academy of Sciences (Vol. 1167, pp. 87–102). 
https://doi.org/10.1111/j.1749-6632.2009.04541.x 
Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y., … Fujiwara, 
M. (2007). Impaired social interaction and reduced anxiety-related behavior in 
vasopressin V1a receptor knockout mice. Behavioural Brain Research, 178(1), 
123–127. https://doi.org/10.1016/j.bbr.2006.12.009 
 161 
Engelmann, M., Wotjak, C. T., & Landgraf, R. (1995). Social discrimination procedure: 
An alternative method to investigate juvenile recognition abilities in rats. 
Physiology and Behavior, 58, 315–321. https://doi.org/10.1016/0031-
9384(95)00053-L 
Farabollini, F., Porrini, S., Della Seta, D., Bianchi, F., & Dessì-Fulgheri, F. (2002). 
Effects of perinatal exposure to bisphenol A on sociosexual behavior of female 
and male rats. Environmental Health Perspectives, 110(SUPPL. 3), 409–414. 
https://doi.org/10.1289/ehp.02110s3409 
Ferguson, J. N., Aldag, J. M., Insel, T. R., & Young, L. J. (2001). Oxytocin in the medial 
amygdala is essential for social recognition in the mouse. The Journal of 
Neuroscience : The Official Journal of the Society for Neuroscience, 21(20), 
8278–85. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11588199 
Ferreira-Nuño, A., Morales-Otal, A., Paredes, R. G., & Velázquez-Moctezuma, J. (2005). 
Sexual behavior of female rats in a multiple-partner preference test. Hormones 
and Behavior, 47(3), 290–296. https://doi.org/10.1016/j.yhbeh.2004.11.012 
Frame, G. M., Wagner, R. E., Carnahan, J. C., Brown, J. F., May, R. J., Smullen, L. A., & 
Bedard, D. L. (1996). ON DB-I CAPILLARY GC COLUMNS, 33(4), 603–623. 
Frye, C., Bo, E., Calamandrei, G., Calzà, L., Dessì-Fulgheri, F., Fernández, M., … 
Panzica, G. C. (2012). Endocrine disrupters: A review of some sources, effects, 
and mechanisms of actions on behaviour and neuroendocrine systems. Journal of 
Neuroendocrinology. https://doi.org/10.1111/j.1365-2826.2011.02229.x 
Frye, C. A. (2014). Endocrine-Disrupting Chemicals. Elucidating Our Understanding of 
Their Role in Sex and Gender-Relevant End Points. Vitamins and Hormones, 94, 
41–98. https://doi.org/10.1016/B978-0-12-800095-3.00003-1 
Giesy, J., & Kannan, K. (1998). Dioxin-like and non-dioxin-like toxic effects of 
polychlorinated biphenyls (PCBs): implications for risk assessment. Crit Rev 
Toxicol, 28(6), 511–569. 
Gillette, R., Miller-Crews, I., Nilsson, E. E., Skinner, M. K., Gore, A. C., & Crews, D. 
(2014). Sexually dimorphic effects of ancestral exposure to vinclozolin on stress 
reactivity in rats. Endocrinology, en20141253. https://doi.org/10.1210/en.2014-
1253 
Gillette, R., Miller-Crews, I., Nilsson, E. E., Skinner, M. K., Gore, A. C., & Crews, D. 
(2014). Sexually dimorphic effects of ancestral exposure to vinclozolin on stress 
reactivity in rats. Endocrinology, 155(10), 3853–3866. 
https://doi.org/10.1210/en.2014-1253 
Gillette, R., Reilly, M. P., Topper, V. Y., Thompson, L. M., Crews, D., & Gore, A. C. 
(2017). Anxiety-like behaviors in adulthood are altered in male but not female 
rats exposed to low dosages of polychlorinated biphenyls in utero. Hormones and 
Behavior, 87, 8–15. https://doi.org/10.1016/j.yhbeh.2016.10.011 
 162 
Gladen, B. C., Doucet, J., & Hansen, L. G. (2003). Assessing human polychlorinated 
biphenyl contamination for epidemiologic studies: Lessons from patterns of 
Congener concentrations in Canadians in 1992. Environmental Health 
Perspectives, 111(4), 437–443. https://doi.org/10.1289/ehp.5858 
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., … 
Zoeller, R. T. (2015). Executive Summary to EDC-2: The Endocrine Society’s 
second Scientific Statement on endocrine-disrupting chemicals. Endocrine 
Reviews. https://doi.org/10.1210/er.2015-1093 
Gorski, R. A., Harlan, R. E., Jacobson, C. D., Shryne, J. E., & Southam, A. M. (1980). 
Evidence for the existence of a sexually dimorphic nucleus in the preoptic area of 
the rat. The Journal of Comparative Neurology, 193(2), 529–39. 
https://doi.org/10.1002/cne.901930214 
Grandjean, P., Barouki, R., Bellinger, D. C., Casteleyn, L., Chadwick, L. H., Cordier, S., 
… Heindel, J. J. (2015). Life-long implications of developmental exposure to 
environmental stressors: New perspectives. Endocrinology, 156(10), 3408–3415. 
https://doi.org/10.1210/EN.2015-1350 
Gréco, B., Allegretto, E. A., Tetel, M. J., & Blaustein, J. D. (2001). Coexpression of ER 
beta with ER alpha and progestin receptor proteins in the female rat forebrain: 
effects of estradiol treatment. Endocrinology, 142, 5172–5181. 
https://doi.org/10.1210/en.142.12.5172 
Henley, C. L., Nunez, A. A., & Clemens, L. G. (2011). Hormones of choice: The 
neuroendocrinology of partner preference in animals. Frontiers in 
Neuroendocrinology. https://doi.org/10.1016/j.yfrne.2011.02.010 
Hines, M., Allen, L. S., & Gorski, R. A. (1992). Sex differences in subregions of the 
medial nucleus of the amygdala and the bed nucleus of the stria terminalis of the 
rat. Brain Research, 579(2), 321–326. https://doi.org/10.1016/0006-
8993(92)90068-K 
Hong, W., Kennedy, A., Burgos-Artizzu, X. P., Zelikowsky, M., Navonne, S. G., Perona, 
P., & Anderson, D. J. (2015). Automated measurement of mouse social behaviors 
using depth sensing, video tracking, and machine learning. Proceedings of the 
National Academy of Sciences, 112(38), E5351–E5360. 
https://doi.org/10.1073/pnas.1515982112 
Hopf, N. B., Ruder, A. M., & Succop, P. (2009). Background levels of polychlorinated 
biphenyls in the U.S. population. The Science of the Total Environment, 407(24), 
6109–19. https://doi.org/10.1016/j.scitotenv.2009.08.035 
Ito, S., Murakami, S., Yamanouchi, K., & Arai, Y. (1986). Prenatal androgen exposure, 
preoptic area and reproductive functions in the female rat. Brain and 
Development, 8(4), 463–468. https://doi.org/10.1016/S0387-7604(86)80070-5 
 163 
Jacobsen, P. R., Axelstad, M., Boberg, J., Isling, L. K., Christiansen, S., Mandrup, K. R., 
… Hass, U. (2012). Persistent developmental toxicity in rat offspring after low 
dose exposure to a mixture of endocrine disrupting pesticides. Reproductive 
Toxicology, 34, 237–250. https://doi.org/10.1016/j.reprotox.2012.05.099 
Jacobson, C. D., Shryne, J. E., Shapiro, F., & Gorski, R. A. (1980). Ontogeny of the 
sexually dimorphic nucleus of the preoptic area. The Journal of Comparative 
Neurology, 193, 541–548. https://doi.org/10.1002/cne.901930215 
Jessen, H. M., Kolodkin, M. H., Bychowski, M. E., Auger, C. J., & Auger, A. P. (2010). 
The nuclear receptor corepressor has organizational effects within the developing 
amygdala on juvenile social play and anxiety-like behavior. Endocrinology, 
151(3), 1212–20. https://doi.org/10.1210/en.2009-0594 
Johnston, R. E. (2003). CHEMICAL COMMUNICATION IN RODENTS: FROM 
PHEROMONES TO INDIVIDUAL RECOGNITION. Journal of Mammalogy. 
https://doi.org/10.1644/BLe-010 
Jolous-Jamshidi, B., Cromwell, H. C., McFarland, A. M., & Meserve, L. A. (2010). 
Perinatal exposure to polychlorinated biphenyls alters social behaviors in rats. 
Toxicology Letters, 199, 136–143. https://doi.org/10.1016/j.toxlet.2010.08.015 
Jolous-Jamshidi, B., Cromwell, H. C., McFarland, A. M., & Meserve, L. A. (2010). 
Perinatal exposure to polychlorinated biphenyls alters social behaviors in rats. 
Toxicology Letters, 199, 136–143. https://doi.org/10.1016/j.toxlet.2010.08.015 
Kaidanovich-Beilin, O., Lipina, T., Vukobradovic, I., Roder, J., & Woodgett, J. R. 
(2011). Assessment of social interaction behaviors. Journal of Visualized 
Experiments : JoVE, (48), 6–10. https://doi.org/10.3791/2473 
Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, 
M., … Diamanti-Kandarakis, E. (2011). Endocrine Disruptors and Polycystic 
Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with 
PCOS. The Journal of Clinical Endocrinology & Metabolism, 96(3), E480–E484. 
https://doi.org/10.1210/jc.2010-1658 
Kawaguchi, M., Morohoshi, K., Imai, H., Morita, M., Kato, N., & Himi, T. (2010). 
Maternal exposure to isobutyl-paraben impairs social recognition in adult female 
rats. Experimental Animals / Japanese Association for Laboratory Animal 
Science, 59(5), 631–5. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/21030791 
Keverne, E. B., & Curley, J. P. (2004). Vasopressin, oxytocin and social behaviour. 
Current Opinion in Neurobiology. https://doi.org/10.1016/j.conb.2004.10.006 
Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Yang, S.-I., Cheong, J. H., … Ko, K. H. 
(2011). The critical period of valproate exposure to induce autistic symptoms in 
Sprague-Dawley rats. Toxicology Letters, 201(2), 137–42. 
https://doi.org/10.1016/j.toxlet.2010.12.018 
 164 
Kipervarg, Y. (1992). Stress: Neurobiology and Neuroendocrinology. The Yale Journal 
of Biology and Medicine, 65(1), 56–57. 
Kundakovic, M., Gudsnuk, K., Franks, B., Madrid, J., Miller, R. L., Perera, F. P., & 
Champagne, F. a. (2013). Sex-specific epigenetic disruption and behavioral 
changes following low-dose in utero bisphenol A exposure. Proceedings of the 
National Academy of Sciences of the United States of America, 110, 9956–61. 
https://doi.org/10.1073/pnas.1214056110 
Kuwahara, R., Kawaguchi, S., Kohara, Y., Cui, H., & Yamashita, K. (2013). Perinatal 
Exposure to Low-Dose Bisphenol A Impairs Spatial Learning and Memory in 
Male Rats. Journal of Pharmacological Sciences, 123, 132–139. 
https://doi.org/10.1254/jphs.13093FP 
Laflamme, N., Nappi, R. E., Drolet, G., Labrie, C., & Rivest, S. (1998). Expression and 
neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) 
throughout the rat brain: anatomical evidence of distinct roles of each subtype. 
Journal of Neurobiology, 36, 357–378. 
Landgraf, R., & Neumann, I. D. (2004). Vasopressin and oxytocin release within the 
brain: A dynamic concept of multiple and variable modes of neuropeptide 
communication. Frontiers in Neuroendocrinology. 
https://doi.org/10.1016/j.yfrne.2004.05.001 
Lee, H., Yamanouchi, K., & Nishihara, M. (206AD). Effects of perinatal exposure to 
phthalate/adipate esters on hypothalamic gene expression and sexual behavior in 
rats. J Reprod Dev, 52(3), 343–352. 
Lee, H. J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008). A 
conditional knockout mouse line of the oxytocin receptor. Endocrinology, 149, 
3256–3263. https://doi.org/10.1210/en.2007-1710 
Leng, G., Brown, C. H., & Russell, J. A. (1999). Physiological pathways regulating the 
activity of magnocellular neurosecretory cells. Progress in Neurobiology. 
https://doi.org/10.1016/S0301-0082(98)00072-0 
Levine, S. (2001). Primary social relationships influence the development of the 
hypothalamic--pituitary--adrenal axis in the rat. Physiology & Behavior, 73(3), 
255–60. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11438350 
Lin, Y., Pessah, I. N., & Puschner, B. (2013). Simultaneous determination of 
polybrominated diphenyl ethers and polychlorinated biphenyls by gas 
chromatography-tandem mass spectrometry in human serum and plasma. Talanta, 
113, 41–8. https://doi.org/10.1016/j.talanta.2013.04.001 
Ludwig, M. (1995). Functional role of intrahypothalamic release of oxytocin and 
vasopressin: consequences and controversies. The American Journal of 
Physiology, 268, E537–E545. 
 165 
 
Margaret R. Bell, Lindsay M. Thompson, Karla Rodriguez, A. C. G. (2015). Two-hit 
exposure to polychlorinated biphenyls at gestational and juvenile life stages: 1. 
Sexually dimorphic effects on social and anxiety-like behaviors Margaret. 
Hormones and Behavior, 78, 168–177. 
https://doi.org/10.1177/0963721412473755.Surging 
Meaney, M. J., & Stewart, J. (1979). Environmental factors influencing the affiliative 
behavior of male and female rats (Rattus norvegicus). Animal Learning & 
Behavior. https://doi.org/10.3758/BF03209692 
Milenkovic, M., Diaz-Garcia, C., Wallin, A., & Brännström, M. (2012). Viability and 
function of the cryopreserved whole rat ovary: comparison between slow-freezing 
and vitrification. Fertility and Sterility, 1–7. 
https://doi.org/10.1016/j.fertnstert.2012.01.123 
Miller, M. A., Urban, J. H., & Dorsa, D. M. (1989). Steroid dependency of vasopressin 
neurons in the bed nucleus of the stria terminalis by in situ hybridization. 
Endocrinology, 125, 2335–2340. https://doi.org/10.1210/endo-125-5-2335 
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., … 
Crawley, J. N. (2004). Sociability and preference for social novelty in five inbred 
strains: An approach to assess autistic-like behavior in mice. Genes, Brain and 
Behavior, 3, 287–302. https://doi.org/10.1111/j.1601-1848.2004.00076.x 
Murakami, G., Hunter, R. G., Fontaine, C., Ribeiro, a, & Pfaff, D. (2011). Relationships 
among estrogen receptor, oxytocin and vasopressin gene expression and social 
interaction in male mice. The European Journal of Neuroscience, 34(3), 469–77. 
https://doi.org/10.1111/j.1460-9568.2011.07761.x 
Nadler, J. J., Moy, S. S., Dold, G., Trang, D., Simmons, N., Perez, A., … Crawley, J. N. 
(2004). Automated apparatus for quantitation of social approach behaviors in 
mice. Genes, Brain and Behavior, 3, 303–314. https://doi.org/10.1111/j.1601-
183X.2004.00071.x 
Nishizuka, M., & Arai, D. Y. (1983). Male-female differences in the intra-amygdaloid 
input to the medial amygdala. Experimental Brain Research, 52(3), 328–332. 
https://doi.org/10.1007/BF00238027 
Noonan, L. R., Continella, G., & Pedersen, C. A. (1989). Neonatal administration of 
oxytocin increases novelty-induced grooming in the adult rat. Pharmacology, 
Biochemistry, and Behavior, 33, 555–558. https://doi.org/10.1016/0091-
3057(89)90386-9 
Norman W. Heimstra, A. L. M. (1962). Social Influence on the Reponse to Drugs: IV. 
Stimulus Factors. The Psychological Record, 12, 383–386. 
 166 
Ostby, J., Monosson, E., & Gray, L. E. (1999). Environmental antiandrogens: Low doses 
of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicology 
and Industrial Health, 15(2), 48–64. 
https://doi.org/10.1177/074823379901500106 
Padmanabhan, V., Cardoso, R. C., & Puttabyatappa, M. (2016). Developmental 
programming, a pathway to disease. Endocrinology. 
https://doi.org/10.1210/en.2016-1003 
Paredes, R. G., Tzschentke, T., & Nakach, N. (1998). Lesions of the medial preoptic 
area/anterior hypothalamus (MPOA/AH) modify partner preference in male rats. 
Brain Research, 813(1), 1–8. https://doi.org/10.1016/S0006-8993(98)00914-7 
Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time 
RT-PCR. Nucleic Acids Research, 29, e45. https://doi.org/10.1093/nar/29.9.e45 
Phoenix, C. H., Goy, R. W., Gerall, A. A., & Young, W. C. (1959). ORGANIZING 
ACTION OF PRENATALLY ADMINISTERED TESTOSTERONE 
PROPIONATE ON THE TISSUES MEDIATING MATING BEHAVIOR IN 
THE FEMALE GUINEA PIG, 65(3), 369–382. 
Picton, H. M., Kim, S. S., & Gosden, R. G. (2000). Cryopreservation of gonadal tissue 
and cells. British Medical Bulletin, 56(3), 603–15. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11255548 
Pierman, S., Sica, M., Allieri, F., Viglietti-Panzica, C., Panzica, G. C., & Bakker, J. 
(2008). Activational effects of estradiol and dihydrotestosterone on social 
recognition and the arginine-vasopressin immunoreactive system in male mice 
lacking a functional aromatase gene. Hormones and Behavior, 54(1), 98–106. 
https://doi.org/10.1016/j.yhbeh.2008.02.001 
Platt, J. R. (1964). Strong Inference, 146(3642), 347–353. 
Porrini, S., Belloni, V., Seta, D. Della, Farabollini, F., Giannelli, G., & Dessì-Fulgheri, F. 
(2005). Early exposure to a low dose of bisphenol A affects socio-sexual behavior 
of juvenile female rats. In Brain Research Bulletin (Vol. 65, pp. 261–266). 
https://doi.org/10.1016/j.brainresbull.2004.11.014 
Poster, P.-, & Lyon, C. B. (n.d.). ART , laboratory : cryopreservation of gonads P-404 
Poster ART , laboratory : embryo selection. Perfusion, (July 2007), 157–158. 
Reilly, M. P., Weeks, C. D., Topper, V. Y., Thompson, L. M., Crews, D., & Gore, A. C. 
(2015). The effects of prenatal PCBs on adult social behavior in rats. Hormones 
and Behavior, 73(3), 47–55. https://doi.org/10.1016/j.yhbeh.2015.06.002 
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005). 
A transmembrane intracellular estrogen receptor mediates rapid cell signaling. 
Science (New York, N.Y.), 307, 1625–1630. 
https://doi.org/10.1126/science.1106943 
 167 
Roselli, C. E., Horton, L. E., & Resko, J. A. (1985). Distribution and regulation of 
aromatase activity in the rat hypothalamus and limbic system. Endocrinology, 
117(6), 2471–2477. https://doi.org/10.1210/endo-117-6-2471 
Roselli, C. E., Larkin, K., Schrunk, J. M., & Stormshak, F. (2004). Sexual partner 
preference, hypothalamic morphology and aromatase in rams. Physiology and 
Behavior. https://doi.org/10.1016/j.physbeh.2004.08.017 
Ross, H. E., & Young, L. J. (2009). Oxytocin and the neural mechanisms regulating 
social cognition and affiliative behavior. Frontiers in Neuroendocrinology. 
https://doi.org/10.1016/j.yfrne.2009.05.004 
Sakamoto, H., Matsuda, K. I., Hosokawa, K., Nishi, M., Morris, J. F., Prossnitz, E. R., & 
Kawata, M. (2007). Expression of G protein-coupled receptor-30, a G protein-
coupled membrane estrogen receptor, in oxytocin neurons of the rat 
paraventricular and supraoptic nuclei. Endocrinology, 148, 5842–5850. 
https://doi.org/10.1210/en.2007-0436 
Sawchenko, P. E. (1987). Evidence for differential regulation of corticotropin-releasing 
factor and vasopressin immunoreactivities in parvocellular neurosecretory and 
autonomic-related projections of the paraventricular nucleus. Brain Research, 
437(2), 253–263. https://doi.org/10.1016/0006-8993(87)91641-6 
Schug, T. T., Janesick, A., Blumberg, B., & Heindel, J. J. (2011). Endocrine disrupting 
chemicals and disease susceptibility. Journal of Steroid Biochemistry and 
Molecular Biology. https://doi.org/10.1016/j.jsbmb.2011.08.007 
Scordalakes, E. M., & Rissman, E. F. (2004). Aggression and arginine vasopressin 
immunoreactivity regulation by androgen receptor and estrogen receptor α. 
Genes, Brain and Behavior, 3(1), 20–26. https://doi.org/10.1111/j.1601-
183X.2004.00036.x 
Shapiro, R. A., Xu, C., & Dorsa, D. M. (2000). Differential transcriptional regulation of 
rat vasopressin gene expression by estrogen receptor alpha and beta. 
Endocrinology, 141, 4056–4064. 
Shekhar, P. V. M., Werdell, J., & Basrur, V. S. (1997). Environmental estrogen 
stimulation of growth and estrogen receptor function in preneoplastic and 
cancerous human breast cell lines. Journal of the National Cancer Institute, 
89(23), 1774–1782. https://doi.org/10.1093/jnci/89.23.1774 
Shughrue, P. J., Lane, M. V, & Merchenthaler, I. (1997). Comparative distribution of 
estrogen receptor-alpha and -beta mRNA in the rat central nervous system. The 
Journal of Comparative Neurology, 388, 507–525. 
https://doi.org/10.1002/(SICI)1096-9861(19971201)388:4<507::AID-
CNE1>3.0.CO;2-6 [pii] 
 168 
Siviy, S. M., & Panksepp, J. (2011). In search of the neurobiological substrates for social 
playfulness in mammalian brains. Neuroscience and Biobehavioral Reviews, 
35(9), 1821–30. https://doi.org/10.1016/j.neubiorev.2011.03.006 
 
Slamberová, R., Mikulecká, A., Pometlová, M., Schutová, B., Hrubá, L., & Deykun, K. 
(2011). Sex differences in social interaction of methamphetamine-treated rats. 
Behavioural Pharmacology, 22, 617–623. 
https://doi.org/10.1097/FBP.0b013e32834afea4 
So, N., Franks, B., Lim, S., & Curley, J. P. (2015). Associations between Mouse Social 
Dominance and Brain Gene Expression, 1–27. 
https://doi.org/10.1371/journal.pone.0134509 
Sobolewski, M., Conrad, K., Allen, J. L., Weston, H., Martin, K., Lawrence, B. P., & 
Cory-Slechta, D. a. (2014). Sex-specific enhanced behavioral toxicity induced by 
maternal exposure to a mixture of low dose endocrine-disrupting chemicals. 
Neurotoxicology, 45C, 121–130. https://doi.org/10.1016/j.neuro.2014.09.008 
Stack, A., Carrier, N., Dietz, D., Hollis, F., Sorenson, J., & Kabbaj, M. (2010). Sex 
differences in social interaction in rats: role of the immediate-early gene zif268. 
Neuropsychopharmacology : Official Publication of the American College of 
Neuropsychopharmacology, 35, 570–580. https://doi.org/10.1038/npp.2009.163 
Steinberg, R. M., Walker, D. M., Juenger, T. E., Woller, M. J., & Gore, A. C. (2008). 
Effects of perinatal polychlorinated biphenyls on adult female rat reproduction: 
development, reproductive physiology, and second generational effects. Biology 
of Reproduction, 78, 1091–1101. https://doi.org/10.1095/biolreprod.107.067249 
Steinberg, R. M., Juenger, T. E., & Gore, A. C. (2007). The effects of prenatal PCBs on 
adult female paced mating reproductive behaviors in rats. Hormones and 
Behavior, 51, 364–372. https://doi.org/10.1016/j.yhbeh.2006.12.004 
Stewart, P. W., Lonky, E., Reihman, J., Pagano, J., Gump, B. B., & Darvill, T. (2008). 
The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-
old children. Environmental Health Perspectives, 116(10), 1416–1422. 
https://doi.org/10.1289/ehp.11058 
Sullivan, A. W., Beach, E. C., Stetzik, L. A., Perry, A., D’Addezio, A. S., Cushing, B. S., 
& Patisaul, H. B. (2014). A novel model for neuroendocrine toxicology: 
Neurobehavioral effects of BPA exposure in a prosocial species, the prairie vole 
(Microtus ochrogaster). Endocrinology, en20141379. 
https://doi.org/10.1210/en.2014-1379 
Sun, Y., Huang, H., Sun, Y., Wang, C., Shi, X. L., Hu, H. Y., … Fujie, K. (2013). 
Ecological risk of estrogenic endocrine disrupting chemicals in sewage plant 
effluent and reclaimed water. Environmental Pollution. 
https://doi.org/10.1016/j.envpol.2013.05.006 
 169 
Suzuki, S., & Handa, R. J. (2005). Estrogen receptor-??, but not estrogen receptor-??, is 
expressed in prolactin neurons of the female rat paraventricular and supraoptic 
nuclei: Comparison with other neuropeptides. Journal of Comparative Neurology, 
484, 28–42. https://doi.org/10.1002/cne.20457 
Takagi, Y., Aburada, S., Hashimoto, K., & Kitaura, T. (1986). Transfer and distribution 
of accumulated (14C) polychlorinated biphenyls from maternal to fetal and 
suckling rats. Archives of Environmental Contamination and Toxicology, 15(6), 
709–715. https://doi.org/10.1007/bf01054917 
Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., … 
Nishimori, K. (2005). Pervasive social deficits, but normal parturition, in oxytocin 
receptor-deficient mice. Proceedings of the National Academy of Sciences of the 
United States of America, 102, 16096–16101. 
https://doi.org/10.1073/pnas.0505312102 
Tang, A. C., Nakazawa, M., Romeo, R. D., Reeb, B. C., Sisti, H., & McEwen, B. S. 
(2005). Effects of long-term estrogen replacement on social investigation and 
social memory in ovariectomized C57BL/6 mice. Hormones and Behavior, 47(3), 
350–357. https://doi.org/10.1016/j.yhbeh.2004.10.010 
Thomas, G. M., & Huganir, R. L. (2004). MAPK cascade signalling and synaptic 
plasticity. Nature Reviews Neuroscience, 5(3), 173–183. 
https://doi.org/10.1038/nrn1346 
Topper, V. Y., Walker, D. M., & Gore, A. C. (2015). Sexually dimorphic effects of 
gestational endocrine-disrupting chemicals on microRNA expression in the 
developing rat hypothalamus. Molecular and Cellular Endocrinology, 414, 42–
52. https://doi.org/10.1016/j.mce.2015.07.013 
Uhlenhaut, N. H., Jakob, S., Anlag, K., Eisenberger, T., Sekido, R., Kress, J., … Treier, 
M. (2009). Somatic sex reprogramming of adult ovaries to testes by FOXL2 
ablation. Cell, 139(6), 1130–42. https://doi.org/10.1016/j.cell.2009.11.021 
Unni, S., Kasiviswanathan, S., D’Souza, S., Khavale, S., Mukherjee, S., Patwardhan, S., 
& Bhartiya, D. (2012). Efficient cryopreservation of testicular tissue: effect of 
age, sample state, and concentration of cryoprotectant. Fertility and Sterility, 
97(1), 200–8.e1. https://doi.org/10.1016/j.fertnstert.2011.10.018 
Veenit, V., Cordero, M. I., Tzanoulinou, S., & Sandi, C. (2013). Increased corticosterone 
in peripubertal rats leads to long-lasting alterations in social exploration and 
aggression. Frontiers in Behavioral Neuroscience, 7, 26. 
https://doi.org/10.3389/fnbeh.2013.00026 
Vela, J. (2005). Sexual behavior of female rats in a multiple-partner preference test, 47, 
290–296. https://doi.org/10.1016/j.yhbeh.2004.11.012 
Vela, J. (2005). Sexual behavior of female rats in a multiple-partner preference test, 47, 
290–296. https://doi.org/10.1016/j.yhbeh.2004.11.012 
 170 
Venerosi, A., Ricceri, L., Tait, S., & Calamandrei, G. (2012). Sex dimorphic behaviors as 
markers of neuroendocrine disruption by environmental chemicals: The case of 
chlorpyrifos. NeuroToxicology, 33, 1420–1426. 
https://doi.org/10.1016/j.neuro.2012.08.009 
Viau, V., & Meaney, M. J. (1991). Variations in the hypothalamic-pituitary-adrenal 
response to stress during the estrous cycle in the rat. Endocrinology, 129, 2503–
2511. https://doi.org/10.1210/endo-129-5-2503 
Walker, D. M., Goetz, B. M., & Gore, A. C. (2013). Dynamic postnatal developmental 
and sex-specific neuroendocrine effects of prenatal PCBs in rats. Molecular 
Endocrinology (Baltimore, Md.), 1–17. https://doi.org/10.1210/me.2013-1270 
Walker, D. M., Kirson, D., Perez, L. F., & Gore, A. C. (2012). Molecular profiling of 
postnatal development of the hypothalamus in female and male rats. Biology of 
Reproduction, 87, 129. https://doi.org/10.1095/biolreprod.112.102798 
Walker, D. M., Juenger, T. E., & Gore, A. C. (2009). Developmental profiles of 
neuroendocrine gene expression in the preoptic area of male rats. Endocrinology, 
150, 2308–2316. https://doi.org/10.1210/en.2008-1396 
Walker, D. M., Kermath, B. A., Woller, M. J., & Gore, A. C. (2013). Disruption of 
reproductive aging in female and male rats by gestational exposure to estrogenic 
endocrine disruptors. Endocrinology, 154, 2129–2143. 
https://doi.org/10.1210/en.2012-2123 
Wang, Z., & De Vries, G. J. (1993). Testosterone effects on paternal behavior and 
vasopressin immunoreactive projections in priarie voles (Microtus ochrogaster). 
Brain Research, 631, 156–160. https://doi.org/10.1016/0006-8993(93)91203-5 
Weissbrod, A., Shapiro, A., Vasserman, G., Edry, L., Dayan, M., Yitzhaky, A., … 
Kimchi, T. (2013). Automated long-term tracking and social behavioural 
phenotyping of animal colonies within a semi-natural environment. Nature 
Communications, 4, 2018. Retrieved from http://dx.doi.org/10.1038/ncomms3018 
Wersinger, S. R., R. Kelliher, K., Zufall, F., Lolait, S. J., O’Carroll, A. M., & Young, W. 
S. (2004). Social motivation is reduced in vasopressin 1b receptor null mice 
despite normal performance in an olfactory discrimination task. Hormones and 
Behavior, 46, 638–645. https://doi.org/10.1016/j.yhbeh.2004.07.004 
Williams, S. A., Jasarevic, E., Vandas, G. M., Warzak, D. A., Geary, D. C., Ellersieck, 
M. R., … Rosenfeld, C. S. (2013). Effects of Developmental Bisphenol A 
Exposure on Reproductive-Related Behaviors in California Mice (Peromyscus 
californicus): A Monogamous Animal Model. PLoS ONE, 8. 
https://doi.org/10.1371/journal.pone.0055698 
 
 171 
Williams, S. A., Jasarevic, E., Vandas, G. M., Warzak, D. A., Geary, D. C., Ellersieck, 
M. R., … Rosenfeld, C. S. (2013). Effects of Developmental Bisphenol A 
Exposure on Reproductive-Related Behaviors in California Mice (Peromyscus 
californicus): A Monogamous Animal Model. PLoS ONE, 8. 
https://doi.org/10.1371/journal.pone.0055698 
Witty, C. F., Foster, T. C., Semple-Rowland, S. L., & Daniel, J. M. (2012). Increasing 
Hippocampal Estrogen Receptor Alpha Levels via Viral Vectors Increases MAP 
Kinase Activation and Enhances Memory in Aging Rats in the Absence of 
Ovarian Estrogens. PLoS ONE, 7(12), 1–10. 
https://doi.org/10.1371/journal.pone.0051385 
Wolf, C., Gerald Leblanc, Ostby, J., & Gray, L. (2000). Characterization of the Period of 
Sensitivity of Fetal Male Sexual Development to Vinclozolin. Toxicol. Sci., 55(1), 
152–161. 
Wolstenholme, J. T., Goldsby, J. A., & Rissman, E. F. (2013). Transgenerational effects 
of prenatal bisphenol A on social recognition. Hormones and Behavior, 64, 833–
839. https://doi.org/10.1016/j.yhbeh.2013.09.007 
Wolstenholme, J. T., Taylor, J. A., Shetty, S. R. J., Edwards, M., Connelly, J. J., & 
Rissman, E. F. (2011). Gestational exposure to low dose bisphenol a alters social 
behavior in juvenile mice. PLoS ONE, 6. 
https://doi.org/10.1371/journal.pone.0025448 
Young, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006). The vasopressin 1b 
receptor is prominent in the hippocampal area CA2 where it is unaffected by 
restraint stress or adrenalectomy. Neuroscience, 143(4), 1031–1039. 
https://doi.org/10.1016/j.neuroscience.2006.08.040 
Zhang, W., Sargis, R. M., Volden, P. A., Carmean, C. M., Sun, X. J., & Brady, M. J. 
(2012). PCB 126 and other dioxin-like PCBs specifically suppress hepatic 
PEPCK expression via the aryl hydrocarbon receptor. PLoS ONE, 7(5). 
https://doi.org/10.1371/journal.pone.0037103 
Zingg, H. H., & Lefebvre, D. L. (1988). Oxytocin and vasopressin gene expression 
during gestation and lactation. Brain Res, 464  
 
 
 
